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Background: Heavy alcohol consumption is associated with an increased risk of postoperative
complications and extended hospital stay. Alcohol consumption therefore represents a modifiable risk
factor for surgical outcomes. Brief behavioural interventions have been shown to be effective in reducing
alcohol consumption among increased risk and risky drinkers in other health-care settings and may offer a
method of addressing preoperative alcohol consumption.
Objectives: To investigate the feasibility of introducing a screening process to assess adult preoperative
drinking levels and to deliver a brief behavioural intervention adapted for the target population group.
To conduct a two-arm (brief behavioural intervention plus standard preoperative care vs. standard
preoperative care alone), multicentre, pilot randomised controlled trial to assess the feasibility of
proceeding to a definitive trial. To conduct focus groups and a national web-based survey to establish
current treatment as usual for alcohol screening and intervention in preoperative assessment.
Design: A single-centre, qualitative, feasibility study was followed by a multicentre, two-arm (brief
behavioural intervention vs. treatment as usual), individually randomised controlled pilot trial with an
embedded qualitative process evaluation. Focus groups and a quantitative survey were employed to
characterise treatment as usual in preoperative assessment.
Setting: The feasibility study took place at a secondary care hospital in the north-east of England.
The pilot trial was conducted at three large secondary care centres in the north-east of England.
Participants: Nine health-care professionals and 15 patients (mean age 70.5 years, 86.7% male)
participated in the feasibility study. Eleven health-care professionals and 68 patients (mean age 66.2 years,
80.9% male) participated in the pilot randomised trial. An additional 19 health-care professionals were
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recruited to one of three focus groups, while 62 completed an electronic survey to characterise treatment
as usual.
Interventions: The brief behavioural intervention comprised two sessions. The first session, delivered face
to face in the preoperative assessment clinic, involved 5 minutes of structured brief advice followed by
15–20 minutes of behaviour change counselling, including goal-setting, problem-solving and identifying
sources of social support. The second session, an optional booster, took place approximately 1 week
before surgery and offered the opportunity to assess progress and boost self-efficacy.
Main outcome measures: Feasibility was assessed using rates of eligibility, recruitment and retention.
The progression criteria for a definitive trial were recruitment of ≥ 40% of eligible patients and retention
of ≥ 70% at 6-month follow-up. Acceptability was assessed using themes identified in qualitative data.
Results: The initial recruitment of eligible patients was low but improved with the optimisation of recruitment
processes. The recruitment of eligible participants to the pilot trial (34%) fell short of the progression criteria
but was mitigated by very high retention (96%) at the 6-month follow-up. Multimethod analyses identified the
methods as acceptable to the patients and professionals involved and offers recommendations of ways to
further improve recruitment.
Conclusions: The evidence supports the feasibility of a definitive trial to assess the effectiveness of brief
behavioural intervention in reducing preoperative alcohol consumption and for secondary outcomes of
surgical complications if recommendations for further improvements are adopted.
Trial registration: Current Controlled Trials ISRCTN36257982.
Funding: This project was funded by the National Institute for Health Research Health Technology
Assessment programme and will be published in full in Health Technology Assessment; Vol. 24, No. 12.
See the National Institute for Health Research Journals Library website for further project information.
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Glossary
Abstainer A person who does not drink alcohol.
Abstinence Never consuming alcohol.
Alcohol Ethanol (ethyl alcohol) the psychoactive ingredient of alcoholic drinks.
Alcohol dependence A cluster of behavioural, cognitive and physiological factors including craving
alcohol, tolerance, continuing to drink despite experiencing the harmful consequences and prioritising
alcohol consumption over other activities and obligations.
Alcohol misuse A term used to capture both alcohol dependence and higher-risk (‘harmful’) drinking.
Alcohol use disorder(s) A range of alcohol-related mental health problems including alcohol
dependence, higher-risk drinking (previously harmful drinking) and increased risk drinking (previously
hazardous drinking) recognised in the international disease classification systems [International Statistical
Classification of Diseases and Related Health Problems, Tenth Revision (ICD-10), and Diagnostic and
Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV)].
Alcohol Use Disorders Identification Test A validated alcohol screening tool to assess the presence
of increased risk and higher-risk alcohol consumption and to identify possible instances of alcohol
dependence requiring further assessment.
Alcohol Use Disorders Identification Test Consumption A validated alcohol screening tool consisting
of the three consumption-focused questions (the first three questions) of the Alcohol Use Disorders
Identification Test.
Alcohol withdrawal Physical symptoms resulting from a reduction in the amount of alcohol consumed or
the complete cessation of alcohol consumption.
Alcoholic drink A beverage containing ethanol.
Binge drinking Single-occasion high-volume alcohol consumption, specifically the consumption of six or
more units of alcohol on one occasion.
Blood alcohol concentration The concentration of alcohol in the blood.
CAGE questionnaire A four-question validated screening tool used to identify the presence of possible
alcohol dependence.
Dependence See Alcohol dependence.
Feasibility study A research study used to assess the practicality of planned methods.
Harmful drinking Previously used to describe a pattern of alcohol consumption resulting in mental or
physical harm. Now termed ‘higher-risk’ drinking.
Hazardous drinking Previously used to describe a pattern of alcohol consumption that increases an
individual’s risk of experiencing harm. Now termed ‘increased risk’ drinking.
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Lower-risk drinking guidelines Guidelines set by the UK Government detailing amounts of alcohol and
patterns of alcohol consumption that can be consumed without a serious impact on health.
Pilot randomised controlled trial A small-scale randomised controlled trial employed to determine the
feasibility of a full trial and to inform the design of such a trial.
Preoperative assessment An assessment focused on identifying factors and comorbidities that may
present a risk of complications during anaesthesia, during surgery or in the postoperative period.
Preoperative assessment clinic A hospital clinic dedicated to conducting assessments of patients prior
to surgery.
Randomised controlled trial A trial in which individuals are randomly allocated to two or more groups,
one of which (the control) is ‘treatment as usual’ or no treatment.
Randomised trial A trial in which individuals are randomly allocated to two or more groups.
Risky drinking Drinking alcohol in a way that increases the person’s chance of experiencing physical,
mental or social harm, specifically drinking in excess of the lower-risk drinking guidelines. In this report, the
term it is used to capture both ‘increased risk’ and ‘higher-risk’ (formerly harmful and hazardous) drinking
but not alcohol dependence.
Standard drink A measurement of alcoholic drinks. In the UK, one standard drink contains 8 g or 10 ml
of ethanol and is equivalent to 1 unit.
Unit A standardised measurement of alcoholic drinks. One unit contains 8 g or 10 ml of ethanol.
GLOSSARY
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List of abbreviations
AUDIT Alcohol Use Disorders Identification
Test
AUDIT-C Alcohol Use Disorders Identification
Test Consumption
BA brief advice
BBI brief behavioural intervention
BCT behaviour change technique
BI brief intervention
BMI body mass index
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CONSORT Consolidated Standards of
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CQUIN Commissioning for Quality and
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GP general practitioner
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MAST Michigan Alcoholism Screening Test
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Plain English summary
Most patients undergoing knee and hip replacements are over 65 years old. Older patients have anincreased risk of complications following surgery.
Heavy alcohol consumption in the weeks before surgery increases the risk of complications after surgery,
which can extend recovery times. Advice that helps patients reduce their alcohol consumption before
surgery may have benefits for recovery.
The PRE-OP BIRDS study had two parts: a feasibility study followed by a pilot randomised controlled trial with
focus groups and an electronic survey used to characterise usual care in the preoperative assessment clinic.
The feasibility study took place at one hospital. It aimed to develop materials that help health-care professionals
provide brief advice to patients on how to reduce alcohol consumption before surgery. This brief advice was
delivered to eligible patients and the acceptability to staff and patients was assessed in interviews.
The pilot trial took place in three hospitals. Patients who agreed to take part were placed, by equal chance,
into either a group that received usual care or a group that received usual care plus brief advice about reducing
alcohol use. The aim was to count how many people agreed to take part and how many also agreed to
complete a follow-up 6 months later. Interviews were carried out with patients and staff to explore their views
on the intervention and the trial as a whole.
All of this information was collected to help decide if a future larger trial was possible. This work found that
the tools used were acceptable to both patients and staff. Although the number of people who agreed to
take part was smaller than hoped, almost all of those who took part also completed the 6-month follow-up.
Therefore, a future larger trial was found to be possible, but some changes could be made to encourage
more people to take part.
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Scientific summary
Background
Increased preoperative alcohol consumption is associated with an increased risk of postoperative complications
and extended length of hospital stay following surgery. Many of the physiological effects of alcohol
consumption can be reduced or reversed within 2–7 weeks. As such, reducing alcohol consumption before
surgery represents a modifiable target to improve postoperative outcomes. Previous evidence has identified
a benefit of pharmacological interventions for alcohol cessation for dependent drinkers. However, aiming
these interventions specifically at patients with preoperative alcohol dependency would have limited effect
on outcomes, given that these patients represent only a small proportion of those at risk because of
alcohol consumption.
By contrast, brief behavioural interventions have shown effectiveness in reducing alcohol consumption in
the larger population of ‘increased risk’ and ‘risky drinkers’ in other health-care settings. These interventions
may offer one method of addressing alcohol intake reduction in a significantly higher proportion of surgical
patients, than concentrating on the alcohol dependent group, thereby increasing the possible impact on
associated postoperative complications.
Our study aimed to investigate the feasibility and acceptability of a brief behavioural intervention to reduce
alcohol consumption before surgery in patients being listed for elective orthopaedic surgery.
Objectives
The primary objectives of the project were to:
1. investigate the feasibility of introducing a screening process to assess adult preoperative drinking levels
and to deliver a brief behavioural intervention adapted for the target population group
2. conduct a two-arm (brief behavioural intervention plus standard preoperative care vs. standard
preoperative care alone) multicentre, pilot randomised controlled trial to test processes that would be
used in a definitive trial and, hence, assess the feasibility of proceeding to a definitive trial
3. conduct focus groups and a national web-based survey to establish current treatment as usual
regarding alcohol screening and intervention in preoperative assessment.
Each aspect of the project (feasibility, pilot randomised controlled trial, characterising treatment as usual)
had its own specific secondary objectives.
Methods
This was a non-randomised feasibility study conducted at a single secondary care hospital site followed by
a three-centre pilot randomised controlled trial.
The feasibility study commenced with a group training session that enabled health-care professionals employed
in the preoperative assessment clinic to conduct screening and intervention. Following this, potential participants
were approached in a surgical outpatient clinic and asked to complete the Alcohol Use Disorders Identification
Test Consumption screening tool. Patients who screened eligible (Alcohol Use Disorders Identification Test
Consumption score of ≥ 5 and drinking six or more standard drinks on a single occasion at least weekly) were
provided with a verbal introduction to the study; those who expressed interest were provided with a copy of the
DOI: 10.3310/hta24120 HEALTH TECHNOLOGY ASSESSMENT 2020 VOL. 24 NO. 12
© Queen’s Printer and Controller of HMSO 2020. This work was produced by Snowden et al. under the terms of a commissioning contract issued by the Secretary of State for
Health and Social Care. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional
journals provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should
be addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science
Park, Southampton SO16 7NS, UK.
xxv
patient information sheet and completed the expression of interest form giving their permission to be contacted
further about the study. Research staff contacted patients by telephone or e-mail to confirm ongoing interest
in the study and arrange intervention delivery. On the day of the preoperative assessment, patients were met
by a member of the research team and completed the consent process before completing the full Alcohol Use
Disorders Identification Test questionnaire. Those who scored ≥ 8, indicating that they were drinking at risky
levels, received the brief behavioural intervention.
In the pilot randomised controlled trial, group training sessions covering the delivery of preoperative
alcohol screening and brief intervention were provided to health-care professionals employed in the
preoperative assessment clinic. Patients were initially approached either in a surgical outpatient clinic or by
post and then by telephone and asked to complete Alcohol Use Disorders Identification Test Consumption
screening. Patients who were screened as eligible (Alcohol Use Disorders Identification Test Consumption
score of ≥ 5) were provided with a verbal introduction to the study. Those who expressed interest were
given or sent a copy of the patient information sheet. Ongoing expression of interest was gauged after a
minimum of 24 hours. Consent, randomisation, baseline assessment and, where appropriate, intervention
were conducted in the preoperative assessment clinic. Patients were followed up at 1 week pre surgery
(intervention group only), 1–3 days pre surgery, 3–5 days post surgery, 6 weeks post surgery and 6 months
post intervention.
Patient and health-care professional participants had the option of participating in qualitative interviews
about their experience of taking part in the trial.
In both the feasibility study and the pilot randomised controlled trial, intervention sessions were audio-
recorded (when patients provided consent for this) and an assessment of the fidelity of delivery was carried
out. Fidelity assessments employed a predefined standardised checklist of 18 behaviour change techniques.
Treatment as usual was characterised through focus groups (n = 3 groups) with health-care professionals
involved in the surgical care pathway at the three sites included in the pilot randomised controlled trial
(n = 19 participants) and a quantitative online survey of health-care professionals employed in preoperative
assessment centres across the country.
Results
The initial recruitment of eligible patients to the feasibility study was low but improved with amendments to
optimise the screening and recruitment process. Fifteen patients and nine health-care professionals consented
to participate in the feasibility study, with 13 patients and three health-care professionals going on to
participate in qualitative interviews about their experience of being involved in the study. Interviews identified
the optimised screening and intervention processes as broadly acceptable. However, patient participants
rejected any categorisation of themselves as ‘risky drinkers’ and showed poor understanding of the term
‘standard drink’. Interviews with health-care professionals also identified some barriers to intervention delivery,
including not having adequate time available and the need for regular delivery of interventions in order to gain
experience and familiarity with the process.
Recruitment to the pilot randomised controlled trial was 85% of target, with 34% of eligible patients
recruited to the trial. The most frequent reason patients were found ineligible was negative Alcohol Use
Disorders Identification Test Consumption screen. The most frequent reasons eligible patients declined
participation were lack of interest and not having enough time.
Retention at 6 months post consent was very high (96% at 6-month follow-up) and was complemented by small
numbers of missing data on the proposed primary outcome measure (Alcohol Use Disorders Identification Test).
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Compliance with randomisation was high, with 32 of the 33 patient participants allocated to the intervention
arm receiving the intervention. Fidelity of delivery improved between the feasibility study (40%) and the pilot
trial (65.9%). The delivery of behaviour change techniques aimed at increasing motivation to change was
more consistent than the delivery of volitionally focused ones.
The results of the survey and focus groups show that treatment as usual relating to alcohol screening,
availability of advice and availability of referral varies between individuals and sites, with few employing
validated screening tools.
Conclusions
Preoperative alcohol screening using the Alcohol Use Disorders Identification Test Consumption and full Alcohol
Use Disorders Identification Test is acceptable to patients and health-care professionals. Similarly, delivering a
brief behavioural intervention in the preoperative assessment clinic is possible, and the intervention methods
adopted were acceptable to patients and health-care professionals. The evidence supports the feasibility of a
definitive trial to assess the effectiveness of these methods in bringing about reductions in preoperative alcohol
consumption and secondary outcomes of surgical complications.
Trial registration
This trial is registered as ISRCTN36257982.
Funding
This project was funded by the National Institute for Health Research Health Technology Assessment
programme and will be published in full in Health Technology Assessment; Vol. 24, No. 12. See the
National Institute for Health Research Journals Library website for further project information.
DOI: 10.3310/hta24120 HEALTH TECHNOLOGY ASSESSMENT 2020 VOL. 24 NO. 12
© Queen’s Printer and Controller of HMSO 2020. This work was produced by Snowden et al. under the terms of a commissioning contract issued by the Secretary of State for
Health and Social Care. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional
journals provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should
be addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science
Park, Southampton SO16 7NS, UK.
xxvii

Chapter 1 Introduction
Reproduced with permission from Snowden et al.1 This article is distributed under the terms of theCreative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/),
which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate
credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if
changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/
publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Structure of this report
This report documents a feasibility study and pilot randomised controlled trial (RCT) of brief behavioural
interventions (BBIs) to reduce alcohol consumption before elective orthopaedic surgery.
Chapter 1 describes the context of the issue, considering postoperative complications and the role of the
preoperative assessment clinic (PAC) in identifying and addressing surgical risk in the context of reducing
postoperative complications. This is followed by a review of the literature regarding brief interventions (BIs)
and alcohol-focused interventions in the perioperative period.
Chapter 2 details the development of the intervention, the intervention training package and research
conducted to characterise the comparator condition of ‘treatment as usual’ (TAU).
Chapter 3 presents the methods and results from the feasibility study, including qualitative interviews with
health-care professionals (HCPs) and patient participants.
Chapter 4 describes the methods and results of the pilot RCT, including rates of recruitment and retention
of patient participants, rates of completion of outcome measures and qualitative work exploring the
acceptability of processes to both patient and HCP participants.
The key findings of the project are summarised and discussed in Chapter 5, with conclusions and
recommendations for future research presented in Chapter 6.
Background
Perioperative morbidity and mortality after elective surgery is an important public health issue.2 Although
surgical mortality is reducing worldwide,3,4 even at the lowest mortality rate estimation of 1.1%, the
volume of surgery being performed means that approximately 85,000 patients per year will not survive to
30 days following surgery. By contrast, postoperative morbidity or ill health is more common than mortality
and remains at a relatively consistent level across sites and over time.3 This clinical paradox has led to the
accepted concept of ‘failure to rescue’, whereby the failure to identify and treat complications at an early
stage following surgery leads to early mortality.3,5
Although overall mortality rates remain important in a global sense,2 there has been a shift of focus to the
reduction of morbidity after both high- and low-risk surgeries.5 Postoperative complications have profound
implications in terms of both patient well-being4 and utilisation of health-care resource increasing the costs
of surgery two- to threefold.2,6,7
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The spectrum of alcohol use from abstinence to dependence is broad and can be subdivided in a number of
ways. The research and clinical literature has, and still does, employ a variety of terms, often interchangeably,
to describe different patterns of drinking. Many of these terms are included in the Glossary. Terms of specific
interest to this work are described here. In the UK, ‘lower-risk’ drinking is considered to be the consumption
of ≤ 14 units of alcohol per week (1 unit is 8 g of alcohol), with additional guidelines specifying that drinks
should be spread evenly over ≥ 3 days and that ‘binge drinking’ (i.e. the consumption of ≥ 6 units on a
single occasion) should be avoided. Any drinking above this level can be considered to increase the risk of
experiencing alcohol-related harm. The term ‘increased risk’ drinking has replaced the term ‘hazardous drinking’
and is used to describe patterns of alcohol consumption that exceed the lower-risk drinking guidelines and are
associated with an increased risk of experiencing harm as a result of alcohol consumption, although actual
harm may not yet have occurred. Regular consumption in the range of 15–35 units per week for women
and 15–50 units per week for men would usually fall into this category.8 Higher-risk drinking, previously
‘harmful drinking’, is a pattern of alcohol consumption that results in harm to physical or mental health,
with regular consumption in excess of 35 units per week for women and of 50 units per week for men.8
A number of screening tools have been developed to identify different patterns of alcohol use. One of the
most frequently employed in health-care settings is the Alcohol Use Disorders Identification Test (AUDIT).9,10
The AUDIT, originally developed by the World Health Organization9 and validated for use in medical settings,11
is a 10-item questionnaire that assesses alcohol consumption alongside social and health consequences of
drinking behaviour and indications of possible alcohol dependence.12 Scores range from 0 to 40 and a cut-off
point of ≥ 8 has been found to have a sensitivity of 92% and a specificity of 94% for detecting increased risk
or higher-risk drinking.9
Following the development of the AUDIT, a number of shorter variants have been developed. The Alcohol
Use Disorders Identification Test Consumption (AUDIT-C) measure, which comprises the first three items of
the AUDIT that focus on assessing frequency and volume of consumption as well as the frequency of high
intensity or binge drinking,13 has been shown to have a similar level of accuracy,14 including validity and
reliability, as the full AUDIT.13,15 With a cut-off point of 5, this measure has been found to have a sensitivity
of 74% and a specificity of 83% for detecting increased risk drinking.16
Orthopaedic surgery and postoperative complications
Among the elective orthopaedic surgical population, average rates of mortality (0.2–0.6%)17–19 and morbidity
(4–6%)17,20–22 are relatively low when compared with those for other surgical populations such as cardiac or
abdominal surgery. However, orthopaedic surgery is a high-volume elective specialty,23 meaning that even
low rates of mortality and morbidity can have a significant population impact. In 2017, over 100,000 primary
knee replacements and 90,000 total hip replacements were performed in England and Wales.24 The most
common complications include systemic infections and cardiovascular events (e.g. pulmonary embolism),
deep-vein thrombosis, wound infections, wound dehiscence, perioperative fracture and nerve injury.17,22
In general non-cardiac surgery, any complication is associated with an average 101% increase in hospital
costs.25 In orthopaedic surgery specifically, surgical site infections are associated with, approximately,
a 61% increase in costs.26
In addition, many elective orthopaedic procedures are performed in an older population. Advancing age
predisposes patients to an increased risk of acquired, multiple comorbidities, which in turn confer an
increased risk of post-surgical complications. As life expectancy continues to increase, more orthopaedic
procedures will be performed in older people, leading to an increase in overall surgical morbidity.17,22,27
Any perioperative intervention that aims to reduce known preoperative risk factors that predispose patients
to postoperative complications will be important in improving future postoperative outcomes.
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The role of the preoperative assessment clinic
Preoperative assessment clinics aim to assess patients’ suitability for elective surgery early in the surgical
pathway through the detection, optimisation and modification of coexisting conditions. Indirectly, these clinics
have been shown to reduce surgical cancellations and improve day-of-surgery arrival rates.28 Importantly, they
also provide an early opportunity to identify and address modifiable risk factors associated with postoperative
complications, an approach often referred to as ‘prehabilitation’. This approach has included interventions
to improve nutritional status, correct diet-induced iron deficiency anaemia,29 promote smoking cessation,30
reduce anxiety,31,32 provide patients with information regarding the perioperative pathway33,34 and increase
physical activity. Regarding the last, the promotion of structured exercise regimes has been shown to improve
aerobic fitness35,36 and enhance functional capacity both pre- and postoperatively in total knee arthroplasty
patients37 and decrease length of stay in hospital for adult surgical patients across a range of specialties.38
Preoperative alcohol intake also represents an important target for modifiable risk factor reduction.
Subsequent sections of this chapter present existing literature concerning the association of alcohol
consumption and postoperative outcomes, the identification and management of alcohol consumption
in the PAC and interventions that have been found to be effective in other clinical settings.
Alcohol consumption
Alcohol is a component cause of > 200 health conditions39 and has a range of negative social
consequences, including familial and relationship problems,40 involvement in crime,41,42 loss of productivity
and unemployment.43,44 Alcohol consumption is a leading cause of ill health globally, accounting for an
estimated 4.2% of the global burden, of disease and injury.45 In addition, alcohol-related harm represents
a large economic burden, with the combined cost of alcohol-related health harms, crime, antisocial
behaviour and loss of productivity in England estimated at £21B in 2012.46 Both volume of consumption
and drinking pattern are important predictors of alcohol-related health harms.45
With a dose–response relationship between alcohol consumption and many forms of harm, those who
consume the most alcohol, including those who are alcohol dependent, undoubtedly experience the
highest levels of alcohol-related harm at the individual level. However, because a far greater number of
individuals drink at increased risk and higher-risk levels, it is these drinking patterns that account for the
largest proportion of population-level alcohol-related harm.47 Therefore, it is this group, who drink in
excess of the lower-risk guidelines but are not alcohol dependent, who are a primary target of interventions
seeking to minimise alcohol-related harm,48 a phenomenon known as the prevention paradox.
Alcohol consumption and postoperative complications
The physiological effects of alcohol (e.g. liver damage, risk of accidental injury) may directly result in a need
for surgery, or may indirectly increase surgical risk. Of specific concern are systems that are inhibited by both
alcohol consumption and surgery. These include the haemostatic, immune, cardiac and endocrine systems.49
The same mechanisms by which moderate alcohol consumption can protect against the formation of
blood clots50 also place those with increased levels of alcohol consumption at increased risk of prolonged
bleeding during and after surgical procedures.51 Reduced immune system function as a result of alcohol
consumption is further inhibited by surgery52 and leaves the patient susceptible to both surgical site and
systemic infections; subclinical cardiac insufficiency and arrhythmias53 present increased risks of cardiac
complications and an altered endocrine stress response49,51 may also increase the risk of complications.
With this myriad of physiological effects of alcohol, it is not surprising that studies have identified
associations between alcohol intake and perioperative complication rates across a wide range of surgical
procedures (e.g. cardiac, orthopaedic and gastric). The complications most frequently associated with
alcohol use are infection, sepsis, bleeding, cardiac events and deep-vein thrombosis.51,54,55
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Within this literature, a number of studies have focused on those consuming ≥ 60 g of alcohol per day
and those identified as having alcohol use disorders (AUDs) or alcohol dependence.52,56 In 1999, a review51
identified a two- to threefold increase in postoperative morbidity among individuals consuming > 60 g of
alcohol per day for a minimum period of ‘several months’. However, the risk of increased postoperative
complication rates may not be limited to those identified as ‘alcohol misusers’ or those with alcohol use
disorder. Comparison of postoperative complication rates with scores on validated alcohol screening tools
has demonstrated that the incidence of complications increases with increased screening scores among all
adult drinkers. Bradley et al.57 identified that patients with an AUDIT-C score of ≥ 5 (score range 0–12)
were at increased risk of postoperative complications. Complication rates increased from 5.6% for those
scoring 0–4 on AUDIT-C to 14% for those scoring 11–12 on the screening tool.
In 2013, a review conducted by Eliasen et al.58 assessed the association between preoperative alcohol
consumption and postoperative complications across a wider population of drinkers than were included in
the review by Tønnesen and Kehlet.51 They found that alcohol consumption (of 24 g per day for women and
36 g per day for men) was associated with increased rates of postoperative complications, including a 23%
increased risk of wound complications, an 80% increased risk of pulmonary complications, a 24% increased
risk of prolonged hospital stay and a 29% increased risk of intensive care admission. Furthermore, high, but
not low to moderate (< 24 g per day for women and < 36 g per day for men), alcohol consumption was
associated with increased mortality. Two similar reviews by Wåhlin and Tønnesen59 and Shabanzadeh and
Sørensen60 in 2014 and 2015, respectively, concluded that the consumption of two or more standard drinks
per day is enough to increase the rate of postoperative complications.
This pattern of dose-dependent association of alcohol intake with postoperative complications is also
reported in orthopaedic surgical populations. Among patients undergoing total hip or knee arthroplasty,
those with high levels of alcohol use showed significantly higher incidences of complications (12 out of
15 assessed),61 with an overall complication rate of 33.5% among alcohol misusers compared with 22.6%
in their non-alcohol-misusing counterparts. This population was also found to have significantly longer
stays in hospital.61 Another study62 reported a 29% increase in the number of complications for every
additional point on the AUDIT screening tool in patients undergoing total joint arthroplasty. This is also
supported by the results of a registry-based study that considered patients who reported abstinence, low
to moderate or high alcohol consumption and found a similar dose-dependent association with rates of
mortality and morbidity.63
With a strong evidence base for an association between increased alcohol consumption and increased rates
of postoperative complications, it is reasonable to suggest that interventions that reduce or cease alcohol
consumption in the preoperative period may result in fewer complications and better postoperative outcomes.
Existing literature suggests that many of the physiological effects of increased alcohol consumption thought
to explain the increased risk of postoperative complications may be improved or entirely reversed within a
relatively short period of alcohol cessation (between 2 weeks and 3 months depending on the specific effect
considered).51,64,65 The effects of reduction rather than cessation of alcohol consumption are less clear.
Achieving such improvements requires two key things: first, clinicians must be able to effectively identify
patients at increased risk of perioperative complications as a result of alcohol consumption and, second,
they must be able to provide an acceptable and effective intervention to bring about timely changes in
alcohol consumption behaviour.
Preoperative alcohol screening
Although the assessment of alcohol consumption is part of standard care in preoperative assessment (PA),
the use of validated screening tools is not widespread. Until recently, the more formal validated screening
tools developed to assess of alcohol consumption (e.g. AUDIT, AUDIT-C), had not been employed in the
preoperative setting.
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Concerning the detection of alcoholism in the preoperative period, Martin et al.66 found that routine
practice identified only 16% of alcohol-dependent patients at the first visit, although this increased to
34% if the patient was seen three or more times in the preoperative period. When a screening
questionnaire was used, the rates of detection on first visit were much higher (64%).
Because alcohol-dependent patients are at highest risk of intra- and postoperative complications and are
at risk of the life-threatening complication of experiencing alcohol withdrawal syndrome, it is critical that
they be identified and effectively manged in the preoperative period. However, they represent only a
small proportion of those who may be at increased risk as a result of alcohol consumption. Kip et al.67
considered a wider range of AUDs and compared detection rates from screening with computerised AUDIT
questionnaire with those from anaesthesiologist assessment. The findings support those of Martin et al.,66
with only 17.4% of patients who were found to be AUDIT positive (score of ≥ 8) also detected by
anaesthesiologists. In addition, although anaesthesiologists were reliably able to detect patients who
showed signs of dependence (25.2%), the patients with harmful (20%) or hazardous (17.2%) drinking
were not detected. Furthermore, subgroup analysis found that anaesthesiologists were significantly less
likely to identify AUDs in women and those aged < 50 years.67
Among both elective and emergency orthopaedic surgical patients in Australia, 34% were identified as
having hazardous drinking behaviour using the AUDIT questionnaire but only 38% of these patients
reported a history of problematic alcohol consumption,68 indicating that a majority of those drinking at
hazardous levels may be unaware that their drinking could represent a risk to their health.
In combination, these findings demonstrate that utilisation of validated screening tools in the preoperative
period is likely to increase detection rates of AUDs across the spectrum.
Alcohol screening using validated screening tools has been shown to have good patient acceptance in
both preoperative and wider health-care settings.57,62,68–70 Indeed, the need to improve detection rates for
increased risk alcohol consumption (and smoking behaviour) in hospitals has been recognised in the UK,
where the Commissioning for Quality and Innovation (CQUIN) has identified these health behaviours
as a priority.
The CQUIN framework aims to improve care by providing financial incentives to health-care providers in
the UK who demonstrate delivery of quality and innovation in prespecified areas. The 2017–19 CQUIN
targets include a goal to support people to change their behaviour in order to reduce the risk to their
health from alcohol and tobacco use through identification, advice and referral to specialist services for
inpatients in all acute trusts.71 Regarding alcohol consumption, the CQUIN promotes screening with the
AUDIT-C questionnaire followed by delivery of brief advice (BA) to those identified as increased risk or
higher-risk drinkers and the referral of those identified as alcohol dependent. Although PA is an outpatient
appointment, patients are subsequently admitted as inpatients for the surgical procedure. Thus, the PA
provides an important opportunity for the CQUIN screening, intervention and referral package to be
implemented earlier in the surgical pathway.
Preoperative alcohol cessation interventions
A small number of studies have considered interventions concerned with bringing about preoperative
alcohol cessation among heavy drinkers with a minimum level alcohol consumption equivalent to between
4.5 and 7.5 units per day (36–60 g of alcohol) or 31.5 and 52.5 units per week (252–420 g of alcohol).
The results of three RCTs (one published,64 two unpublished72,73) that targeted alcohol cessation in the
preoperative period have been included in the most recent update of the Cochrane review concerning
perioperative alcohol cessation interventions.74 All three trials employed intensive interventions, including
the provision of disulfiram (Antabuse® Pliva, East Hanover, NJ, USA), and aimed to achieve between 1 and
3 months of alcohol abstinence prior to surgery. Two trials also offered chlordiazepoxide hydrochloride for
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the treatment of withdrawal symptoms and provided motivational counselling each week, with staff available
for telephone contact if required.72,73 All three trials identified significantly higher rates of abstinence in the
intervention groups than in the control. An associated finding of lower rates of postoperative complications
following intervention was not statistically significant. However, when pooled data were analysed,74 there
was a significant reduction in complication rates associated with reduced alcohol consumption immediately
following completion of the intervention.
It is important to consider that all three of these trials were conducted in Denmark and results cannot be
assumed to be generalisable to the UK setting. These trials are all concerned with individuals drinking at
more than double the current UK lower-risk drinking guidelines, levels that suggest possible dependence,
and thus require the provision of specialist support including pharmacotherapy. However, such intensive
interventions are unlikely to be acceptable to, or appropriate for, patients drinking at increased risk levels
(> 14 units per week). Because this group also confer additional risk as a result of their alcohol consumption,
present for surgery in much greater numbers and are unlikely to recognise the risks associated with their own
drinking behaviour, it is necessary to consider alternative, more appropriate interventions. BIs in the form
of structured advice or behaviour change counselling, have been shown to be effective in bringing about
reductions in alcohol consumption in other health-care settings, including primary and emergency care,75–77
and represent a potential alternative that could be employed in the PAC at relatively low cost and with minimal
burden to the patient.
Brief alcohol interventions
The terms ‘brief intervention’, ‘brief behavioural intervention’ and ‘brief advice’ are often used interchangeably
in the literature to describe short sessions of advice and/or behaviour change counselling that are usually
delivered by a care provider. Such methods have frequently been used to address increased and higher-risk
drinking behaviours. BIs usually last between 5 and 30 minutes with key intervention content including
feedback on alcohol consumption often with comparison to social norms; identification of the drinker as the
only one who can change their behaviour; identification of the potential harms of drinking behaviour and
the potential benefits of reducing alcohol intake; advice about how to reduce alcohol consumption; and
goal-setting or the development of a plan to reduce drinking. In addition to this content, the interventionist or
care provider adopts a non-judgemental, empathic approach with roots in motivational enhancement therapy,
which seeks to increase motivation to change and enhance self-efficacy. These core components and the
associated therapeutic approach are summarised by the FRAMES (Feedback, Responsibility, Advice, Menu,
Empathy, Self-efficacy) acronym.78
Although research trials often identify decreases in alcohol consumption in both intervention and control
groups (e.g. Fleming et al.79 and Lock et al.80), systematic reviews and meta-analyses have consistently
identified positive effects of providing BI over and above changes in comparator groups.81–83 This approach
has been most frequently studied in primary care settings, where the focus is on reducing alcohol
consumption in the longer term.75,84,85 In these settings, BIs have been shown to result in an average
reduction of between 20 g75 and 38 g82 of alcohol per week (2.5–5 units) compared with control groups at
6–12 months post intervention.
However, the implementation of BIs into standard practice has been limited,86 with a number of studies
documenting barriers to implementation, including lack of resources, training and support.87
There is now a small, but growing, body of evidence considering the use of BIs for alcohol consumption
in other settings including general hospital wards76,88 and outpatient clinics.89 A recent review and
meta-analysis of interventions delivered to general hospital inpatients identified a significant benefit of BIs
over control conditions in terms of reduction in alcohol consumption at 6 (–70 g per week) and 9 months
(–183 g per week) post intervention as well as a reduction in mortality rates at 6-month (relative risk 0.42)
and 1-year (relative risk 0.60) follow-up.76 Meanwhile, it has been shown that screening and BI in
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outpatient clinics can reach a large number of patients90 and can result in significant reductions in alcohol
consumption and in the percentage of hazardous drinkers (intervention, reduction from 60% to 27%;
control, reduction from 54% to 51%).89
With the implementation of BIs in primary care being limited, it is important to establish when and where
such interventions can best be implemented in standard care. Previous research shows that patients are
more accepting of health behaviour advice when it is delivered in an appropriate setting or linked to the
presenting health condition.91,92 In some settings, such as emergency care, some level of alcohol-related harm
may already be present (e.g. alcohol-related injuries). On the other hand, the PAC offers an opportunity to
introduce the idea of health behaviour and behaviour change before many will have incurred any significant
harm but when there is a positive, salient and temporally proximal focus (i.e. elective surgery). In other words,
it offers a ‘teachable moment’. The benefit of BIs targeting shorter-term changes in alcohol consumption
(e.g. preoperative alcohol reduction or cessation) has not been widely studied and thus it is unclear what
magnitude of effect is likely in such contexts. However, broader intervention studies predominantly show a
higher level of behaviour change post intervention and at early follow-up (e.g. ≤ 3 months) than at longer-term
follow-up (e.g. 12 months).93
Further to this, the PAC patient population is both large and diverse, with most patients who receive elective
surgeries being referred for at least some level of assessment. As such, the PAC offers an opportunity to
screen and intervene with a large number of patients across a wide age range, many of whom may not
frequently present to primary or emergency care.
If brief alcohol interventions are to be implemented in PACs, it is likely that they will be delivered by nurses
rather than anaesthetists because the clinics tend to be nurse led. Although there is some evidence to
suggest that physician-delivered interventions may be better received by patients,91 others have reported
that nursing staff may be best placed to deliver interventions92 and that patients view interventions
delivered by nursing staff as equivalent to those delivered by general practitioners (GPs).94
Behavioural interventions in the preoperative period
To date, four trials have considered the effectiveness of behavioural interventions (including both brief
and more extended interventions) targeting alcohol reduction or cessation in the preoperative period.
The majority have included alcohol interventions as part of a multimodal intervention package targeting
multiple health behaviours, which precludes firm decisions on the effectiveness of isolated intervention
components for individual behaviours. The only trial to assess an alcohol intervention alone was reported
by Shourie et al.95 This trial commenced as a randomised trial but difficulty in recruiting patients at least
7 days before surgery led to the adoption of a non-randomised method whereby those with ≥ 7 days
to surgery received the intervention and those with < 7 days to surgery were allocated to the control
condition. The intervention employed was a revised version96 of the manualised BI from the ‘Drink-less’
campaign,97 which aimed to facilitate preoperative alcohol cessation. No significant intervention effect
on alcohol consumption was demonstrated. This finding was attributed the intervention being delivered
too close to surgery, thereby allowing too little time for either behaviour or physiological change. Three
further trials used behavioural interventions targeting preoperative alcohol consumption as part of multimodal
intervention packages. McHugh et al.98 conducted a RCT with patients awaiting coronary artery bypass
surgery. Patients allocated to the intervention group had their physical and mental health needs assessed
and were provided with a tailored intervention package delivered in monthly health education sessions.
Interventions targeted smoking, alcohol use, physical activity, diet, hypertension and hypercholesterolemia
as indicated by screening and patients’ readiness to change. In addition to providing advice and information,
the interventionists used a ‘pros and cons’ approach to behaviour change, goal-setting and progress monitoring.
Patients in the intervention group showed greater rates of smoking cessation, physical activity and weight
loss than the control group and greater improvements in blood pressure. Alcohol consumption outcome
data were not published in this original study report but were included in a subsequent review,99 which
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identified a significant group × time interaction whereby the intervention group decreased their weekly
alcohol consumption by 1.2 standard drinks per week between baseline and follow-up, whereas the control
group showed an average increase of 1.3 drinks per week over the same period. With an average of
> 8 months from trial entry to surgery date, patients had adequate time to implement behaviour change
and observe positive health outcomes. However, the maintenance of change over an extended period,
alongside the targeting of multiple health behaviours, presents its own difficulties.
Kummel et al.100 conducted a RCT to assess the effects of guidance and counselling delivered in individual
and group sessions on health behaviours in older (> 65 years) coronary artery bypass patients. Patients
received one group session in the preoperative period and four sessions postoperatively. Sessions included
health counselling, guidance and adjustment education, including information on risk factors for coronary
heart disease, peer support and goal-setting. The primary focus of this intervention package was outcomes
in the postoperative period rather than preoperative changes in health behaviour. The intervention was
found to reduce alcohol consumption relative to baseline at 3-month follow-up, whereas the control group
showed greater alcohol consumption at 6- and 12-month follow-up than at baseline.
The third trial101 assessing the effectiveness of a multimodal intervention package used a quasi-experimental
design with patients referred for fast-track hip and knee arthroplasty. Patients were recruited over 4 months,
with those undergoing surgery in the first 2 months of 2007 allocated to the control group and those
receiving surgery in the next 2 months of the same year allocated to the intervention. The intervention
involved completion of a preoperative risk-screening questionnaire, followed by a motivational conversation
addressing identified risks with interventions for nutritional risk, physical activity, health, medication and
alcohol use and/or smoking. Interventions for smoking and alcohol consumption involved the provision of
information and identification of the potential benefits of stopping or abstaining in the preoperative period.
Information leaflets about the identified risks were also provided. Findings showed a reduced number of
‘unplanned’ surgical pathways (including complications, readmission and mortality in the postoperative
period) among intervention patients compared with controls. However, it is notable that only 4 of the
78 participants in the intervention condition were identified ‘at risk’ in terms of drinking more than the
recommendations from the Danish National Board for Health (i.e. 21 units per week for men, 14 units per
week for women).101 As a result, it is not possible to conclude what, if any, benefits were gained from
identifying and intervening to address risky drinking in this population.
A further trial considered preoperative alcohol consumption as part of a multimodal ‘prehabilitation’
package and planned to provide interventions for risky drinking but did not identify any patients drinking
at risky levels.102
The four studies assessing behavioural interventions for alcohol consumption in the preoperative period
have been drawn together in a narrative review conducted by Fernandez et al.99 This review identified
some positive findings, with two of the trials identifying significant reductions in alcohol consumption
and one identifying a significant reduction in postoperative complications. However, it also highlighted
a number of methodological weaknesses of the current evidence and made multiple recommendations
for future research. They pointed to difficulties in recruitment across the trials. Specifically, the studies by
Shourie et al.,95 McHugh et al.98 and Kummel et al.100 took between 15 months and 3.5 years to recruit
117–136 participants. These issues were further exacerbated by the fact that rates of risky drinking in
participants recruited to multimodal trials were low. For example, Hansen et al.101 identified just 4 out of
78 intervention participants as drinking above recommended guidelines and Kummel et al.100 identified
12 out of 49 intervention patients and 21 out of 68 control patients as using alcohol at least once per
week at baseline. This is in contrast to alcohol screening data, which identify 8–43% of surgical patients
as screening positive for alcohol misuse,57,62–103 and rates increase to as high as 82% when considering
surgeries for conditions strongly associated with alcohol use (e.g. head and neck tumour surgeries).103
This suggests a number of possibilities: alcohol consumption levels may be much lower in certain surgical
populations, those drinking at risky levels may be less likely to participate in intervention trials or alcohol
consumption may be under-reported by trial participants. Fernandez et al.99 recommend adopting clear,
precise definitions of risky drinking and using unbiased screening to detect those drinking at risky levels.
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Further recommendations resulting from this review99 include assessing change in alcohol use preoperatively
as well as postoperatively to allow the assessment of preoperative change on postoperative outcomes; a focus
on the needs of older adults because the average age of trial participants is < 50 years; using empirically
supported interventions and improving the reporting of both intervention content and fidelity of delivery;
delivering interventions early enough in the preoperative care pathway to allow adequate time for behaviour
change and subsequent pathophysiological improvement; and careful consideration of the sample size
required to ensure adequately powered evaluations.
Feasibility and acceptability of preoperative screening and
alcohol intervention
There has been limited work exploring the acceptability of screening and BI methods to patients and
HCPs in the context of perioperative care. Acceptability has tended to be judged on rates of uptake of
screening and interventions.57,62,68 Considering the difficulties experienced in recruiting patients to trials
of preoperative alcohol interventions in previous studies, qualitative methods may provide important insight.
To the authors’ knowledge, only two studies have used qualitative methods to provide more detailed
findings regarding the acceptability of perioperative alcohol intervention methods. Pedersen et al.104
carried out qualitative interviews to assess patients’ views of the intervention materials and methods used
in their trial of postoperative alcohol interventions following surgery for ankle fractures. Findings show
that patients held positive views about the intervention in relation to surgery and the proposed materials.
Approximately half of the patients interviewed reported that they were open to changing their drinking
behaviour. The validity of these findings is restricted by the sampling technique. Specifically, patients
interviewed did not receive the intervention as part of the trial but were presented with the intervention
materials and asked to provide their views. Lauridsen et al.105 interviewed 11 participants from the ongoing
‘STOP-OP’ trial of alcohol and smoking cessation interventions delivered to patients awaiting radical
cystectomy. Of those interviewed, three had received an alcohol intervention alone and two had received
both the smoking and the alcohol interventions. The authors reported that the interventions were well
received and that patients perceived it to be a part of their treatment package rather than something
separate or distinct. A number of facilitators of effective intervention were identified, including having
intervention sessions scheduled alongside other appointments or delivered over the telephone, and the
empathic approach of interventionists. Facilitators of alcohol and smoking cessation were also identified;
these included aspects of undergoing surgery (e.g. hospital stay, nausea) that removed either the desire
or the opportunity to smoke/drink, as well as a feeling of obligation to do what they could for their own
health or to please family or HCPs who were ‘invested’ in the outcome of their surgery.
Despite the limited research in perioperative care, trials of BI for alcohol reduction and cessation in other
contexts have assessed the acceptability of methods that may inform work in PA. Qualitative studies in
other health-care settings support the findings of Pedersen et al.104 and Lauridsen et al.,105 with patients
and staff expressing generally positive attitudes towards alcohol screening and intervention (HCPs106,107
and patients108,109). However, they have also identified a number of barriers to alcohol screening and
intervention in health-care settings. These barriers include logistical issues, having the necessary alcohol
knowledge and having the required training and skills.106,110
In combination, findings from these qualitative works suggest that alcohol screening and intervention is
likely to be acceptable to patients, and that surgery may increase the salience of health behaviour change
and facilitate change in the short term. However, there is a need for further exploration, and overcoming
or addressing logistical barriers will be important to ensure effective implementation.
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Outcomes of interest for trials of preoperative alcohol interventions
With previous research having identified that alcohol consumption in the preoperative period is associated
with increased risk of postoperative complications, interventions leading to alcohol reduction or cessation
in the preoperative period may reduce postoperative complications and improve outcomes. Therefore,
the effectiveness of a preoperative alcohol intervention would be judged initially in terms of changes in
alcohol consumption behaviour and, later, by any resultant reduction in complications or improvements
in outcomes. A trial of a preoperative alcohol intervention should therefore include measures of alcohol
consumption, complications and condition-specific as well as general health outcomes.
As detailed in Background, the AUDIT-C and full AUDIT tools are frequently used to screen for different
patterns of drinking and to assess changes in drinking behaviour.
Regarding postoperative complications, two measures are frequently used in health-care settings: the Post
Operative Morbidity Survey (POMS),111 which collects data on minor complications related to postoperative
pathways, and the Clavien–Dindo tool,112 which classifies the presence of more significant postoperative
complications.
Specific to the disease process requiring orthopaedic surgical intervention is the Western Ontario and McMaster
Universities Osteoarthritis Index (WOMAC),113 which aims to evaluate the functional ability of patients with
knee and hip osteoarthritis and includes items related to pain, stiffness and physical functioning of the affected
joints. In addition, broader patient-reported health outcomes may be of interest. These are frequently assessed
with quality-of-life114 questionnaires, such as the EuroQol-5 Dimensions (EQ-5D).114,115
Characterising treatment as usual in preoperative assessment
In a setting where alcohol consumption is routinely assessed as part of TAU, it is important to clearly
document the characteristics of TAU to allow accurate comparisons between that and any intervention
delivered, and to ascertain whether or not the proposed intervention is in fact sufficiently different from
TAU. A national survey116 of consultant anaesthetists involved in perioperative care found that the majority
of PACs involve some form of alcohol screening, with almost half having alcohol intervention services
available. However, the survey provided little detail of screening approach, or of the form and content of
any interventions available. Although anaesthetists play a key role in leading PA units, the majority of PAs
are conducted by nurses, who are therefore likely to be better placed to provide insight into the delivery of
alcohol screening and intervention in PA.
Conclusions
Preoperative alcohol consumption is firmly associated with postoperative complications and poorer surgical
outcomes and represents a modifiable risk factor suitable to be addressed using an appropriate presurgical
intervention. Evidence exists to support the effectiveness of intensive interventions, combining pharmacological
and behavioural aspects, in bringing about abstinence in heavy and dependent drinkers and leading to reduced
rates of postoperative complications.64,72–74 However, these methods are unlikely to be either appropriate
or acceptable for the majority of increased risk drinkers, who represent a greater proportion of the surgical
patient population. Although there is evidence for the effectiveness of BIs in other settings (e.g. primary care,
emergency care), less is known about the use of such methods in the preoperative period. Studies employing
preoperative behavioural interventions have been confounded by several methodological issues, including:
l the use of multimodal interventions targeting a number of health behaviours98,100,101
l poor reporting of the uptake, content and delivery98,100,101 of interventions
l small numbers of risky drinkers in the overall trial population101
l delivery of interventions close to the date of surgery, allowing little time for behaviour change95
l the use of non-randomised study designs.95
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Given these limitations, drawing firm conclusions about the effectiveness of any intervention to reduce
or cease alcohol consumption in the perioperative period is difficult, and further high-quality RCTs are
required. In addition, with a number of the studies conducted to date having also identified issues with
recruitment and having limited data regarding the acceptability of preoperative alcohol screening and
intervention, it is important to explore the acceptability of proposed screening, recruitment and intervention
methods with participants in order to optimise both research and intervention methods before seeking to
assess effectiveness.
Aim and rationale
Summary of rationale
Brief behavioural interventions are effective in reducing alcohol consumption among increasing risk and
risky drinkers and have been demonstrated to be acceptable to patients and HCPs in several clinical settings.
Upcoming major surgery provides an opportunity to deliver a BBI for reducing preoperative alcohol
consumption. Reducing risky drinking preoperatively may have immediate benefits on short-term clinical
outcomes after surgery. Sustained reductions in alcohol consumption are likely to support longer-term
recovery, as alcohol has immunosuppressant effects. Furthermore, any such sustained changes would
also decrease alcohol-related risk to future well-being in a predominantly older, orthopaedic population.
Aim
The overall aim of the project was to establish if a definitive trial of a BBI to reduce drinking prior to
elective orthopaedic surgery is feasible.
Three overarching objectives reflected three sections of work, each of which had its own secondary
objectives:
1. Characterise the intervention and comparator (TAU) conditions.
– Train HCPs to deliver structured screening and BBI to eligible patients in the PA setting.
– Assess fidelity of delivery of the BBI.
– Characterise TAU in the PAC for elective orthopaedic surgery at the three pilot RCT sites using
focus groups.
– Characterise TAU for elective orthopaedic surgery at PACs nationally using a quantitative
electronic survey.
2. Assess the feasibility and acceptability of consent, screening, intervention and outcome
assessment procedures.
– Optimise the screening and behavioural intervention process in a way that nurses and patients
find acceptable.
3. Estimate rates of eligibility, recruitment and retention in a pilot RCT.
– Assess completion rates for all data collection tools, including measures of alcohol consumption,
quality of life and joint functionality.
– Establish response variability of proposed outcome measures for a definitive trial, which will include
drinking status and quality of life.
– Estimate rates of secondary outcomes and perioperative complication rates, including bleeding
and infections.
– Explore the acceptability of intervention and research methods with HCPs and patients through
qualitative interviews.
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Patient, public and professional involvement
There was patient, public and professional involvement at all stages of the study from inception to
completion.
Prior to commencement of the study, formative work conducted at the primary site provided initial
estimates of screening uptake and eligibility based on an AUDIT score of ≥ 8.
Prior to commencing the feasibility study, all patient materials were reviewed by members of a local patient
and public involvement group, Voice North: (www.ncl.ac.uk/ageing/partners/internal_ageing/voice/;
accessed 4 February 2019). Comments were used to inform amendments to the materials before they
were submitted for relevant approvals.
Three members of this group expressed an interest in being involved in the Trial Steering Committee (TSC)
and attended meetings during the research programme. When these members were unable to attend
meetings they were sent a copy of the meeting minutes and asked to provide comments. Further to this,
a member of the research team (EL) met with lay members to discuss proposed changes between the
feasibility study and the pilot RCT phase to ensure that these were considered acceptable.
During the feasibility study, anecdotal feedback from researchers and HCPs involved in the screening
and recruitment of patient participants was collected. With initial rates of recruitment being lower than
anticipated, this information was used to inform the amendments made to the feasibility study processes.
The proposed changes were then discussed with the lay members of the TSC before being submitted
for approval.
Prior to commencing the feasibility study, researchers engaged with HCPs employed in PA to inform the
design of the training session. The HCPs completed questionnaires identifying their training needs and the
acceptability of the proposed training methods. HCPs were also asked to complete feedback questionnaires
after the group training session was delivered.
Prior to commencing the pilot RCT, HCPs involved in pre-assessment at each of the three trial sites were
invited to a launch meeting, where they had the opportunity to discuss the pilot RCT and consider how
the research processes would be implemented at each site. Members of the research team also met with
pre-assessment leads from each site. These meetings led to the decision to allow either face-to-face
screening or postal invitations followed by telephone screening to minimise the impact of extended
waiting times between listing for surgery and attendance at the PAC on recruitment times. With HCPs also
explaining that some patients would attend satellite hospitals for follow-up appointments, the option to
conduct follow-up visits over the telephone was also included in the pilot RCT.
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Chapter 2 Defining the intervention and
comparator
Introduction
When considering behavioural interventions to target alcohol consumption in the preoperative setting, a key
limitation of the literature is the lack of information on intervention content.99 This prevents intervention
replication117 and further exploration of what makes an intervention effective. Furthermore, fidelity of
intervention delivery has not been assessed in the trials reporting on behavioural interventions in the
preoperative period.99 This makes it difficult to determine whether or not the intervention was delivered as
planned and, therefore, has implications for the assessment and interpretation of intervention effectiveness.
Recent reviews of alcohol interventions further highlight the importance of clear reporting of intervention
content.75,118
The field of behavioural science offers a precise and systematic approach to reporting on the content
of behavioural interventions. Specifically, the Behaviour Change Technique (BCT) Taxonomy v1119 provides
standardised definitions of BCTs to make reporting more consistent across disciplines, allowing comparisons
of interventions to be made. Accordingly, in the current study, the behavioural intervention delivered was
described in terms of behavioural components (i.e. BCTs) and fidelity of delivery was assessed in terms of
whether or not specific BCTs were delivered.
Although existing screening and intervention training packages are available, these are not specific to the
PA setting. For this reason, adaptations were made to an existing package to provide HCPs with the
knowledge and skills they required to deliver the screening and intervention during routine clinics.
This chapter provides an overview of the development of the intervention that was then delivered during
the feasibility study and pilot RCT.
Aims
l Train HCPs to deliver structured screening and BBI to eligible patients in the PA setting.
l Assess fidelity of delivery of the BBI.
l Characterise TAU in the PAC for elective orthopaedic surgery at the three pilot RCT sites using
focus groups.
l Characterise TAU for elective orthopaedic surgery at PACs nationally using a quantitative electronic survey.
Optimisation of screening and behavioural intervention process
Screening tool selection
Both the AUDIT67 and the AUDIT-C62 have been used in studies in PA to report on the association of alcohol
consumption with postoperative complication rates, and they have shown good patient acceptability.57,62,68
Therefore, either or both of these tools were considered appropriate for the current study.
Qualitative evidence92 has identified time and burden of new processes as key barriers to the implementation
of alcohol screening and BI, and findings from alcohol screening studies conducted in PA have reported that
the majority of patients drink at ‘safe’ or ‘sensible’ drinking levels.62,103 Therefore, it is appropriate to use a
short initial screen (AUDIT-C) to identify potentially eligible patients, with the longer full AUDIT being used to
inform intervention delivery and, potentially, the tailoring of intervention content.
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Optimisation of the intervention tools
It is appropriate to adopt and adapt an intervention package that has demonstrated effectiveness in other
health-care settings.75 The ‘How much is too much? Simple Structured Advice’ and the ‘How much is too
much? Extended Brief Intervention’ tools, originally developed by the World Health Organization for use in
a collaborative study on alcohol screening and BI,120 later revised for use in the UK as part of the Drink-Less
Brief Intervention programme121 and subsequently updated and utilised in the Screening and Intervention
Programme for Sensible Drinking (SIPS),84 were adopted to guide the BBI. In addition, the Department of
Health and Social Care’s ‘How much is too much?’ booklet122 was used as a leaflet for patients to motivate
and facilitate behaviour change after the session.
The most recent iteration of these intervention materials was reviewed by three members of the project
team (EL, LA and CH) and revised in accordance with developments in alcohol intervention research and to
maximise integration and acceptance among the orthopaedic surgical population and in the preoperative
setting. The following amendments were made:
l The term ‘unit’ was replaced with ‘standard drink’ (standard drink = 1 unit = 8 g of pure alcohol) in
accordance with current research and international agreement.
l Additional drink icons were included to indicate the alcohol content of standard drinks.
l The terms sensible, hazardous and harmful drinking were replaced with low, increased and high risk,
respectively, to reflect the updated Department of Health and Social Care terminology.
l The graphic displaying normative drinking data was amended to show risk categories in place of
alcohol disorders.
l Information relating to the common effects of alcohol use and the benefits of ‘cutting down’ was
tailored to fit the pre-surgical population by including additional information about the relationship
between alcohol use and immune function, recovery time and postoperative complications.
l The category of ‘sensible drinking’ was amended to include one single recommendation for both male
and female drinkers, in line with updated guidelines.
l Information on avoiding alcohol when pregnant was removed as patients who were pregnant would
not undergo this type of elective surgical procedure.
l Information about risks relating to alcohol consumption and the potential benefits of reducing drinking
was reordered so that the items most relevant to surgery appeared first (e.g. risk of complications,
potential for weight loss), followed by those most relevant to older patient populations.
The revised intervention materials were then circulated to members of the patient and public involvement
group Voice North for their consideration and feedback. Comments on the patient booklet were reviewed,
summarised and responded to. Changes made were as follows:
l Addition of ‘when you get bad news’ to the list of examples of difficult times.
l Replacement of the previous logo with a project-specific logo.
l Specification that goal-setting and behavioural monitoring would work only if individuals were honest
about their consumption.
l Clarification that the amount of alcohol in a drink depends on the size and strength of the drink.
l Rewording of the definition of a small glass of wine from ‘8–10% alcohol by volume in a 125 ml glass’
to ‘a 125 ml glass of wine (8–10% alcohol by volume)’.
No comments on the simple structured advice or extended BI tools were received, so no further
amendments were made to these. For the purposes of this study, and to avoid confusion with previous
iterations, the tools were renamed as follows:
l BA tool – formerly the ‘How much is too much? Simple Structured Advice’ tool
l BI tool – formerly the ‘How much is too much? Extended Brief Intervention’ tool
l patient leaflet – formerly the Department of Health and Social Care’s ‘How much is too much?’ booklet.
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Once changes had been made in response to comments, the content of the intervention tools was coded
in terms of BCTs (see Appendix 1).
Description of intervention delivery
The AUDIT-C, with a cut-off point of 5, was employed as an initial screen to identify potentially eligible
patients. After patients provided informed consent to participate, the full AUDIT, with a cut-off point of 8,
was used to assess baseline alcohol use and identify those eligible to receive the intervention. The intervention
was designed to be delivered in up to two sessions, the first to be delivered face to face in the PAC. The
second, an optional booster, could be delivered either over the telephone or face to face in the PAC (as per
patient preference) approximately 1 week before surgery. The screening and intervention tools were used to
guide the content of the sessions, and HCPs were also trained in the use of brief motivational techniques to
enhance motivation to change, which helped guide the style of delivery.
The first session lasted up to 30 minutes and was delivered following completion of the full AUDIT
questionnaire. The outcome of AUDIT was used to provide patients with their screening score and feedback
in relation to this (i.e. whether this related to low- or high-risk drinking behaviour). This was followed by
5 minutes of structured BA using the BA tool. The BA delivered was designed to be tailored to individual
patients. As such, patients were asked about existing knowledge of alcohol consumption and its effects to
avoid the delivery of information that might not be relevant or appropriate. BA could include information
about the lower-risk drinking guidelines, explanation of the term ‘standard drink’, normative comparison
of drinking behaviour, feedback on risk including risk of postoperative complication, the potential benefits
of reducing alcohol consumption and strategies that could be used to reduce drinking (e.g. goal-setting).
This component of the intervention targeted motivation by providing information to increase intention to
make behavioural changes. The remainder of the intervention session (15–20 minutes) involved the delivery
of a behaviour change intervention that aimed to target volition (i.e. enactment of behaviour change). This
component of the intervention could cover assessment of motivation and confidence to change drinking
behaviour; identification of the pros and cons of changing drinking behaviour; goal-setting, problem-solving
and action planning; and identification of sources of social support. Patient participants were given copies of
the BA and BI tools, as well as a copy of the patient leaflet.
As a follow-up to the intervention described above, patients were offered an optional booster session.
Patient participants either consented or declined to be contacted about the booster session during initial
informed consent. Those who consented were contacted approximately 1 week before surgery, when their
interest in the booster session was confirmed and a suitable date and time to receive the booster session
was arranged. The session could be delivered over the telephone or face to face in the PAC as per patient
preference. The booster session commenced with patients completing the full AUDIT questionnaire to
facilitate a review of their progress since delivery of the initial intervention. For patients who had previously
set goals, these could be reviewed and revised if necessary. For those who had not yet set goals or made
action plans, this session provided an opportunity to do so. The session aimed to prompt behaviour change
maintenance for those who had made changes and increase self-efficacy with a view to making changes
for those who had not.
The finalised BBI is summarised in Table 1.
Training development
The HCPs employed in PA at the primary site were involved in the development of the training to make
sure it met their needs. The training was developed in accordance with the Behaviour Change Wheel123
and the various components were selected based on a needs assessment using the Capability, Opportunity
and Motivation to perform a particular Behaviour (COM-B)124 and Theoretical Domains Framework.125
The BCT Taxonomy version 1119 was then used to help select BCTs to help operationalise the theory
within the training.
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The HCPs were asked to complete an adapted version of the COM–B self-evaluation questionnaire
(see Appendix 2) containing 19 items designed to assess existing levels of COM–B, in this case to deliver
alcohol screening and behavioural intervention to patients. They were asked to assess what they felt
needed to change for that behaviour to occur. Tick boxes were provided for each question, with free-text
boxes to collect additional information and context. Twelve HCPs completed and returned questionnaires
(see Appendix 3 for a summary of responses). Assessment of questionnaire responses identified that HCPs
required support to increase all three domains (capability, opportunity, motivation). Having an understanding of
why alcohol reduction or cessation was important in the preoperative period was seen as key to enhancing
HCPs’ motivation to deliver a screening and behavioural intervention, while also providing them with the
capability to motivate patients to change their behaviour.
TABLE 1 Intervention Template for Intervention Description and Replication (TIDieR) summary
Item Details
Name Preoperative Behavioural Intervention to Reduce Drinking before elective orthopaedic Surgery
(Preop BIRDS)
Why? Preoperative alcohol consumption is related to increased risk of postoperative complications.
The aim of the intervention is to support patients to reduce or cease alcohol consumption prior
to elective orthopaedic surgery
What? Materials: HCPs are trained to screen for increased risk alcohol consumption and to deliver the
following behavioural intervention materials – BA tool, BI tool, patient leaflet
Training also covers use of brief motivational techniques to increase motivation for change.
Training of HCPs is supported by a training manual
Procedures: the intervention is delivered over two sessions (the second is optional). The first session
involves provision of 5 minutes of structured advice that aims to increase motivation via use of a
‘BA sheet’. This is followed by delivery of a behaviour change intervention lasting 15–25 minutes
using the BI sheet. This intervention targets volitional aspects of behaviour change. The aim of the
second optional booster session is to review and/or revise behavioural goals, provide feedback on
performance and discuss self-monitoring to increase self-efficacy. This session is also designed to
allow those individuals who have shown an initial intention to make changes, but who have not
formally set behavioural goal(s) and made plans, to do so if desired
Who provided? HCPs employed in the PACs who received training in the delivery of screening and BBI
How? The initial intervention session is delivered face to face during routine clinics. The second session,
an optional booster, is delivered either face to face in clinic or over the telephone, depending on
patient preference. All intervention sessions are delivered one to one
Where? Intervention sessions are delivered during routine PACs. Where the patient opts to receive a
booster session over the telephone, the HCP delivering the session calls from the PAC
When and how
much?
The first session involving delivery of BA and BBI lasts approximately 30 minutes and is delivered
during routine PACs once all clinical procedures have been completed. The second optional
‘booster’ session lasts approximately 20 minutes and is delivered around 1 week before surgery
Tailoring Intervention materials incorporate specific BCTs that target intention formation and enactment of
behaviour change (e.g. information on health consequences, social support, goal-setting behaviour,
problem-solving, restructuring the physical environment). HCPs are trained to use these techniques
to tailor the intervention to the needs and preferences of individual patients, for example providing
information relevant to and requested by the patient and supporting them to set meaningful and
realistic goals that fit in with their own specific circumstances. Brief motivational techniques are
used by HCPs allow them to determine level of motivation to change and tailor the intervention
to target motivation or volition at the appropriate times
How well? Consultations with participating patients are audio-recorded to allow an assessment of skill
acquisition and fidelity of delivery of the intervention post training. The aim is to improve fidelity
of delivery by providing feedback to HCPs including aspects of intervention delivery that went
well and where they could improve. A member of the research team provided feedback to each
HCP following delivery of intervention sessions 2 and 4
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To enhance capability, HCPs reported that they needed training in the BBI and that this should include a
clear plan of how to deliver it. In addition, HCPs requested supporting materials to facilitate intervention
delivery that would include visual aids to help communicate information. The need for adequate ‘protected’
time in their appointment schedule to facilitate delivery was emphasised, as was knowing that all colleagues
would work together to facilitate delivery of the intervention.
The TDF125 was used to identify potential candidate techniques to address HCPs’ training needs. The provision
of education, training and modelling, along with the use of persuasion, incentivisation, and enablement, was
identified as a potential component of the training package. To determine the acceptability of these methods
to HCPs, the lead nurse from the primary site completed an amended version of the APEASE questionnaire
(see Appendix 4), which assessed the anticipated affordability, practicability, effectiveness, acceptability,
safety and equity of these techniques. All suggested techniques were found to be acceptable.
These techniques were subsequently used to guide the selection of training content in terms of BCTs.119
A draft training strategy describing how these BCTs would be delivered was developed and then expanded
into a 2-hour face-to-face group training session with a supporting manual.
Training content
The group training sessions included the following components: education about alcohol consumption
(i.e. recommended limits and accepted terms and definitions) and surgical outcomes; the potential benefits
of delivering a BI for alcohol reduction/cessation during PAs (BCT – education about health consequences,
information about social and environmental consequences, credible source); instructions on how to
perform alcohol screening and intervention with demonstration videos (BCT – instructions on how to
perform the behaviour, demonstration of behaviour); role-play activities to practice intervention delivery
(BCT – behavioural practice/rehearsal, feedback on behaviour); brainstorming of potential barriers to
delivery and formation of plans to address these (BCT – problem-solving); and a quiz and prize to test
nurses’ knowledge (BCT – material incentives). To allow tailoring of the intervention to the needs and
preferences of individual patients, HCPs were trained to identify and use the BCTs embedded in the
intervention tools, for example providing information relevant to and requested by the patient and
supporting them to set meaningful and realistic goals. In addition, the training covered the use of brief
motivational techniques to allow HCPs to determine the level of motivation to change and tailor the
intervention to target motivation or volition at the appropriate times.
Training delivery
During the feasibility study, the training was delivered as a group session led by three psychologists (EL, LA
and Sebastian Potthoff), each of whom covered different aspects of the training based on their own areas
of expertise and experience. Microsoft PowerPoint® (Microsoft Corporation, Redmond, WA, USA) slides and
video recordings of intervention delivery were used as visual aids during the training sessions. A training
manual was also given to each staff member who attended the session alongside a copy of the screening
and behavioural intervention tools.
When new staff members joined the study, additional training sessions were delivered by one of the
psychologists (EL).
Evaluation of the training
The HCPs were asked to complete an evaluation form (see Appendix 5) on completion of the training. This
asked them to indicate how strongly they agreed or disagreed with 15 statements relating to the delivery and
content of the training as well as knowledge and skills gained. Responses were on a scale from 1 (strongly
agree) to 5 (strongly disagree). Five of the 10 HCPs who attended completed the evaluation form. Feedback
indicated that the training was enjoyable and well structured and that the content was appropriate, with
adequate time allocated for questions and discussion. Although the training was considered beneficial for the
delivery of screening and behavioural intervention during the study, it was not rated as beneficial for clinical
practice more generally.
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Fidelity of delivery: feasibility study
Fidelity of delivery was assessed during the feasibility study; the findings were used to document whether
or not interventions were being delivered as intended and to inform further refinement of the intervention
and training package. To facilitate skill acquisition and support effective delivery of interventions by HCPs,
written feedback was provided on the initial intervention sessions delivered by each HCP. During the
feasibility study, feedback was provided on sessions 1 and 4. However, following feedback from HCPs,
this was amended to sessions 2 and 4 for the pilot RCT.
All intervention sessions were audio-recorded when the patient had provided consent for this. Recordings
were transcribed verbatim and anonymised. Transcripts were read and independently coded by two
members of the research team (EL and LA). Where applicable, feedback on skill acquisition and fidelity of
delivery was constructed by the same two researchers (EL and LA). When fidelity of delivery was > 80%,
written feedback was provided to the HCP. When fidelity of delivery was < 80%, the research associate
(EL) contacted the HCP to arrange an additional, one-to-one, face-to-face feedback and training session,
lasting up to 1 hour, to focus on components of the intervention that had been omitted when it might
have been appropriate to deliver them.
When patient participants in sessions 1 and/or 4 did not consent to audio-recording, fidelity of delivery
assessments were conducted and feedback was provided for the next recorded session.
Fidelity of delivery was assessed using a standardised checklist of 18 BCTs (those present in the intervention
materials; see Appendix 1). As interventions were designed to be tailored, coders first rated which BCTs and
counselling techniques were delivered before assessing whether or not they had been delivered appropriately
(i.e. were BCTs delivered that best met the needs of the patient). This was to determine whether or not any
BCTs had been delivered simply because they formed part of the intervention.
Of the 10 HCPs who consented to take part in the study, four went on to deliver intervention sessions.
Staff allocation to each intervention varied based on shift patterns and availability. A total of nine initial
intervention sessions were delivered during the study, with seven of these audio-recorded and assessed for
fidelity of delivery.
All intervention sessions included delivery of BA, BI and the patient leaflet. Delivery of 9 of the 18 possible
BCTs was coded as occurring. Specific content varied between sessions indicating tailoring of interventions.
The most consistently delivered BCTs were information about health consequences (5.1), goal-setting
behaviour (1.1), social support (unspecified) (3.1) and pros and cons (9.2).
Fidelity of delivery was low, with 20–50% (mean = 40%) of BCTs considered to be appropriate being
successfully delivered. However, there were clear indications of attempts to deliver additional BCTs but,
as delivery did not fully meet the definitions in the BCT Taxonomy v1, these were not coded.
Optimisation of the training package
Intervention and interview transcripts generated during the feasibility study were reviewed by three members
of the project team in (EL, LA and CH) to identify barriers to effective intervention delivery and to inform
revision of the training, screening and intervention package ahead of delivery during the pilot RCT. Barriers
identified and addressed are detailed in Table 2.
Pilot randomised controlled trial training delivery
During the pilot RCT, training was delivered as group sessions led by two or three psychologists (EL, LA,
and Sebastian Potthoff) (depending on availability). Training was delivered in two formats. Staff at the
primary centre who had already been involved in the feasibility study received a shorter refresher version,
covering aspects of the training that had been revised after the feasibility study and including revised
project aims and objectives. The staff who had not participated in the feasibility trial (predominantly those
from the two additional centres) received a longer training session that provided a more comprehensive
DEFINING THE INTERVENTION AND COMPARATOR
NIHR Journals Library www.journalslibrary.nihr.ac.uk
18
introduction to the project and information about the use of the screening and intervention package
before covering areas that had not translated well from training to delivery at the primary centre in the
feasibility study. As with the feasibility study, additional training sessions were arranged and delivered by
Ellen Lynch if required.
Pilot randomised controlled trial intervention fidelity of delivery
Of the 11 HCPs who consented to participate in the pilot RCT, nine went on to deliver at least one
intervention session. One HCP conducted screening only.
During the pilot RCT, HCPs delivering the intervention sessions were asked to record whether or not the
patient attended the intervention session, which aspects of the intervention were delivered and whether or
not the patient set any behavioural goals. These details are provided in Table 3 and Box 1.
TABLE 2 Barriers identified and addressed post feasibility study
Barrier Explanation Addressed
Time lag between
training and intervention
A substantial period of time elapsed between
training and commencement of intervention
delivery
Training in the pilot RCT phase to be delivered
as close as possible to the commencement of
screening and recruitment without risking
delays to the project
Infrequent intervention
delivery
With only a small number of patient
participants recruited in the feasibility trial
and consent rates fluctuating, intervention
delivery occurred infrequently over a fairly
extended period
The pilot RCT to include a greater number
of patients and resolution of issues with
recruitment during feasibility trial, which
should lead to more consistent recruitment
rates in the pilot RCT
Adequate time to deliver
intervention
HCPs felt that they sometimes had to ‘make
time’ to deliver the intervention and could be
pressured if the clinic was not running to
time or if other patients arrived either late or
early for their appointments
Extended appointments to be arranged for
research participants, with the participant
attending ahead of their PA appointment
to complete consent and randomisation
processes and additional time for intervention
delivery allocated. Each site in the pilot RCT to
have a HCA available to aid facilitation of the
intervention sessions
Identifying level of
motivation
HCPs were not always able to identify how
motivated patients were to change
Instruction on how to use the questions
exploring motivation to change and confidence
in changing behaviour, which appear in the BI
tool, to identify how motivated patients are
to change their behaviour. During training,
explicitly identify skills HCPs already use that
will help them to identify level of motivation,
specifically ‘listen, ask, think’
Tailoring intervention
content to level of
motivation
HCPs were aware that they should tailor the
interventions but intervention transcripts
showed they were not always successful in
tailoring content to level of motivation
Additional educational aspect in the training
to explain intervention aspects relevant to
motivating patients or targeting volition.
Addressed in expanded ‘action-planning’
section of the training
Tailoring screening and
interventions to address
screening reactivity
HCPs were not clear about how to tailor
intervention sessions or how best to
complete AUDIT questionnaires when patient
participants had changed their drinking
between initial screening and intervention
delivery
Be explicit in training that initial AUDIT is
concerned with drinking over the past 6
months. Include time scale for each AUDIT
questionnaire on the questionnaire. Address
this in the training session along with tailoring
of the intervention to level of motivation
Delivery of BCTs
attempted but not
successful
BCTs ‘social support’, ‘goal-setting’ and
‘problem-solving’ were frequently attempted
but not successfully delivered during
interventions
Additional instruction provided on delivery of
these BCTs. These examples were targeted in
expanded coping planning section of the
training
HCA, health-care assistant.
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TABLE 3 Pilot RCT intervention details
Intervention aspect
Site
Total1 2 3
n % n % n % n %
Attended intervention 8 100 16 94.1 8 100 32 97.0
Consented to audio-recording 19 100 28 82.4 11 73.3 58 85.3
BA delivered 8 100 16 100 8 100 32 100
BI delivered 8 100 16 100 8 100 32 100
Patient leaflet given 8 100 17 100 8 100 33 100
Goals set 4 66.7 15 88.4 8 100 27 87.1
BOX 1 Goals set (verbatim)
Motivational goals
Health, does not want to gain weight as won’t be as active, better recovery time and save money.
Weight, save money, feel better in the morning.
Healthy weight and for surgery.
Weight management and healthy lifestyle.
More money better outcome to reduce the risk of any complications in surgery and to reduce recovery time.
Volitional goals
Swap non-alcoholic drinks for usual drinks and leave environment for drinking (match day/pool nights).
Reduce drinking, at home and to start from today.
Reduce drinking from now and to try and stop drinking altogether.
Stop drinking for 2 days a week and to reduce intake by a third.
To reduce from seven pints per day to four by the surgery day.
To reduce intake to 10 units 1 week for surgery.
Try and reduce alcohol intake.
Reduce alcohol intake.
Reduce number of units of alcohol.
To still have a reduced intake of alcohol.
Other
Patient will see how it goes after intervention session.
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Of the 33 patient participants allocated to the intervention arm, 32 attended the initial session and received
BA, BBI and the patient leaflet. The remaining patient participant received the patient leaflet only. Twenty-seven
of these participants also set goals, details of which were recorded for 16 patient participants and are provided
in Box 1. The level of detail included in the goals varied. Goals can be broadly divided into two categories:
motivationally focused goals, concerning the possible benefits of reduced alcohol consumption; and
volitionally focused goals, which centred on methods of reducing alcohol consumption.
Patient participants were also asked to consent to their intervention session being audio-recorded to allow
a fidelity of delivery assessment to be made. More than half of participants who consented to take part in
the trial also consented to audio-recording of the session, and 17 of the intervention sessions delivered
were audio-recorded (as patients consented to audio-recording before randomisation, the number
consenting to recording exceeds the number allocated to receive the intervention).
As with the feasibility study, all audio-recorded sessions were transcribed verbatim and transcripts were
assessed for fidelity of delivery. Written feedback was provided to HCPs based on early sessions (2 and 4)
to facilitate skill acquisition and support effective intervention delivery. When patient participants in
sessions 2 and/or 4 did not consent to audio-recording, feedback was provided for the next recorded
session. The same standardised checklist developed during the feasibility study was used to code
intervention content, and all transcripts were coded independently by two researchers (EL and LA).
Fidelity of delivery improved from the feasibility study to the pilot RCT (from 40% to 65.9%), with
evidence of delivery of 13 out of 18 possible BCTs identified in coding and an average of 65.9% of BCTs
considered to have been appropriately delivered. Specific content varied between sessions, indicating
tailoring of interventions, but fidelity of delivery also varied among staff members, suggesting different
levels of skill acquisition from training.
The BCTs that targeted motivation were most frequently coded as both appropriate and delivered. Specifically,
those involving informing participants about the health, social and emotional consequences of alcohol
consumption (5.1, 5.3, 5.6) were coded most frequently. Feedback on behaviour (2.2) in the form of an alcohol
screening score was successfully delivered in the majority of sessions; however, feedback on the outcomes
of behaviour (2.7), which would have been appropriate in all sessions, was never successfully delivered.
Delivery of BCTs that targeted volition (i.e. enactment of behaviour change) generated a less consistent
picture: goal-setting (1.1) and social support unspecified (3.1) were frequently utilised/delivered, whereas
pros and cons (9.2) and problem-solving (1.2) were frequently attempted but less often delivered
successfully. Some volitionally focused BCTs were also those most frequently rated as not appropriate
[restructuring the social environment (12.2), reducing exposure to cues for behaviour (12.3), behaviour
substitution (8.2)], although motivationally focused social comparison (6.2) also fell into this grouping.
Characterising treatment as usual
This chapter concludes by reporting on a series of focus groups (n = 3 groups) and an electronic survey
that were utilised to characterise ‘TAU’ in respect of screening and intervention for alcohol consumption
in the context of PA for hip and knee arthroplasty.
Methods
A mixed-methods approach was adopted:
l During the feasibility study, focus groups were used to provide in-depth descriptions of PA for hip and
knee arthroplasty in the three centres included in the pilot RCT.
l During the pilot RCT, a quantitative survey was used to gather data relating to alcohol screening and
intervention in PACs across the UK.
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Focus group methods
The HCPs were eligible to participate in focus group sessions if they were currently involved in the
orthopaedic patient pathway in one of the three centres identified to take part in the pilot RCT. It should
be noted that focus groups were held during the feasibility study recruitment period. As such, some HCPs
from the primary site were already familiar with the project and a smaller number had been involved in
screening and intervention delivery.
Potential participants were sent an e-mail inviting them to participate in one of the focus groups (one was
held at each of the three sites). The HCPs who replied to indicate their intention to attend the sessions
were sent an electronic version of the focus group information sheet (see Appendix 6) at least 24 hours in
advance of the session.
Focus groups were conducted by the research associate (EL), who greeted each participant on arrival and
provided hard copies of the information sheet for further consideration. Before the focus group discussion
commenced she introduced herself to the group, providing a description of her research background and
qualifications before giving a verbal introduction to the project and her role. As a result of her role in the
feasibility study, the associate was already known to some HCPs from the primary site where she had been
involved in training delivery and intervention feedback.
This personal introduction was followed by an explanation of the purpose of the focus group session
(to establish TAU), ethics considerations and ground rules for the discussion. Participants then had the
opportunity to ask any questions and to suggest any of their own ground rules for the session. Once all
questions had been answered, participants completed informed consent forms (see Appendix 7), which
included consent for the session to be audio-recorded.
Discussion commenced by asking the HCPs to introduce themselves and state their job role. The research
associate then used a semistructured topic guide (see Appendix 8) to guide discussion to cover the
preoperative care pathway, alcohol screening, alcohol intervention and referral, perceptions of the current
approach to alcohol screening, previous experience of intervention delivery and acceptability of preoperative
alcohol interventions.
Two hours were allocated per focus group, with the discussion itself lasting between 50 minutes and
1.5 hours.
All focus group recordings were transcribed verbatim and subject to framework analysis,126 with a
deductive approach adopted to focus on the characteristics of the ‘TAU’ condition. All transcripts were
dual coded, with codes discussed and agreed periodically.
Survey methods
An electronic web-based survey was used to gather data from PA staff nationally regarding TAU, with a
specific focus on alcohol screening and intervention in PA.
The electronic survey included 20 questions (see Appendix 9) that collected demographic details (age and
gender) brief information about job role and experience (current job role, time employed in current role,
total time employed in PA) and basic information about preoperative appointment length before proceeding
to explore the current approach to alcohol screening and intervention, with fixed-response questions asking
participants to indicate if alcohol screening, intervention and referral were conducted as part of PA, what
form these took and how patients were identified for information provision or referral. Finally, participants
were asked to indicate any previous or current involvement in intervention delivery for a number of health
behaviours (alcohol, smoking, physical activity, diet or nutrition). Free-text response boxes were provided for
participants to provide additional detail if they chose.
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The link to the electronic survey was circulated to informal groups of PA HCPs, predominantly nurses and
health-care assistants (HCAs), via an e-mail mailing list (n = 22 recipients) and a social media group (n = 98
members). On following the survey link, potential participants were presented with an electronic version
of the survey information sheet. The next screen presented an electronic ‘tick box’ consent form, which
asked participants to indicate their agreement to each point on the consent form. Participants had to
agree to each statement before being able to proceed with the survey. The subsequent screens presented
the survey questions, with branching logic applied to ensure that subquestions (e.g. detail of alcohol
interventions) were displayed only if applicable. At the end of the survey, participants had the option to
either submit or discard their responses. Finally, an electronic thank-you and debrief screen was presented.
The survey took an average of 6 minutes to complete.
Data were subject to descriptive analysis only with frequency of each response category reported.
Results
Focus group results
A total of 19 HCPs, ranging from band 5 nurse to consultant anaesthetist, took part in the focus groups;
all were female (Table 4).
Framework analysis of focus group transcripts revealed five key themes relating to TAU in PA for hip and
knee arthroplasty.
TABLE 4 Focus group participants
Group Participant Job role Site
1 1 PA nurse band 6 1
2 PA nurse band 6 1
3 Student nurse 1
4 PA nurse band 6 3
5 PA lead nurse 3
6 Substance use lead 1
7 PA nurse band 5 1
2 8 PA lead nurse 2
9 PA sister 2
10 PA sister 2
11 PA sister 2
12 PA sister 2
3 13 Consultant anaesthetist 3
14 PA lead 3
15 PA nurse band 6 3
16 PA team leader 3
17 PA nurse band 5 3
18 PA nurse band 6 3
19 PA nurse band 5 3
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It’s a big and busy appointment
The PA appointment for hip and knee arthroplasty was described as lasting 45 minutes at one site and
1 hour at the other two sites. However, staff identified that this could vary if patients were seen as ‘walk
rounds’ immediately following listing for surgery where appointment length was seen to be dictated by
‘supply and demand’. The HCPs identified a variety of tasks, tests and assessments that needed to be
completed as part of PA for primary hip and knee arthroplasty. This included gathering information about
health and social history as well as assessing a variety of physiological systems and considering medication
management:
. . . you start off doing it’s like a ‘major form’ that we use for pre-assessment of orthopaedics if it’s
a hip or a knee erm so you start off like with height, weight and obs and you do bloods and you
do breathing tests and you do an ECG [electrocardiogram] and you do a full medical questionnaire,
look at their drugs erm and ask them all sorts of questions . . .
ID 1, PA nurse band 6, site 1
The HCPs expanded on this to explain that although the PA appointment was a demanding one for them,
the burden on the patient was higher still, with a number of additional forms and assessments. Further to
this, patients also have to see a number of HCPs, including occupational and physiotherapists, as well as
the PA nurse:
They go for the ECG [electrocardiography] that’s usually the last thing we do, get them to go for ECG
when we’re finished, give them the paperwork, they take that with them so they’re busy looking at
the paperwork and it’s quite an in-depth questionnaire, tick-box questionnaire erm and then when
they’ve done that, when they come back then the OT [occupational therapist] wants to see them, she
takes them somewhere else, brings them back. So it’s quite a, it seems like quite a long drawn-out
assessment by that time they’ve had enough.
ID 1, PA nurse band 6, site 1
These numerous assessments and appointments were also seen to result in a large amount of information
being provided to patients, both during the appointment and for them to read and consider in their own
time. The HCPs expressed some concerns that this could be too much for patients and that elderly patients
especially may not be able to process all of this information:
. . . you’re giving them a lot of information, you’re giving them an anaesthetic leaflet and a meds
[medications] leaflet, they’ve got to sign two forms, you’re giving them a leaflet to say why you’re
taking blood for transfusion and sometimes these elderly people maybe can’t see what the hell you’re
talking about sometimes by the time you go away they’ve got bags of paperwork and they don’t even
know what they’re doing with it . . .
ID 1, PA nurse band 6, site 1
Despite concerns about the burden placed on patients, HCPs explained that the duration and intensity
of the assessment process was necessary because of the complexity of the planned surgery as well as the
nature of the orthopaedic patient population, who were considered to be older and more likely to have
comorbid conditions:
. . . the majority still are elderly patients who have the nature of the beast is they’ve got other medical
conditions going on anyway and they’ve got a drugs list like a roll of whatever, yeah so and that’s a
big thing as well we’ve got like a medication list that we instruct ‘em about what drugs they can and
can’t take so those kind of things take quite a while [Interviewer: Yep] just for the type of patients
they are . . .
ID 1, PA nurse band 6, site 1
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. . . it is a big PAC [pre-assessment], it is a major surgery and it needs to have the time and that
credence to do it properly or else you’re just skating around corners . . .
ID 1, PA nurse band 6, site 1
In line with the purpose of PACs, the assessments conducted could be seen as focusing, first, on the
identification of risk and, second, on the mitigation of these risks and the optimisation of the patient
ahead of surgery. Factors identified included both known conditions and previously unidentified risks,
with the identification of cardiac conditions being discussed by HCPs from all three sites:
. . . we may pick up on newly diagnosed heart problems and erm things so they may have to be
referred to a cardiologist . . .
ID 14, PA lead, site 3
. . . umm and as you said sometimes we see a lot of new atrial fibrillations, we see abnormal heart
rhythms or they’ve got poor lung function or they’re diabetic on insulin . . .
ID 1, PA nurse band 6, site 1
Procedures to mitigate risks and optimise patients ahead of surgery addressed a number of factors; these
included medication management, diabetes control and correction of anaemia:
. . . so the patients that are low in iron we transfuse them preoperatively with iron err so it optimises
their post-op care . . .
ID 5, PA lead nurse, site 3
. . . prior to surgery we do some medication management as well because we might have to stop
certain drugs, may have to give them some erm injections prior to surgery to help thin the blood
because we’ve stopped them having a particular drug . . .
ID 14, PA lead, site 3
The only optimisation process identified that directly related to health behaviour was smoking cessation
but one HCP identified that they expected to undertake further optimisation processes in the future:
. . . I know there’s obviously plans afoot, you know pre-assessment’s going to change and there’s
going to be more optimisation of patients . . .
ID 1, PA nurse band 6, site 1
Having the time to identify and manage these different factors was seen to be the predominant reason for
conducting PA well in advance of the date of surgery and this was explained to be important for avoiding
cancellations:
The reason why we see them from same day in our same-day clinic is because it gives them weeks
and weeks and weeks because in our patients we find that we’ve had a lot of brand new heart
problems that weren’t there before so it saves postponing the patients as well so we get all that
sorted first, optimise the patient as much as possible before we give them a date for surgery.
ID 14, PA lead, site 3
The vast majority of the PA was described as being undertaken by members of the nursing team, who
clearly identified themselves as responsible for requesting information and tests, interpreting the results
and identifying how to proceed:
. . . that’s really the nurse who is doing it what she does about it, whether she sees it as a red flag
or not . . .
ID 1, PA nurse band 6, site 1
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However, staff from all three sites discussed the fact that anaesthetists were available to offer additional
support for complex patients or to conduct further assessments when required:
Also we do have a, a consultant anaesthetist or an anaesthetist allocated every single day.
[Interviewer: Yep] In case there’s a patients who needs to see an anaesthetist so there’s somebody
available to see that patient ‘cause others got concerns with their GAs [general anaesthetic] previous
GA problems and things like that so we get them seen before they go home. And also he takes
patient with complex is history via our anaesthetist to have a look and decide what to do . . .
ID 7, PA nurse band 5, site 1
Alcohol is asked about but not ‘screened for’
Health-care professionals from all three sites explained that alcohol was ‘always’ asked about as part of
the PA and that ‘as long as you ask the question it needs to be answered’. However, none of the HCPs
referred to this as ‘screening’ and none currently used validated alcohol screening tools. Instead, the PA
form included a box to indicate how many units the patient consumed per week:
There isn’t any screening but we are mindful of their intake. We always ask that.
ID 9, PA sister, site 2
. . . we do ask them how many units they will drink in an average week . . .
ID 16, PA team leader, site 3
Alcohol consumption did not appear to be a focus of PA, and HCPs described it as ‘just another question’.
There was some indication that HCPs felt that they could be doing more to assess and address alcohol
consumption but that they were restricted by the amount of time available and the small amount of space
on the PA form:
. . . really the space is just how many units a week it doesn’t really give you that much scope. I mean you
could go on if they say yeah I drink every night and whatever but it doesn’t give you a lot of scope . . .
ID 1, PA nurse band 6, site 1
. . . you know really you could spend so long doing so much and making these things so much better
but as it is, the way it is at the moment you just don’t have the time or the resource to do it but I
think you’re just skipping over it . . .
ID 1, PA nurse band 6, site 1
The reliance on self-reports of alcohol consumption was seen as a potential issue. The HCPs discussed
difficulties in gaining honest and accurate information from patients. They were of the opinion that some
patients would be honest about their alcohol consumption whereas others would under-report or ‘lie’
about how much they drank. Reasons for under-reporting included being ‘ashamed’ and providing socially
desirable responses, with some patients having a tendency to ‘tell you what you want to hear’:
But it’s only what people say how many units you know you’re just going by what they say [Interviewer:
Mmm] some people will give you the minimum or just they’ll tell you what you want to hear . . .
ID 1, PA nurse band 6, site 1
You have to rely on the honesty of the patient and sometimes if you are a heavy drinker you don’t
want to acknowledge it like others do. They are quite happy to tell you their units.
ID 9, PA sister, site 2
Some HCPs felt that older patients were more likely to be honest about their drinking and were often
comfortable with the amount that they drank and did not see it as ‘problematic’ regardless of whether or
not this was in excess of the recommended drinking guidelines. Reasons given for this included the fact
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that drinking was part of their routine, that it was part of their social lives, that they had been drinking in
a particular way for a long time and that significant others, including previous generations, had shown
similar drinking patterns:
I think a lot of the older people that we get through and we ask they’re like not proud of it but very
confident they’re like I go out three times a week and I have three pints every time they don’t see that
as a problem because it’s what they’ve always done for years, that’s what their dads done it’s a social
event for them they don’t see that that’s excessive because it’s only three pints and it’s only three
times a week . . .
ID 2, PA nurse band 6, site 1
In some cases it was explained that patients’ responses may be inaccurate not because they wanted to
mislead the HCP but because they did not realise how much alcohol they were consuming until they were
asked to report it day by day:
. . . then you’ve gotta say right so how many do you drink on a weekend when you add it up it’s like
two bottles of wine well that’s 18 units, that’s above and they go ‘oh is it’ . . .
ID 4, PA nurse band 6, site 3
Descriptions of frequency of drinking by patients were also often inconsistent with HCPs interpretations
with perceptions of what constituted ‘regular’ drinking being particularly problematic:
They are totally oblivious, they’re not bothered. I’ve had quite a few say oh I drink occasionally and you
go well when would that be? ‘On a Friday and Saturday.’ Well that’s not occasionally that’s regular . . .
ID 16, PA team leader, site 3
In combination, these issues point to the need for HCPs to probe patients about alcohol consumption
rather than simply ask how many units they drink per week if they are to gain accurate information.
Despite identifying possible issues with self-reports of alcohol consumption, HCPs identified that patients
were the only ones who would actually know how much alcohol they consumed and thus asking them
was the best way to gain the required information:
. . . because nobody knows more than them if they are drinking more than they should be nobody
knows more than them . . .
ID 6, substance use lead, site 1
Objective assessments of alcohol-related harm were available at all three sites in the form of liver function
tests (LFTs) and HCPs from all three sites also talked about conducting LFTs as part of PA. However,
this was not done for every patient but rather was an optional test that could be conducted for patients
considered to have a high alcohol intake to provide a more detailed assessment of surgical risk:
We ask about their intake, how many units a week [Interviewer: Yeah, yeah] and if it was a massive
amount, we would probably check their liver function.
ID 8, PA lead nurse, site 2
It’s not what you ask, it’s how you ask
The majority of HCPs were comfortable asking patients about alcohol consumption but explained that
patient responses to questions about alcohol consumption varied with some being very comfortable and
others being more reluctant or defensive:
ID 1: . . . it’s all, its variable isn’t it?
ID 7: . . . it’s different . . .
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ID 3: . . . you get some that are really defensive when you ask . . .
ID 1, ID 7, ID 3, site 1
I think our patient population here, err they’re very down to earth, they’re very laid back. Yeah I think
it’s quite easy to ask them questions like that.
ID 13, consultant anaesthetist, site 3
Some HCPs explained that patients would laugh or offer joke responses, which they appeared to interpret
as an indication of patients being comfortable with the questions but could also be considered a defensive
response:
ID 8: They usually laugh.
ID 12: Yes.
ID 11: I was gonna say laugh . . .
ID 9: Or they say, ‘Do you want the truth?’.
ID 8, ID 12, ID 11, ID 9, site 2
However, HCPs explained that alcohol could be a sensitive subject for some patients and that how the
questions were asked was important. Asking questions about alcohol use in among a large number of
other questions and once a rapport had been established were seen as ways to reduce the possibility of
adverse responses. HCPs also talked about different methods of ‘selling’ the questions to patients with
techniques such as explaining that the questions were routine and pointing out the relevance of the
questions to their health or the planned surgery being discussed:
I know it can be a bit of embarrassment but don’t worry we ask everybody it’ it’s just that’s how
I sell it as . . .
ID 6, substance use lead, site 1
. . . it’s really important we know how much alcohol you have because that really can affect your
general anaesthetic we need to know whether to bring you in a day early do we need to you know
we need to look after you, we need to make sure that you’re fine you know we don’t want anything
going wrong while you’re here.
ID 6, substance use lead, site 1
The fact that alcohol consumption was routinely asked about was not only a way of assuaging patients’
anxiety about the questions but also meant that HCPs became experienced in asking about alcohol
consumption, which was seen to be beneficial:
I’ve done this a long time so it’s kind of you know it’s not too difficult a conversation for me to have
because I’m used to broaching it . . .
ID 6, substance use lead, site 1
This experience meant that HCPs had been able to develop the skills necessary to broach the subject
of alcohol consumption effectively. Skills described as important included adopting a non-judgemental
approach and knowing when to ‘take a step back’:
I think if people felt you were challenging them and didn’t like it I think we would always, sort of,
be aware of when to draw back a bit because if they don’t want you to know and they don’t want
to tell you, you feel like you are invading their privacy . . .
ID 9, PA sister, site 2
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. . . it’s about as well I think saying to people this is not about judging you . . .
ID 6, substance use lead, site 1
In addition to the experience and skills of the HCPs, patients’ acceptance of questions about alcohol use
was considered to relate to the reason that they were attending the PA. The orthopaedic population were
seen to have a strong desire to have their surgery and HCPs explained that many patients were in pain and
would have waited a long time for surgery. This was seen to make them more compliant:
ID 6: Yeah, yeah] you know they’re a [Interviewer: Ah hu] they are willing and they’re sitting there
listening to you . . .
ID 2: . . . they want their operation . . .
ID 1: . . . they’ll do anything to get it . . .
ID 6, ID 2 and ID 1, site 1
Managing preoperative alcohol consumption
The HCPs talked about a number of different strategies that were available for the management of alcohol
consumption in the preoperative period. How alcohol consumption was managed appeared to be dependent
on the amount of alcohol being consumed. Patients who were drinking more than the drinking guidelines
were often advised simply that it would be beneficial to reduce their alcohol consumption:
I just say someone who drinks like 30-odd units a week I just say something like ‘that’s above the
national guidelines have you thought about cutting down?’ . . .
ID 5, PA lead nurse, site 3
All three sites also had alcohol specialist or alcohol liaison nurses to whom they could refer patients who
required additional support to reduce their drinking. However, not all of the PA staff were aware of this
service, perhaps because outpatient clinics were not focus points for identifying increased risk or dependent
drinkers. Further to this, many of those who were aware reported that their patients consistently declined
any offer of support from this service:
. . . we ask them if they would like any further information, you know once we’ve pointed out that
that is over the national guideline limit and erm they all say no . . .
ID 14, PA lead, site 3
The HCPs reported that those patients who were viewed to be drinking to excess or those identified
through LFTs would be referred on regardless of their preference. In some cases, patients would be
referred to an anaesthetist who would either review the patient’s notes or see the patient in person to
further assess their surgical risk and decide how to manage them:
. . . if that flags up through the like bloods or whatever you’ve taken [Interviewer: Yeah, yeah]
and then alcohol erm anaesthetic review . . .
ID 2, PA nurse band 6, site 1
Alternatively, patients could be referred to the alcohol specialist nurses to help them prepare for surgery
rather than to support them in reducing their drinking. Such management often involved a more in-depth
assessment of alcohol consumption and then preparations to bring the patient into hospital a day before
their surgery date so that withdrawal could be managed and surgery could proceed as planned:
. . . how are they when they’ve not been drinking [Interviewer: Mmhmm] because that’s gonna
guide you when they’re gonna be nil by mouth and whether you’re gonna have to get some meds
[medications] prescribed or whether you need to be advising this chap will need to come in early or
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we need to be prepared or do they need to have a conversation or do they need to come back to
have a full intervention . . .
ID 6, substance use lead, site 1
This option was considered to be only for the ‘big drinkers’ who were thought to be unlikely or unable to
change, indicating possible alcohol dependence:
We do have somebody but that tends to be for if they’re you know drinking loads [Interviewer: Yeah]
like need detox or something. Not for your erm not for the vast majority of patients . . .
ID 1, PA nurse band 6, site 1
The option to refer patients back to their GP was also discussed by some HCPs, albeit less frequently than
other options. The description of patients being ‘referred back’ to the GP suggested that surgery would be
postponed until the GP had seen and reassessed the patient:
It would be referral onto the anaesthetist for him and then he would make a decision as to whether
they needed referring on or back to the GP for further advice.
ID 8, PA lead nurse, site 2
It was clear from the descriptions offered by HCPs that, although measures were in place to ensure the
safety of patients who showed signs of alcohol dependence, little provision was made for those drinking at
‘risky’ or ‘increased risk’ levels:
The ones I’ve referred are the ones who would be having a bottle of vodka every night, not the ones
who would be having, sharing a bottle of wine with their husband every night, that just is gets
ignored really. Not ignored but you would still do certain blood tests but it it’s the big drinkers like
hundreds of units that get referred . . .
ID 18, PA nurse band 6, site 3
. . . there’s nothing really in place for this group of patients as it stands at the moment because they’re
not so high risk that you’re concerned about their perioperative period you, you know you accept it
that I think there’s such a big proportion of people that fall into this category that it becomes normal
erm I think if you can say to patients we’re trying to do this because we’re worried it’s going to take
your wound longer to heal or you’re more at risk of getting an infection afterwards then to be able to
say something like that you know 15-minute chat and if you reduce for 6 weeks it might improve your
outcome that’s very different . . .
ID 13, consultant anaesthetist, site 3
Could be more, could be better
The descriptions of alcohol screening and management in PA showed variation in practice both between
and within the three sites. Although some assessment of alcohol consumption was part of formal PA at
each of the three sites, there did not appear to be any clear or consistent guidelines as to what to do
in response to this questioning. Individual HCPs tended to talk about ‘big drinkers’, ‘excessive drinkers’
and those consuming ‘a massive amount’ as being referred for review or identified as requiring LFTs.
Otherwise, in the absence of specific guidelines and procedures, the HCPs drew on their own training
and experience to make decisions about how to manage alcohol consumption in the preoperative period:
. . . it is very much what the nurse does themself but you know we are all obviously trained enough to
know that someone who drank god knows how many units you would do something about it.
ID 1, PA nurse band 6, site 1
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The HCPs explained that asking questions about alcohol consumption often felt purposeless as the vast
majority of patients received no feedback, intervention or further testing even though their alcohol
consumption exceeded the drinking guidelines. In the absence of any method of addressing risky and
increasing risk drinking, HCPs described simply moving on to the next question in their list:
. . . well you work it out ‘well that’s 70-odd a week’ right have you got any allergies? you think what
do you ask that for because you’re just sweeping over it . . .
ID 1, PA nurse band 6, site 1
Although all three of the sites had alcohol specialist nurses available to whom patients from any part of
the hospital could be referred, the awareness of these services varied between individual HCPs and across
sites, indicating that further communication and clarification of services available was required:
ID 6: . . . if someone asked you that would you know who to refer them to would you know what the
referral process is in [site 1]?
ID 2: No.
ID 6: OK so you need to know that.
ID 2: Because I’ve never done that so I do think we do need a structure like that in PAC.
ID 2, ID 6, site 1
Further to this, even when staff were aware of the processes for making referrals to alcohol specialist
services, they felt that they had no method of following up on this or ensuring that the patient was
actually seen. Beyond this, there was some concern that referrals may not actually lead to any further
treatment or support, and staff did not always agree that the guidelines were appropriate for the effective
delivery of alcohol-related care:
. . . we ask the question, refer them on but nobody there follows them up and makes sure that they
come or go and see [alcohol specialist nurse] . . .
ID 14, PA lead, site 3
What I’ve got concerns with is is I don’t think five should be a referral to us because five is six units
once a month . . .
ID 6, substance use lead, site 1
In addition to the variations between and within sites in current practice, it was clear that practice changed
over time. National incentivised programmes had influenced practice at two sites. Site 3 had previously
employed the Michigan Alcoholism Screening Test (MAST)127 with BA and referral available, and site 1
was in the process of implementing alcohol screening for all inpatients; both of these were part of the
CQUIN initiative:
ID 14: It used to be a CQUIN target so we’ve got the questions on the pro forma like how many do
you drink a week and then we’ve got like . . .
ID 16: . . . the MAST score . . .
ID 14: . . . the MAST score yeah nought to one and then two to four we have to fill that out and then
you’ve got erm brief intervention given . . .
ID 14, ID 16, site 3
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However, negative personal experiences with these processes could lead to failure to adopt or maintain
them, with staff from site 3 identifying that they stopped using the full screening, intervention and referral
process when patients showed little interest in the additional information and support available to them:
. . . we did used to have some written information booklets that mapped it out . . .
. . . no one none of the patients wanted to take it on [Interviewer: Yep] and have this further
information provided so [Interviewer: OK] sort of fizzled out . . .
ID 18, PA nurse band 6, site 3
Survey results
Survey participation Sixty-two participants (51.7% response rate) completed the survey. The majority
of respondents were female (90.3%) but covered a diverse age range, the full spectrum of nursing job
roles (from HCA to matron) and included those new to PA (< 1 year) as well as those with over a decade
working in PACs. Demographics of the sample are summarised in Table 5. All were familiar with PA for hip
and knee arthroplasty.
Appointment details
The typical length of PA appointments for hip and knee arthroplasty ranged between 30 minutes and 1 hour,
with the majority of respondents (knee, 61.3%; hip, 59.7%) reporting appointments lasting 45 minutes.
All respondents indicated that patients were asked about alcohol consumption as part of PA, although two
stated that this was not part of the formal procedure. However, the type of questions used to assess alcohol
TABLE 5 Survey respondent details
Variable Category Respondents, n (%)
Gender Female 56 (90.3)
Male 6 (9.7)
Age 21–30 10 (16.1)
31–40 30 (48.3)
41–50 13 (21.0)
51–60 9 (14.6)
Job role HCA/senior HCA 7 (11.3)
Band 4 2 (3.2)
Band 5 33 (53.2)
Band 6 12 (19.4)
Band 7 1 (1.6)
Team leader 4 (6.5)
Sister/senior sister 1 (1.6)
Matron 2 (3.2)
Time working in PA < 1 year 4 (6.5)
1–5 years 35 (56.5)
6–9 years 11 (17.8)
≥ 10 years 12 (19.4)
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consumption varied, with only 29% using a formal screening tool or questionnaire (Table 6). Similarly,
although > 50% reported that patients were given information about alcohol consumption in PA (14.5%
indicated that this was part of the formal PA procedure) and 80.6% indicated that they could refer patients
for additional advice or support related to alcohol consumption, what information patients received and to
whom they could be referred varied (Table 7).
TABLE 6 Availability of alcohol screening, information and referral
Response option
Yes, standard
practice/formal
procedure, n (%)
Yes, but not standard
practice/formal
procedure, n (%) No, n (%)
Don’t know,
n (%)
Missing,
n (%)
Patients asked about alcohol
use
59 (95.2) 2 (3.2) – (–) 1 (1.6) – (–)
Patients given information
about alcohol use
9 (14.5) 23 (37.1) 26 (41.9) 3 (4.8) 1 (1.6)
Referral for additional advice
or support available
34 (54.8) 16 (25.8) 7 (11.3) 1 (1.6) 4 (6.5)
TABLE 7 Alcohol screening, intervention and referral details
Category Response option Yes, n (%) No, n (%)
Don’t know,
n (%)
Missing,
n (%)
Alcohol screening
(N = 62)
Yes/no indication of alcohol consumption 34 (54.8) 26 (41.9) 1 (1.6) 1 (1.6)
‘How much do you drink?’ 19 (30.6) 42 (67.7) – 1 (1.6)
‘How often do you drink?’ 25 (40.3) 35 (56.5) 1 (1.6) 1 (1.6)
How many units/standard drinks per week? 27 (43.5) 34 (54.8) – 1 (1.6)
How many units/standard drinks per day? 18 (29.0) 40 (64.5) 1 (1.6) 1 (1.6)
Screening tool or questionnaire 18 (29.0) 40 (64.5) 3 (4.8) 1 (1.6)
Alcohol information
(N = 32)
Information leaflet about alcohol in general 11 (34.4) 17 (53.1) 4 (12.5) –
Information leaflet about alcohol and surgery 10 (31.3) 17 (53.1) 5 (15.6) –
Face-to-face information about alcohol in
general
7 (21.9) 22 (68.8) 3 (9.4) –
Face-to-face information about alcohol and
surgery
21 (65.6) 7 (21.9) 4 (12.5) –
Websites to access in their own time 2 (6.3) 24 (75.0) 6 (18.8) –
Contact numbers for telephone
information/support
3 (9.4) 24 (75.0) 5 (15.6) –
Patient is told to contact their GP surgery 1 (3.1) 26 (81.3) 5 (15.6) –
Referrals for additional
information or support
(N = 50)
Referral to consultant anaesthetist 37 (74.0) 9 (18.0) 4 (8.0) –
Referral to GP 5 (10.0) 41 (82.0) 4 (8.0) –
Referral to alcohol liaison or nurse specialist 28 (56.0) 20 (40.0) 2 (4.0) –
Referral to in-hospital addiction psychiatrist 1 (2.0) 42 (84.0) 7 (14.0) –
Referral to Alcoholics Anonymous 2 (4.1) 43 (87.8) 4 (8.2) –
Referral to other external organisation 3 (6.0) 42 (84.0) 5 (10.0) –
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The form of alcohol screening varied; patients were most frequently asked if they drank alcohol and to
provide details of how many units they drank, or how often and how much they drank, so that HCPs
could calculate the number of units consumed:
We have to record units per week so I ask if they drink, when they drink and what they have . . .
ID S4
One respondent provided a possible explanation about why patients are not always directly asked to report
their consumption in units:
Patients don’t always know units so I ask what they drink and calculate . . .
ID S7
A number of respondents also used the text boxes to explain that they had previously used less structured
questioning about alcohol consumption but had recently replaced this with the AUDIT-C questionnaire as
part of the CQUIN initiative:
We have always asked patients if they drink and how much they drink but we recently started using
the AUDIT-C questionnaire as part of the CQUIN . . .
ID S31
A number of sites appeared to provide minimal information or simple advice to cut down or avoid alcohol
before surgery:
Patients told to avoid alcohol before surgery . . .
ID S2
In some cases information was provided only to those considered to be ‘heavy’ drinkers:
I generally suggest that heavy drinkers cut down before surgery and we have some booklets about
alcohol that we can give them . . .
ID S11
This information was not always delivered by PA staff:
Physios [physiotherapists] provide this info . . .
ID S27
Regarding referral, respondents most frequently indicated that they could refer patients to consultant
anaesthetists and alcohol liaison or alcohol nurse specialists.
As can be seen in Table 8, there was a similar level of variation in how patients were identified to receive
information and to be referred for additional information and support. Responses recorded in the free-text
boxes provide some further insight into this. The specialist or service to which patients were referred was
often related to how they had been identified. Specifically, those identified through LFTs would be referred
for consideration by an anaesthetist, whereas those identified by screening tools would be referred to
alcohol liaison or nurse specialists:
If a patient asked for help I’d give them a leaflet and tell them to get in touch with their GP or arrange
alcohol liaison but this has never happened. I usually give patients who score five or more on AUDIT a
bit of advice and/or leaflet. Liver function tests flag and the patients notes go to anaesthetist . . .
ID S11
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Some respondents from sites participating in the implementation of the initial CQUIN initiative explained
that this also included the provision of information and, for screen-positive patients, the option to refer to
alcohol specialists:
CQUIN has referral to alcohol liaison. We can refer to [anaesthetist] . . .
ID S26
Finally, a number of staff indicated that, although patients did not routinely ask for information about
alcohol, this information would be provided if it was requested:
If patients asked I’d give them information but they don’t . . .
ID S6
Methods of identification showed considerable variation, suggesting that there are not clear policies
outlining which patients should receive a referral. Further to this, some respondents indicated that referrals
for additional support would be made only if patients wanted to be referred, whereas referral for review
by an anaesthetist would be made either way:
Patients only referred to alcohol nurse if they want to be. Notes seen by anaesthetist either way . . .
ID S1
TABLE 8 Identification of patients to receive information or referral
Response option Yes, n (%) No, n (%)
Don’t know,
n (%)
Prefer not to
say, n (%)
Information
provided to
(N = 32)
All patients 11 (34.4) 18 (56.3) 2 (6.3) 1 (3.1)
All patients who report drinking 3 (9.4) 26 (81.3) 2 (6.3) 1 (1.6)
All patients who request information 12 (37.5) 17 (53.1) 3 (9.4) –
Patients who consume over a specified number
of units
16 (50.0) 12 (37.5) 4 (12.5) –
Patients who state, when asked, that they
would like to reduce their alcohol consumption
5 (15.6) 23 (71.9) 4 (12.5) –
Patients identified through LFTs 9 (28.1) 17 (53.1) 6 (18.8) –
Patients identified through other blood tests – 26 (81.3) 6 (18.8) –
Other 4 (12.5) 23 (71.9) 5 (15.6) –
Patients receive
referral (N = 50)
All patients – 48 (96.0) 2 (4.0) –
All patients who report drinking alcohol – 49 (98.0) 1 (2.0) –
Patients who consume over a specified number
of units
30 (60.0) 18 (36.0) 2 (4.0) –
Patients who state, when asked, that they
would like to cut down their alcohol
consumption
10 (20.0) 37 (74.0) 3 (6.0) –
Patients identified through LFTs 39 (78.0) 8 (16.0) 3 (6.0) –
Patients identified through other blood tests – 45 (90.0) 5 (10.0) –
Patients who ask to be referred 9 (18.0) 37 (74.0) 4 (8.0) –
Patients who show signs of alcohol dependence 25 (50.0) 21 (42.0) 4 (8.0) –
Patients who are already identified as alcohol
dependent
31 (62.0) 14 (28.0) 5 (10.0) –
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Conclusions
The focus group and survey results both indicated that asking patients about alcohol consumption and
recording their responses was a formal part of PA at almost all sites. Focus group discussions built on this,
with HCPs explaining that they were experienced in asking about alcohol consumption and had the
necessary skills to broach this subject with patients. As a result they were likely to be well placed to provide
additional guidance on alcohol use and surgical risk. The majority of HCPs also stated that they could refer
‘heavy’ drinkers for review by an anaesthetist prior to surgery, with LFTs and units of alcohol consumed
being used to assess whether a patient or their notes should be reviewed by an anaesthetist. However,
few specific details were provided on how LFTs were interpreted and what, if any, cut-off points were used
to decide if such a referral was appropriate.
This suggests that there are few formal guidelines regarding how to identify alcohol consumption that
potentially represents a risk for surgery and when and how to address alcohol consumption as a ‘risky’
behaviour. Just over 50% of survey respondents indicated that they provided patients with some form of
information related to alcohol consumption but < 15% stated that this was part of formal PA; the form
of information varied from a simple leaflet about alcohol consumption to face-to-face information about
alcohol consumption and surgery. Free-text responses indicated that when face-to-face information was
provided, this was predominantly in the form of a brief recommendation to avoid alcohol consumption
before surgery, with little or no explanation of why or guidance on how long alcohol intake should
be altered.
At the point of conducting the focus groups (October–December 2016), none of the three sites used a
validated alcohol screening questionnaire. This is in line with the previous survey of medical perioperative
assessment leads.116 At the time of the PRE-OP BIRDS survey (2018), 29% of respondents indicated that
they used a validated screening tool. Many of these utilised the free-text response boxes to indicate that
this was a recent change as a result of the CQUIN initiative, which came into effect in the period between
the focus groups being completed and the survey commencing. With previous research67 demonstrating
that using screening tools improves the detection of both alcohol dependence and increased risk drinking,
the deployment of a validated tool may lead to a reduction in alcohol-related complications.
Awareness of in-hospital alcohol specialist services was low among PAC staff at two of the three sites
included in the focus groups, with the third site requiring patients to agree to a referral to alcohol specialist
nurses, something that they indicated was widely refused. Awareness appeared to be higher among survey
respondents, with 45% indicating that they could refer patients to alcohol liaison or alcohol specialist
nurses. However, the methods for identifying patients to receive information or referral also varied, with
biological tests (LFTs), self-reported alcohol consumption, indications of alcohol dependence and previous
alcohol history all being used.
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Chapter 3 Feasibility study
Background
Feasibility studies offer the opportunity to work with patients and HCPs from the proposed target
populations to gain insight and to explore the appropriate optimisation and acceptability of interventions,
outcome measures and research processes. Pilot trials may then be performed to provide an accurate
estimation of rates of eligibility, recruitment and retention to inform a decision about the feasibility of
proceeding to a definitive trial.
Aims
The study aims were to:
l assess the feasibility and acceptability of consent, screening, intervention and outcome
assessment procedures.
l optimise the screening and behavioural intervention process in a way that nurses and patients
find acceptable.
Methods
Design
A mixed-methods design was used, including qualitative interviews combined with assessment of screening
and recruitment rates.
During the feasibility study, focus groups (n = 3 groups) to characterise TAU and assessments of fidelity of
delivery of intervention sessions were also conducted. These are reported in Chapter 2.
Setting
Patient participants were recruited from a single site, a large secondary care teaching hospital in an urban
location in the north-east of England. The site has an orthopaedic preoperative surgical care pathway of
6–10 weeks from PA to surgery. Patient screening took place in a surgical outpatient clinic with the BBI
delivered in the PAC, and an optional booster session was delivered either over the telephone or face to
face at the PAC.
Outcome measures
Acceptability and feasibility were assessed using a combination of quantitative (eligibility, screening, recruitment
and retention rates) and qualitative (themes identified in analysis of staff and patient interview transcripts) data.
Procedure
Health-care professional recruitment, training and interviews
Screening and intervention were conducted by HCPs employed in the PAC. As such, it was necessary first
to recruit and train HCPs to deliver the screening and intervention processes.
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Health-care professionals were eligible if they were currently employed in the PA unit and were both
willing and able to attend study-specific training. HCPs were excluded if they were unwilling to consent
to audio-recording of intervention sessions, which was required in order to conduct assessments of fidelity
of delivery (described in Chapter 2), or if they were unwilling or unable to attend the required training.
A group training session (described in detail in Chapter 2) was delivered to HCPs on 15 April 2016 and
a further session was held on 1 September 2016 to train a newly appointed HCA dedicated to the role
of conducting initial eligibility screening with patients.
Health-care professional interviews
All HCPs involved in screening or screening and intervention delivery were eligible to participate in a
qualitative interview about their experience of being involved in the research. The research associate (EL)
sent all HCPs involved in the delivery of screening and/or interventions an e-mail inviting them to take part
in an interview. E-mail invitations included the HCP interview-specific information sheet (see Appendix 10)
as an attachment. Interviews were arranged at a time and place that suited the HCP participant; all three
were conducted in a private room at the hospital immediately following a shift in the PAC. Interviews
were conducted by the research associate, who gave a verbal introduction to the interview process before
completing the informed consent form with the HCP participant. A topic guide (see Appendix 11) was
used to structure the interview, which included questions about participants’ experience of being involved
in the study, the acceptability of the study processes, barriers and difficulties encountered during alcohol
screening and/or intervention delivery and recommendations for improvements. Interviews lasted between
20 minutes and 1 hour; all were audio-recorded and transcribed verbatim.
Patient screening and recruitment
From the patient perspective, the feasibility study was based around four key points of contact or ‘visits’.
This study process is summarised in Figure 1. The activities completed at each visit are displayed in Table 9
and all processes are described in detail here.
Inclusion and exclusion criteria
Patients were eligible for the study if they:
l were aged ≥ 18 years and listed for elective primary hip or knee arthroplasty
l had capacity to provide informed consent
l were able to write and converse in English (i.e. able to understand English sufficiently to complete the
study questionnaires without the need for an interpreter)
l had screened positive for increased risk drinking (AUDIT-C score of ≥ 5 and reported consuming ≥ 6 units
in one session at least weekly).
Patients were excluded from the study if they:
l scored < 5 on the AUDIT-C screen or did not report consuming of 6 units on a single occasion at
least weekly
l were likely to undergo sequential (on different dates) joint replacements (for bilateral disease) within
the scope of the proposal (because of reduced availability for follow-up)
l displayed current (active) withdrawal from alcohol
l had a severe psychiatric disorder requiring medical therapy, or severe cognitive impairment or dementia,
affecting their ability to interact with the intervention and increasing the likelihood of postoperative delirium.
Patient participants were eligible to receive the intervention if they reported a score of ≥ 8 and consumption
of ≥ 6 units in one session at least weekly on the full AUDIT questionnaire. Patient participants were excluded
from the intervention if they scored < 8 on the full AUDIT or reported consuming ≥ 6 units on a single
occasion monthly or less frequently.
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Visit 1: screening
Initial screening for alcohol consumption using the AUDIT-C was conducted in a surgical outpatient clinic
following listing for surgery. Patients were approached by a HCP trained in delivery and scoring of the
AUDIT-C tool. The HCP completed the AUDIT-C with all willing patients and immediately assessed the
responses for study eligibility. Eligibility was confirmed if the patient scored ≥ 5 on the AUDIT-C and reported
consuming six or more standard drinks in one session at least weekly. Eligible patients were given a verbal
explanation of the study and asked if they were interested in taking part. Those who expressed an interest
were provided with a copy of the participant information sheet to take away with them and were asked for
permission for follow-up contact to discuss the study further. Expressions of interest, contact information
and preferred method of contact were recorded in writing by the HCP on the expression of interest form.
Patients were then given 1 week to consider taking part in the study. After this time, the HCP contacted
them by telephone or e-mail (depending on patient preference) to establish ongoing interest in participation
and to arrange intervention delivery for those patients who confirmed ongoing interest.
Setting Timeline
(Week n)
Intervention Staff member
Surgical
outpatients
Outpatient
Outpatient
Outpatient
Inpatient
hospital
(4–7 days)
Outpatient
post operation
(6 weeks post
surgery)/
patient’s home
PAC clinic
Listed for elective
arthroplasty
AUDIT-C (score of ≥ 5)
AUDIT (score of ≥ 8)
Intervention
session 1
Intervention
session 2 and
AUDIT
Expression of
interest
Phone/e-mail
expression of
interest
confirmation
Written consent
Surgery and in
hospital
recovery
Weeks
0–6
Weeks
6–9
Week
10
Week
11
Weeks
12–16
Interview with
patient
Research associate
Research associate/
screening-trained
PAC HCA
Research nurse
Research nurse
Intervention-
trained
PAC nurse
Intervention-
trained
PAC nurse
FIGURE 1 Feasibility study process.
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Visit 2: consent and intervention
Consent, completion of the full AUDIT questionnaire and intervention delivery (when patients were eligible)
took place in the PAC. On arrival at the PAC, patients were met by a research nurse, who checked that the
patient was still committed to taking part and, if so, confirmed their eligibility, including establishing their
capacity to consent, before completing the informed consent discussion and asking patients to complete and
sign the informed consent form; this included an indication of whether or not they were willing to have their
intervention session audio-recorded and if they were willing to be contacted about participating in a qualitative
interview at 6 weeks post surgery. The participant was given a copy of the completed consent form. After
consenting to the study, patients completed the full AUDIT questionnaire with an appropriately trained HCP
prior to intervention delivery. Patients who scored ≥ 8 on the full AUDIT or reported consuming six or more
standard drinks on a single occasion at least weekly were eligible for intervention delivery. Patients who scored
< 8 on the full AUDIT and reported drinking six or more standard drinks on a single occasion less than weekly
were thanked for agreeing to take part, received positive feedback and were informed that the more in-depth
measure indicated that their drinking fell within the lower-risk category and that nothing further was required
of them in the preoperative period. As these patients were able to provide information about the acceptability
of preoperative alcohol screening and study consent procedures, all those who provided consent to be
contacted about a qualitative interview were contacted 6 weeks post surgery to gauge their interest in
interview participation.
There was no upper limit of alcohol consumption or screening score that would lead to exclusion from the
study. However, patients displaying current (active) withdrawal from alcohol were excluded from the study
and assessed by the principal investigator to consider if a referral to an addiction psychiatrist for additional
support was appropriate.
Intervention
The intervention and its development are described in detail in Chapter 2 and their content, defined in
terms of BCTs, is presented in Appendix 1. The intervention tools and processes are summarised here.
The BBI was structured around three tools utilised as follows:
l The BA tool acted as a visual aid for communicating information and provided HCPs with prompts to
structure and deliver this advice to participating patients.
TABLE 9 Feasibility study schedule of enrolment, interventions and assessments
Time point
Study period
Visit 1: screening
Visit 2: consent
and intervention
Visit 3: booster
session
Visit 4: qualitative
interview
Enrolment
AUDIT-C ✗
Expression of interest ✗
Consent ✗
Intervention
AUDIT ✗
Intervention ✗
Booster ✗
Follow-up
Interview ✗
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l The BI tool provided prompts to guide discussion of behaviour change with participating patients.
This discussion could include motivation to change, pros and cons of change, goal-setting and problem-
solving. This tool also provided space to record aspects of the intervention (e.g. goals and plans) to
prompt behaviour outside the clinical setting.
l The patient leaflet106 was introduced in the intervention sessions and given to patients at the end of the
intervention session along with copies of the BA and BI.
Following completion of the full AUDIT, eligible patients received the BBI. The first session was delivered
face to face in the PAC by an appropriately trained HCP. The session lasted 20–30 minutes, beginning with
5 minutes of BA delivered using the BA tool as a visual aid and prompt. The remainder of the session
involved providing of the behaviour change intervention, targeting motivation and volition to target
alcohol reduction or cessation in the preoperative period and using the BI tool to guide the discussion.
At the end of the session, participants were provided with copies of the intervention materials to take
away with them, as well as a copy of the patient leaflet.
Visit 3: booster session
Patients who indicated at the time of consent that they were willing to be contacted about participating in
the optional booster intervention session were contacted by their preferred method (telephone or e-mail)
approximately 2 weeks prior to surgery to gauge their continued interest in the booster session. For those
who agreed to participate in the booster session, arrangements were made for the session to be delivered
either face to face in the PAC or over the telephone approximately 1 week before surgery. The booster
session, delivered by the same HCP who delivered the initial intervention session, lasted between 10
and 20 minutes and began with completion of the full AUDIT tool. The aim of this session was to revisit
any goals and plans made during the first session, to provide feedback on performance and to boost
self-efficacy, supporting behaviour change maintenance. For patients who indicated a desire to change
but who did not set goals and plans during the first session, this booster provided an opportunity for
them to do so. For those who had set goals and plans, it served as an opportunity to make any revisions
and to receive feedback to target behaviour change maintenance.
Visit 4: post-intervention interview
All patient participants who consented to take part in the feasibility study indicated on the consent form
that they were willing to be contacted about participating in a qualitative interview. These interviews
aimed to explore the acceptability of screening, intervention and research processes to patient participants.
The research associate (EL) contacted participants by telephone approximately 5 weeks post surgery with a
view to arranging interviews to take place at, or around, the 6-week post-surgical outpatient appointment.
Interviews took place in a private room at the hospital site, either immediately before or immediately after
their outpatient appointment (n = 10) or in their own home on a day when they were not attending the
hospital (n = 3). Those wanting to take part were provided with an interview-specific patient information
sheet (see Appendix 12) using their preferred method (e-mail or post) prior to the interview. On the day
of the interview, the research associate gave a verbal explanation of the interview process and a brief
overview of her research background. Participants then completed the interview-specific informed consent
form. All interviews were conducted using a topic guide (see Appendix 13) including questions about
alcohol consumption, the acceptability and feasibility of alcohol screening and BI in the preoperative
setting, their views of the intervention, their experience of being involved in the study, their opinions of
the study tools and the acceptability of planned methods for a subsequent RCT. Of the 15 participants in
the feasibility study, 13 took part in an interview (one could not be contacted and one failed to attend
interview). All interviews were audio-recorded and transcribed verbatim.
Protocol amendments during the study
Recruitment to the study was initially lower than anticipated. Assessment of initial screening and
recruitment rates identified that considerable numbers of patients were being screened as potentially
eligible, with many expressing interest in the study and taking away a copy of the patient information
sheet. However, on further contact (when possible) the majority did not express ongoing interest in the
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study and only a small minority went on to take part in the study. A number of factors were identified as
contributing to this issue and three amendments were made to address this:
l A number of patients demonstrated adverse attitudes to the term ‘risky drinking’, which appeared in
the initial study title and study documentation (Preoperative Behavioural Intervention for Risky Drinkers
before elective orthopaedic Surgery).
¢ Amendment: the wording of the study title was amended to focus on the benefits of reducing
alcohol consumption rather than identification of patients as ‘risky drinkers’. The new title adopted
was ‘Preoperative behavioural intervention to reduce drinking before elective orthopaedic surgery’.
l Allowing 1 week for consideration of the study before the research team made contact with patients
who had expressed interest in the study meant that many had lost interest. This gap also presented
issues in terms of arranging consent and intervention around the PAC appointment, as many
appointments had already been scheduled.
¢ Amendment: to facilitate the arrangement of research procedures and intervention delivery, the
time allowed for consideration of study participation was reduced from 1 week to 24 hours before
the research team attempted to make contact to gauge ongoing interest.
l The inclusion criteria required patients to score ≥ 5 on the AUDIT-C and to report consuming ≥ 6 units
in a single session at least weekly. This significantly reduced the number of patients who were eligible
for the study and meant that many frequent heavy drinkers who could potentially benefit from the
intervention were being excluded from the study because they either did not report high intensity
drinking (consumption of six or more standard drinks in a single session) or reported doing so less
frequently than weekly.
¢ Amendment: to capture both regular heavy drinkers and high intensity drinkers, the inclusion criteria
were amended to an ‘and/or’ criterion rather than an ‘and’ criterion alone.
The amendments were approved by the funder, the Research Ethics Committee and the Health Research
Authority in November 2016 and were implemented at the recruiting site shortly thereafter.
Results
Sample
Health-care professional participants
A total of nine HCPs consented to take part in the feasibility study and received the study training; four
(44%) were involved in screening and intervention delivery during the study period and three went on to
take part in qualitative interviews.
Patient participants
Patient screening commenced on 3 May 2016 and the first patient was recruited on 24 May 2016. The
study closed to recruitment on 2 March 2017; over the 10-month screening and recruitment period, a
total of 15 patients consented to and participated in the feasibility study (two were recruited in the first
5 months and, 13 were recruited in the subsequent 5 months). Patient participants were predominantly
male (87%) and had an average age of 70.5 years. Details of the sample are shown in Table 10 and
participant health behaviour data are displayed in Table 11.
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Analysis
Quantitative data were subject to descriptive analysis only. Screening and recruitment rates are detailed
along with mean scores on the AUDIT questionnaires completed at baseline and the booster session
(when applicable).
Qualitative data from patient and HCP interviews were analysed thematically. Framework analysis was used
to analyse the interview transcripts.31 For patient participant interview data, two experienced qualitative
researchers (EL and CH) repeatedly read and coded a subset of transcripts independently. Initial codes were
discussed and a framework of themes and subthemes for the analyses was produced. All transcripts were
TABLE 10 Feasibility study patient participant baseline characteristics
Characteristic n (%)
Gender
Male 13 (86.7)
Female 2 (13.3)
Ethnicity
White British 5 (33.3)
Missing 10 (66.6)
Operation
Hip 3 (20)
Knee 12 (80)
AUDIT score
≥ 8 9 (60)
< 8 6 (40)
TABLE 11 Feasibility study patient participant health behaviour at consent
Variable Mean Standard deviation
Alcohol units per week (n = 7, missing = 8) 19 8.9
BMI (kg/m2) (n = 6, missing = 9) 31.3 8.1
Number of days active per week (n = 6, missing = 9) 3.2 3.1
Physical activity (n, %)
Yes 6 40.0
No 1 6.6
Missing 8 53.3
Smoking (n, %)
Current smoker 0 0.0
Ex-smoker 1 6.6
Never smoked 6 40.0
Missing 8 53.3
BMI, body mass index.
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then coded by EL and CH within this framework with additional emergent themes and subthemes added
to the framework. Codes were discussed on an ongoing basis to inform the analysis and resolve any
disagreement about the interpretation of the data. Analysis was discussed with the full research team to
identify areas for closer consideration (including negative case analysis) and to enhance the credibility of
the thematic framework and interpretation.32 Finally, themes relevant to the aim of assessing the acceptability
and feasibility of the study and intervention methods were selected and are discussed here.
For HCP interviews, initial descriptive codes were generated from the transcripts and these codes were then
grouped into a framework that used the components and constructs of normalisation process theory (NPT)128
as themes and subthemes but was left open enough to allow the emergence of additional themes relating
to the acceptability of the study research, screening and intervention methods. NPT is an implementation
theory that can help us understand how research, screening and intervention processes translate into
real-world practice. This translation is often key to the acceptability of processes to HCPs. It provides a
theoretical framework to guide the exploration of how processes are implemented (operationalisation and
organisation), embedded (routinised in day-to-day practice) and integrated (sustained). NPT proposes that
it is the work of people individually and collectively to implement practices that lead to these becoming
embedded in practice. The theory has four key constructs (coherence, cognitive participation, collective
action and reflexive monitoring), each of which has four components.
Patient screening and recruitment
The flow of participants through the study is displayed in Figure 2. A total of 620 patients were screened,
of whom 105 (17%) were potentially eligible (based on AUDIT-C score). Fifteen of these (14%) were
recruited and nine of those recruited (60%) received interventions. Of the 15 patients recruited, 13 (87%)
participated in qualitative interviews about their experience.
Approached
(n = 658)
Not screened
(n = 38)
• Not interested, n = 28
• Not enough time, n = 3
• Follow-up patients, n = 3
• Did not want to walk to room, n = 2
• Study exclusion criteria, n = 1
• Involved in another study, n = 1Screened
(n = 620)
Expression of interest
completed
(n = 101) Not consented
(n = 86)
• Not interested, n = 30
• Other treatment, n = 25
• Unable to contact in time, n = 14
• Did not attend/cancelled, n = 6
• Unable to attend, n = 5
• Treated elsewhere, n = 3
• Study exclusion criteria, n = 2
• Admitted to hospital, n = 1
No expression of interest
(n = 4)
• Not enough time, n = 2
• Not interested, n = 2
Eligiblea
(n = 105)
Consentedb
(n = 15)
Not eligible
(n = 515)
Interview
(n = 13)
FIGURE 2 Feasibility study Consolidated Standards of Reporting Trials (CONSORT) flow diagram. a, 75 out of
470 screened eligible based on original inclusion criteria and 30 out of 150 screened eligible based on amended
inclusion criteria; b, nine received the intervention, four of whom also received the booster session.
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Figure 3 shows that, across the study as a whole, approximately 29% of patients screened scored ≥ 5 on
the AUDIT-C, with almost 16% reporting consuming six or more standard drinks on a single occasion at
least weekly and 14% of eligible patients consenting to participate in the study.
Screening and recruitment rates both before and after amendments were made to the study procedure are
detailed in Table 12. These figures demonstrate that the recruitment rate improved from 9.33% of eligible
patients to 26.67% following implementation of the amendments. Recruitment rates are displayed in Figure 3
and show the influence of the amendments as well as the benefit of a HCA joining the PAC team in October
2016, who, after completing the study-specific training, took ownership of the study at their site.
Patient alcohol consumption
All patients completed the full AUDIT questionnaire to assess eligibility to receive the intervention and the four
participants who received a booster session also completed the full AUDIT questionnaire at this time. The mean
AUDIT score at consent was 8.3 [standard deviation (SD) 3.0, n = 15] and at visit 3 (booster session) was 6
(SD 1.4, n = 4). Among AUDIT-positive patients only (≥ 8) the mean score was 10.4 (SD 1.6, n = 9) at consent.
Intervention delivery
As part of data collection, HCPs who delivered intervention sessions were asked to record whether or not
patients received each of the three key intervention aspects (BA, BI and patient information leaflet) and,
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FIGURE 3 Recruitment graph for feasibility study.
TABLE 12 Recruitment rates before and after amendments to the feasibility study
Variable
Original criteria Post-amendment criteria Total
n % % of eligible n % % of eligible n % % of eligible
Screened 470 100.0 150 100.0 620 100
AUDIT-C
score of ≥ 5
148 31.5 30 20 178 28.7
AUDIT-C question 3
score of ≥ 3
75 16.0 22 14.7 97 15.7
Eligible 75 15.0 100.0 30 20 100.0 105 16.3 100
Consented 7a 1.5 9.3 8 5.3 26.7 15 2.4 14.3
a Two patients were recruited under original criteria; five patients were screened under original criteria but consented in
October following the amendments.
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whether or not goals were set during the initial intervention session. Of the nine patients who screened as
eligible to receive the intervention, all received BA, BI and the patient information leaflet, and 56% (n = 5)
set goals.
Qualitative results
Interviews (HCPs, n = 3; patients, n = 13) found that proposed screening and intervention techniques
(i.e. behaviour change and brief motivational techniques) were acceptable both to patients and to HCPs
delivering the intervention. It was also found that screening and intervention could be conducted without
having a negative impact on patient care.
Patient interviews
Initial framework analysis of patient interview data identified eight themes, seven of which were
considered to relate to the aim of assessing the feasibility and acceptability of the research, screening
and intervention processes. Themes concerned patient perceptions of their drinking behaviour (Defensive
othering); the acceptability of screening [Alcohol screening is expected in the NHS but not specifically
preoperative assessment; Alcohol screening (using AUDIT) is acceptable]; the acceptability and effectiveness
of intervention methods (Preoperative assessment is a window of opportunity for screening and brief
behavioural intervention, Brief behavioural intervention targeting alcohol consumption is acceptable
although with mixed effects, Screening alone may lead to alcohol reduction) and terminology used in
screening and intervention (It’s pints not units, but units rather than standard drinks). These themes,
supported by quotations from the interview transcripts, are discussed below.
Defensive othering
In line with findings early in the feasibility study, which showed that patients responded adversely to the
use of terminology around ‘risky drinking’ in the study materials, all participants interviewed resisted the
narrative of being a ‘risky’ or ‘problem’ drinker. Instead they drew on the strategy of ‘defensive othering’,
whereby they made comparisons with others who drink more or more frequently than them in order to
normalise their own drinking and distance themselves from those perceived as ‘problem drinkers’. In this
way participants were able to admit that they drank and that they may have drank in excess of the drinking
guidelines but also to portray their drinking behaviour as acceptable. Reasons used by participants to explain
why their drinking behaviour was not a concern included that it was within the old recommended limits, it
was not excessive or dependent or alcoholic or alcohol abuse or binge, they were not a spirit drinker, they
did not drink in the house, they drank only with meals, they drank only socially, they did not drink as much
as their peers, young people or health professionals and they did not get drunk, have hangovers or drink
and drive:
Well it didn’t really, it didn’t, the drinking, it didn’t apply at all really. It’s, as I say, it’s I mean that’s all
I have, it’s nothing compared with some of them I’ve seen, some of them and they’ve way more than
me I have me pints that’s it no more than that . . . Oh I drink a lot less than other men.
ID 120, male, 87 years
I know that I should cut down. But I also like it. I don’t have a problem in as much as I’m dependent
on it. I think maybe a little bit dependent but I do like it. I don’t think about it all the time.
ID 14, female, 62 years
Alcohol screening is expected in the NHS but not specifically at preoperative assessment
Alcohol screening was generally viewed as a ‘normal’ part of health-care appointments in the NHS as a
whole. As a result, just over half of participants expected to be asked about their alcohol consumption
during PA:
As I say, for years I’ve had it [alcohol screening] from the NHS through the doctor’s surgery, all my life,
even the chemists ask now.
ID 108, male, 77 years
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However, the majority of participants did not associate alcohol use with surgery or consider that it would
be relevant to the perioperative period. As such, many did not expect to be asked about their drinking
behaviour at PA:
No, I didn’t think it [alcohol] had any bearing on a hip replacement basically.
ID 70, male, 68 years
However, two of the 13 participants interviewed were able to identify ‘risks with the anaesthetic and
drinking’ and ‘if you cut down beforehand and afterwards your recovery should be much better’. Despite
the clearly limited patient knowledge of the associations between alcohol and surgical outcomes, a couple
of participants reported that they would not consume alcohol before surgery:
When I went in for surgery I wouldn’t drink any alcohol anyway really.
ID 120, male, 87 years
Alcohol screening (using AUDIT) is acceptable
Regardless of whether or not alcohol screening was expected or thought to be relevant to surgery in general
and to orthopaedic surgery more specifically, it was widely considered to be acceptable. At least some of
this acceptability seemed to derive from the perceived normality of alcohol screening in health-care settings,
with patients explaining ‘they always ask about how much alcohol you drink’ and ‘it’s always asked in
hospital’. The approach adopted by screening staff also appeared to be important in ensuring acceptability,
with participants describing the process as ‘non-judgemental’, ‘not intimidating’ and ‘comfortable’:
I felt fine, because she asked it in such a non-judgemental way she didn’t put it over to me that she
was criticising or judging or anything.
ID 14, female, 62 years
The AUDIT, used for screening in this study, was found to be acceptable to patients, who described it as
easy to complete and understand:
Well, I think it covers every aspect, and it gives you plenty of choices. Yes, I think it’s a very good laid
out questionnaire.
ID 103, male, 67 years
Although there was no indication that alcohol screening was unacceptable to even the heaviest drinkers in
our sample, some participants explained that alcohol use could be a ‘sensitive subject’ for some people,
with the amount of alcohol consumed being related to the acceptability of screening:
. . . people who are drinking perhaps erm to a level that is not healthy that would be a little bit
uncomfortable and then you’ve got the people who would be in the excess area who probably would
refuse to take part . . .
ID 126, male, 65 years
Brief behavioural intervention targeting alcohol consumption is acceptable albeit with
mixed effects
All the participants who had received the BBI reported that it was acceptable. Participants explained that
they were ‘comfortable with it’ and ‘happy to get the advice’ and that the intervention gave them ‘insight’:
It did focus my mind more as well because I know that I have been at risk or I am at risk but it did
focus my mind on do I really want that one? No well let’s stop there . . .
ID 14, female, 62 years
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However, the acceptability of the intervention did not necessarily mean that it would lead to behaviour
change. Some participants explained that although they were happy to receive the information they would
‘take no notice of that’, or that it ‘didn’t change us one bit’, and some linked their lack of intent to change
with their age, stating ‘I’m too old to change now’.
Despite this, over half of the participants who received the intervention reported that it had led to a
reduction in their alcohol consumption. However, the magnitude of the change and the period of time
during which the change was maintained varied:
I knocked a pint off each session . . . and now that I’m on the mend I still probably knocked a pint off.
ID 104, male, 70 years
From the week before I had surgery I didn’t have any drink for 6 weeks. Completely 6 weeks,
possibly 7 . . . that I didn’t have any alcohol at all.
ID 108, male, 77 years
These changes in drinking behaviour were reported by some to be a result of having the consequences of
alcohol consumption on surgery explained:
. . . it was explained that it was, it would help us in healing . . . and there was less chance of catching
any bugs or anything.
ID 108, male, 77 years
Screening alone may lead to alcohol reduction
Although information received in the intervention was linked to behaviour change, some participants
reported that it was the AUDIT screening tool that had led them to change their drinking behaviour.
These participants explained that it ‘focused’ or ‘concentrated’ the mind and ‘crystallised how often I drink’:
. . . answering them and going through them and I thought ‘mmm that might be a little bit too much’
or ‘mmm I’m OK with that’ so I think the information was clear and it, it did focus my mind down
on things.
ID 14, female, 62 years
The issue of honesty in self-report measures of alcohol consumption also arose here. Although one
participant reported that other patients may conceal the truth when asked about their alcohol consumption
in a health-care setting, another identified that the time between completing the screening and attending
the intervention session allowed for reflection on the reasons for screening and led to more honest
responses when completing the baseline measures (i.e. the full AUDIT):
It might be in the back of your mind that you know you’re going in for surgery, and that they might
get a bit wobbly with you. Really I don’t, but it’s the syndrome where you don’t tell medical people.
ID 76, male, 64 years
. . . when they’ve had chance to think and reflect they might think that honesty is the best policy.
ID 108, male, 77 years
Preoperative assessment as a window of opportunity for screening and brief
behavioural intervention
The preoperative period and the PAC were seen as an acceptable time and place for the delivery of alcohol
screening and intervention. However, it was generally seen as important that screening and intervention
were conducted around existing appointments, with some participants explaining that it was a case of
catching them at the ‘right place, right time’ and others explicitly identifying the benefit of not having to
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‘make a special trip’. One patient also explained that the time and setting would be beneficial to both the
patient and the NHS:
Yes, it was probably good timing, with coming in, you know, to going to be coming in for
an operation.
ID 103, male, 67 years
However, some patients indicated that the orthopaedic patient population may not be the ideal target for
alcohol screening and intervention specifically because they tend to undergo surgery later in life than those
attending PA for other conditions. When asked about screening and intervening with people of a similar
age, participant responses varied. Some indicated that interventions may be less relevant as their alcohol
consumption was already lower than it had been in their younger years:
I think there must be 60, 70 per cent of people who 10, 20 years ago were big drinkers. I’m not
saying it’s like that now [Interviewer: Mmm] but most of them have come to common sense and they
don’t drink as much [Interviewer: Yep] but years ago when you were younger I think most people
drank far too much . . .
ID 117, male, 67 years
Others explained that older people may be less motivated to change:
I think you are wasting your time really . . . I shouldn’t say that like but ah well I don’t think at my age,
I don’t think I would take a lot of notice to be honest . . . a lot of young ones would but the older
ones wouldn’t I don’t think oh at my age I wouldn’t they are set in their ways.
ID 120, male, 87 years
On the other hand, some participants felt that screening and intervention with older people would be
more effective, with one explaining that older people were likely to be more honest, and another that
they were likely to listen more than younger people. One participant also explained that respect and
a non-judgemental approach were particularly important if interventions were to be acceptable to
older people.
It’s pints not units, but units rather than standard drinks
To accurately document alcohol consumption and to understand the sensible drinking guidelines, patients
and HCPs must understand the amount of alcohol in different beverages and servings. The screening and
intervention tools in this study used the term ‘standard drink’ to describe a drink or serving containing 8 g
of alcohol. From interview transcripts, it was clear that participants had little to no understanding of this
term prior to participation in the study; however, they stated that they were able to understand the term
when it was explained:
I’ve not heard it before . . . my interpretation of standard drink is how many units you should have.
You hear it all the time on the television, you hear it on advertising, you hear it on all sorts of things
but it, until I was actually taking part in the study it didn’t really mean a lot to me.
ID 14, female, 62 years
Participants described being more familiar with the term ‘unit’, although it was clear that the understanding
of what a unit comprised was limited. Some participants suggesting that further health promotion and
communication relating to this terminology would be beneficial:
I think they advertise 3 units for a pint. So, if you go in a pub for a drink, or if you buy a can, do you
have a standard drink, or do you have 3 units? Or is there only 2 units in it?
ID 103, male, 67 years
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Overall, the consensus was that patients were most comfortable talking about the quantity of alcohol
consumed in terms of pints or glasses:
No, well I, I only know, like, ‘a pint’ or ‘a pint and a half’, you know what I mean?
ID 109, male, 66 years
Health-care professional interview results
Five overarching themes were identified, four relating to components of NPT (defined in Box 2), which
provide insight into the work of HCPs to implement the screening, intervention and research processes in
the context of PA. Although these four themes show that interview transcripts revealed evidence of all
four of the key constructs of NPT, there was no evidence that all four components were present within
each construct, although findings may have emerged in these areas had the topic guide included probes
for each specific construct. The final theme (Perception of patient responses) emerged from the data but
did not directly fit within the NPT framework and relates to the various patient responses to screening and
intervention processes.
Owing to the small pool of potential interviewees and the visibility of their involvement in the trial to
others (e.g. colleagues in PA, research team members), quotations are labelled using ID numbers only.
Coherence
During interviews, HCPs did not directly differentiate their roles in day-to-day clinical practice from their
roles in the feasibility study (differentiation). However, they did consider how the study activities fitted in
with usual care and how screening and BBI may best be implemented into PA (communal specification),
BOX 2 Core constructs of NPT
Coherence
The ‘sense-making’ work that people do individually and collectively when an intervention is delivered
(e.g. How is the intervention understood by patients? Do they share a view of its purpose, understand how it
will affect them personally, and grasp its potential benefits?).
Cognitive participation
The ‘relational’ work involved in engaging and legitimising an intervention and associated practice
(e.g. How do patients participate in an intervention? What keeps them motivated to continue taking part?).
Collective action
The ‘operational’ work performed by individuals to organise and enact a new practice (e.g. How do patients
make the changes work? What strategies do they employ to organise and structure their lives to accommodate
the new practice?).
Reflexive monitoring
The ‘appraisal’ work that people do to understand and evaluate the impact of a new practice (e.g. how it
affects them and the people around them, and how patients come to decide whether or not the intervention is
worthwhile over time).
FEASIBILITY STUDY
NIHR Journals Library www.journalslibrary.nihr.ac.uk
50
as well as providing clear descriptions of their own roles and tasks in the study (individual specification).
They also discussed the benefits of being involved in the study as well as benefits of screening and BBI
(internalisation).
Communal specification
Communal specification involves individuals working together to understand the aims and objectives of
a new practice. In the case of this feasibility study, much of this understanding can be seen to relate to
how screening and intervention processes can be embedded in PA. HCPs considered how the screening
and intervention process fitted with existing preoperative processes from both their own perspective and
that of patients. The HCPs explained that, for both them and patients, discussion about alcohol use and
specifically the impact of alcohol use on surgery fitted well with the existing PA because alcohol use was
already asked about. Further to this, staff felt that conducting the TAU PA with the patient before going
into the intervention allowed them to develop a rapport with the patient and to anticipate how the
patient was likely to react to different questions. The HCPs perceived this as facilitating effective
intervention delivery:
. . . when we are doing it as part of the PAC, I did a couple that way and that actually flows quite well.
Because again, you’ve got that, sort of, you know, rapport going already with them and you just,
kind of, you mention the alcohol thing at the start of the pre-assessment. You go, ‘You’re part of the
study but we’ll come back to that at the end,’ so actually it, kind of, filters in quite nicely that way and
it did work a lot better that way . . .
HCP 4
However, owing to staff availability and involvement in the study, it was not always possible for the same
HCP who conducted the TAU pre-assessment to deliver the intervention, which meant that these benefits
could not be gained:
I think a few people I did the intervention with, I’d never met them before, I didn’t have the notes,
it was quite difficult to go in and go, ‘All right, OK, so you’ve triggered you drink X amount of units,’
and I think sometimes that can be a little bit hostile for people coming into that.
HCP 5
The HCPs also considered the potential burden on patient participants. Arranging screening and intervention
around existing appointments so that the patient did not need to travel to the hospital specifically for the
study was seen as important. Making the most of time usually spent waiting for appointments by using that
time to conduct screening was also beneficial:
. . . they’re already here in the hospital erm and if they are waiting for their appointment it passes a bit
of time for them and they don’t mind it if they come in early and things like that.
HCP 9
Following up on initial expressions of interest in a timely manner was also seen to be beneficial both for
patients and for study staff as it meant that the study information was still fresh in patients’ minds and
that they were more likely to have maintained an interest in taking part:
. . . waiting a week for to do the ‘phone call, that was a bit, because by the time they’d gone home,
if they’ve read it or if they didn’t read it they’d forgot about it and they just didn’t want to know but
now that that’s been fixed it’s just to a day thing’s will go, go better . . .
HCP 9
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Individual specification
Individual specification relates to how individuals develop an understanding of their specific tasks and
responsibilities. HCPs identified that the study training had provided them with an idea of what tasks they
personally would have to complete as part of the study. However, having the opportunity to practise the
screening and intervention and to develop real-world experience of delivery was more important in terms
of learning how to complete these tasks:
Well, again, it comes with experience, it’s good to have that initial training so you know what you’re
asking, you know what you’re roughly wanting to get from it and then you just find your own way of
asking the questions. I think yes, again, practice.
HCP 5
All three of the HCPs interviewed also demonstrated a clear understanding of their own role and
responsibilities, including the specific activities that they needed to complete. There was also an indication
that they had an understanding of how their role fitted with the roles of others in the project:
I have been interviewing people after they have already seen [HCA] and been identified so they have
agreed to participate in it. We have spoken about strategies they might want to use or have thought
of to try and, not abstain from drink, but to try to reduce the amount they drink prior to anaesthetics.
HCP 4
Internalisation
Internalisation is concerned with understanding the value and benefit of the processes being implemented.
The HCPs demonstrated knowledge of the benefits both from involvement in the study and from the
delivery of screening and intervention. The HCPs identified benefits for themselves as individuals as well as
benefits for the patients involved. For HCPs, being involved in the study was viewed as ‘interesting’ and
‘enjoyable’. Similarly, being involved in new care practices was seen as beneficial:
I think just being involved in something that’s quite new and upcoming and will play a very big part in
pre-assessment in the future, I think this is obviously just the benchmark for it now, so I think it’s quite
good to be involved in something like that.
HCP 5
The knowledge gained from the training, which was then communicated to patients in the intervention
sessions, was also seen as worthwhile and a key driver of ensuring that patients engaged with the
intervention:
. . . because a lot of the patients want the surgery, so if you can say to them, ‘You know that it’s
proven that it can improve your post-operative recovery,’ a lot of them are quite keen to do it. I know
it was identified in a lot of our training, people hadn’t realised that alcohol can be a contributing
factor to blood pressure or another issue that they’re dealing with, weight loss and that type of thing,
so when you’ve actually sat and gone through stuff like that, people had responded really well to it.
HCP 5
Cognitive participation
Cognitive participation is the work individuals do to develop practice around new processes and then to
sustain these. There was no specific evidence in the interviews of managers or team leaders working to
drive the implementation of screening and intervention (initiation). However, there was clear evidence that
the HCA responsible for screening also acted to co-ordinate the project activities, increase engagement and
facilitate the roles of other staff members (enrolment). In contrast to the clear consideration that had been
given to how best to implement screening and intervention in to the PA setting, there was no evidence to
suggest that HCPs had considered whether or not they were the right people to be involved in delivering
screening and intervention (legitimation), although the feedback provided on intervention delivery was used
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by one staff member as a method of ensuring that they were fulfilling their role within the study. The HCPs
did discuss difficulties in maintaining engagement with the study and the limited profile of the study within
the PAC (activation).
Enrolment
The HCA responsible for conducting the initial screening of patients identified that she was involved in
co-ordinating other HCPs involved in the study and facilitating their delivery of intervention sessions,
as well as connecting with other HCPs in the clinic to help promote screening:
I just speak to the nurse and say ‘oh I’m down here if they want to talk about some research that’s
going on erm bob them down’ . . .
HCP 9
This work was also identified by one of the other HCPs, who explained that the HCA was the person to go
to with questions about the study:
We’ve got [HCA] which is great, she’s doing a fantastic job and anyone just goes to her now which is
great to have . . .
HCP 4
Activation
The HCPs identified time lags, both between the initial training and recruitment of the first patient and
between each recruited patient, as limiting implementation of the study into PA. With practice and
experience of delivering screening and intervention being identified as key to effective delivery of the study
activities, such delays were likely to have an impact not only on the implementation of the study but also
on the quality of intervention delivery:
There are huge gaps between doing it and then, I mean, it seemed like a massive gap between our first
training and then doing it because I thought it had been such a long time. Then big gaps between times
when you have seen patients and then you are all ready to see them and they just don’t turn up . . .
HCP 4
The HCPs explained that they thought that ‘there would be more going on’ as part of the study. The small
number of participants recruited over a relatively extended period restricted the visibility of the study in the
PAC and led to both reduced confidence and reduced capability in delivering the interventions:
I think I would just feel more comfortable and more proficient if we did it more often and if it was
more visible . . . Just make it more of an established thing.
HCP 4
Collective action
Collective action is the work that people do to enact a set of new practices. Interviews included descriptions
of how the HCPs and patients interacted with the screening and intervention tools (interactional workability),
as well as the skills they had that enabled their delivery of the screening and intervention (skill set workability);
however, there was no discussion of HCPs’ trust in the intervention or in each other’s ability to deliver the
required tasks (relational integration). As with cognitive participation, where there was no evidence of
higher-level management involvement in the implementation of the study, there was no discussion of support
for the study from management, but there was some discussion of how staff time was allocated to the study
activities (see Contextual integration).
Interactional workability
The screening and intervention processes were based around the full AUDIT and AUDIT-C screening
questionnaires, the BA tool and the BBI tool. In interviews, HCPs discussed how they interacted with these
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tools and how patients responded to them. The screening questionnaire was described as easy to use,
with the inclusion of an infographic explaining standard drinks being particularly beneficial:
It’s, it was easy, it’s easy for them to understand and me as well. Erm and with it having the little table
on the top of what a, a standard drink is I can [Interviewer: Yeah] show them that and they can
understand it as well as me . . .
HCP 9
Similarly, the BA and BI tools were described as ‘good’, ‘not difficult’ to use, containing all the required
information and acting as effective prompts to guide intervention delivery:
The intervention is really in detail, it is all there. There is loads of information and it points you to
exactly where you need to be so it is good.
HCP 4
However, having time to become familiar with the intervention materials was considered to be important
in improving interaction with them, which was, in turn, important in maintaining a professional
demeanour during intervention delivery:
. . . once you’ve done it a couple of times and you, kind of, get familiar with the paperwork, with the
questions, with the intended outcomes, I think it becomes a lot easier to do it and a lot more fluid . . .
HCP 5
. . . you don’t want them to think you don’t know what you’re doing or looking through endless bits
of paper. I don’t feel comfortable doing that.
HCP 4
The tools were also seen to aid interaction between the HCPs and patients during intervention delivery.
The tools supported the communication of information, reinforced the intervention session by offering
space to record key aspects of the discussion and enhanced engagement:
. . . definitely showing them something because then they lean in and they’ll start reading off
the page.
HCP 5
Skill set workability
The HCPs discussed a number of skills that enabled them to deliver the screening and intervention
effectively. They explained that they were experienced in and comfortable with discussing alcohol with
patients and were able to do so in a non-judgemental manner:
I don’t talk to people in a judging way. I feel quite comfortable and confident to talk about that kind
of thing. I don’t think I have to shy away from stuff . . .
HCP 4
Further to this, HCPs explained that they had existing skills in recognising and managing different patient
responses, which was important in tailoring questioning and interventions to maintain a positive
interaction with patient participants:
. . . the response of the patients if they were like a bit abrupt and you know about it then I would feel
a little bit oh I’m I’m putting on to this patient a bit too much so I kinda back off a little bit and let
them talk about it . . .
HCP 9
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Contextual integration
Regarding contextual integration, HCPs discussed the allocation of staff time to deliver screening and
intervention. There was a clear focus on wanting to ‘do things properly’, which was considered to require
dedicated time:
Have you got valid time where you don’t feel like you’re going to be rushed? Because if you do feel
rushed then I know I have to skim through it and I’m not going to do it the way I should do . . .
HCP 4
Effective co-ordination and organisation of the study sessions was necessary with pre-planning to ensure
that staff were available and appointments were arranged to give them the additional time needed to
deliver the intervention:
. . . it’s fitting everything in it’s trying to fit things in and moving other appointments around to fit the
intervention in as well but if it’s planned in advance it works out good . . .
HCP 9
However, in some circumstances, for example when patients arrived late, these factors were outside HCPs’
control. This was particularly relevant for screening, which was usually conducted while patients were
waiting for an appointment:
. . . if they turn up late it’s it’s hard for me to get them, they don’t always want to stay and talk or
they’re too busy with something . . .
HCP 9
Similarly, if a HCP allocated time to deliver an intervention or indeed to deliver a number of interventions
on one day but patients failed to attend the sessions, this was problematic:
I had a morning set aside, there were two or three people booked for the intervention . . . so when I
was set aside the morning, I think only one or two people came for it . . .
HCP 5
Reflexive monitoring
Reflexive monitoring focuses on the work that individuals do to appraise new processes. The HCPs did
not specifically discuss the collection of evidence to gauge the effectiveness of the intervention or the
implementation of screening and intervention into the PA (systematisation). However, there was evidence
that the individuals involved had drawn on both anecdotal evidence from their own experiences and the
feedback provided by the research team (individual appraisal) to determine whether or not screening and
intervention was effective. Two of the interviewees pointed to collaborative assessments of how effectively
screening and intervention could be implemented in PA (communal appraisal). Finally, participants discussed
formal modifications (made to the study procedures through the submission of an amendment) and informal
modifications made to tailor delivery of the intervention (reconfiguration).
Individual appraisal
The HCPs appraised their involvement in the study and described it as enjoyable and interesting. Beyond
this, they identified the benefits of the screening process in terms of raising patients’ awareness of their
alcohol consumption and motivating change:
. . . a lot of them actually don’t realise that they’re drinking more than what is recommended, so if you
tell them that they are, they’ll go, ‘Ah!’ [gasps], you know, and they’re completely in shock. So they
want to know more . . .
HCP 5
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The HCPs also identified instances when they had been able to assess whether or not the interventions
had led to patients changing their alcohol consumption behaviour:
I recognised him the second time so that was quite good because usually I get moved around.
So, I think it just being a longer-term thing, it is interesting to see results . . .
HCP 4
These positive appraisals of screening and intervention effectiveness had also led to some of the HCPs
changing their usual practice during PA:
I’ve actually had people, not for orthopaedic surgery . . . they’ve questioned me on the alcohol
and does it, sort of, pose any difference either way. So I’ve brought it in a little bit there without
actually bringing it in, but just saying, ‘Well, actually yes, you know, we’re running this study for
certain ones.’
HCP 5
Communal appraisal
Although HCPs did not specifically discuss participating in communal appraisal of the interventions, two
of the interviewees alluded to its occurrence. The first anticipated that interviews with other HCPs would
produce similar findings, suggesting that the study processes had been discussed:
I imagine that whoever is doing it has probably got similar things . . . you might get repetition for the
same sort of things going on.
HCP 4
Another interviewee explained that, although NHS staff are often averse to change, discussion of positive
experiences of delivering the screening and intervention processes had helped to alter this view and that
this would, in turn, aid future implementation:
. . . people are reluctant to change and reluctant to change the ways that they do the practice. I think
it actually has gone down a lot easier than I thought it was going to and I think it will continue to
do that because I think people are now saying it’s not as bad as anybody thought it was going to be,
it’s actually all right, it’s quite easy . . .
HCP 4
Reconfiguration
The study processes were formally reconfigured during the course of the feasibility study via the submission
of an amendment, which had been informed by the experiences of the HCPs and research team to this
point. The positive impact of this was discussed by one interviewee, who felt that the change of the study
title and the reduction of the time between initial and follow-up expression of interest were both beneficial:
I think things will go better now with it just being 24 hours . . .
HCP 9
I think now that the titles changed it’s a lot better . . .
HCP 9
All three interviewees also pointed to less formal modifications that they made to the delivery of screening
and intervention processes with reference to finding ‘your own way’. The key here appeared to be rewording
questions and amending the terminology used to help improve the acceptability of screening and intervention
to patient participants. In some instances it appeared that specific terms could be problematic, regardless of
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the individual patient. This specifically related to avoiding any implication that drinking behaviour may be
problematic or that patients were being ‘accused’ of being a dependent drinker:
I perhaps might say pattern for that rather than behaviour because I think that gives a negative vibe
to people . . .
HCP 5
I don’t know, I think just the wording of those, so it was trying to find a way around wording that so
that people didn’t feel like they were being, almost accused of being an alcoholic . . .
HCP 5
In other cases, it was important to tailor the phrasing of questions and information to specific patients:
. . . it’s trying to get the wording to suit the person in front of you because again, it varies from person
to person, not everybody will respond the same way to the same question.
HCP 5
Perception of patient responses
The HCPs’ perceptions of alcohol screening were that it was generally acceptable to patients, with very
few declining screening and the majority being open to discussion about their alcohol consumption:
. . . good, yeah good ah I’ve never had one say ‘oh no I a can’t be bothered with it . . .
HCP 9
However, some demographic characteristics of patients were seen to make certain groups more open to
screening and more likely to provide honest responses, with men and younger patients being perceived as
more accepting of the screening and more open about their drinking behaviour:
I think the men are they the tend to be a bit more honest than the women erm women get quite a bit
more defensive . . .
HCP 9
The HCPs identified once again that patients generally showed a favourable response to the intervention:
. . . the majority of the time it’s been really fine, people responded really well.
HCP 5
Nonetheless, specific aspects of both the screening and intervention were identified as potentially leading
to adverse responses from patients. The HCPs identified individual questions and phrases as well as a view
that individuals were being ‘singled out’ as potentially making patients more defensive or less open. Each
of these issues appeared to relate to a potential implication of judgement that the individual’s drinking
was problematic:
I think it’s just a general issue erm some people get defensive because I think they think you’re
insinuating that they are drinking too much and I don’t think they kinda get that it’s for everybody
on the list not just a single person . . .
HCP 9
However, it was clear that HCPs felt that the majority of patients were comfortable discussing their alcohol
consumption.
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Discussion
Although recruitment of patient participants initially proved to be challenging, amendments to the inclusion
criteria, study title and period for consideration of participation led to a clear improvement in the percentage
of eligible patients consented to the trial. This indicates that the amended study materials and processes
were acceptable. Qualitative data from interviews with patient and HCP participants support this as they
identify screening and intervention methods as acceptable and the PA as a suitable setting. Further to this,
qualitative data provide additional insight into factors that can enhance the acceptability of methods and
those that can aid behaviour change.
Qualitative data show that, despite patient participants having little to no knowledge of the association
between alcohol consumption and surgical outcomes, screening and intervention in the PAC were
acceptable. The finding that alcohol screening is acceptable supports findings from previous quantitative
research, which also indicated good patient acceptance.57,62,68 Meanwhile, the findings that alcohol
interventions delivered in the PA are acceptable mirror those relating to interventions delivered either
predominantly105 or entirely in the postoperative period.104
This study builds on previous work by providing further detail on factors that contribute to the acceptability
of screening and intervention in PA. Specifically, arranging screening and intervention around existing
preoperative appointments so that no additional trips to the hospital were required was important, and
the perceived normality of screening, along with the non-judgemental approach of staff, contributed to
its acceptability. Although both patient and HCP participants identified alcohol as a potentially sensitive
subject and suggested that some patients would not be comfortable completing the screening questionnaire,
there was no evidence of this being the case even among the heaviest drinkers in our sample.
This work provides some early indications that BBIs may bring about reductions in alcohol consumption
in the preoperative period, with half of the participants who received the intervention reporting at least
some change to their drinking behaviour. Further to this, the subgroup of participants who did not
change still reported receipt of the intervention as acceptable. This work also provides some insight into
the components of screening and intervention techniques that were most useful to participants, namely
information about the effects of alcohol on recovery, healing and surgical outcomes, along with effects
on body weight and medication use and information about the lower-risk guidelines and health benefits of
cutting down. However, the small number of patient participants and the variability in the information and
advice identified as important highlights the need for interventions and interventionists in the preoperative
setting to be sufficiently flexible to allow the tailoring of delivery to the individual patient.129,130
With previous research131,132 finding that older adults are one of the least well-informed groups when it
comes to alcohol measurement and terminology, it is perhaps not surprising that patient participants in
this study were unfamiliar with the term ‘standard drink’. Although participants reported being able to
understand the screening questionnaires that use this term, their descriptions of standard drinks and
units were not always consistent with this and participants consistently reported being more comfortable
describing their consumption in terms of pints or glasses. Based on these findings, providing HCPs with
adequate training and guidance to ensure that they are confident in converting patient descriptions of
alcohol consumed in terms of pints or glasses into standard drinks or units is likely to enhance the accuracy
of screening. Further to this, interventions designed for or implemented with older patient populations
should seek to include descriptions of units or standard drinks in relation to common beverage servings
(e.g. pints of beer, glasses of wine) in order to enhance the interpretation of low-risk drinking guidelines.
Similarly, as participants in this study rejected any categorisation of their drinking as ‘risky’ and endorsed
the ‘non-judgemental’ approach of HCPs delivering screening and interventions, future screening and
intervention work should avoid the use of such categorisations and ensure that the non-judgemental
approach is maintained. Furthermore, the tendency for patients to use defensive othering to distance
themselves from ‘problem drinkers’ suggests that interventions that focus on individual-level,
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and context-specific (e.g. surgery), risks and benefits are likely to be more acceptable to patients in the
preoperative setting.
Some barriers to effective delivery and receipt of screening and intervention methods were identified.
Lack of adequate time to deliver screening and intervention to a high standard was identified as a barrier
by the HCP participants. Scheduling of intervention sessions appropriately, providing research staff to
conduct research-specific tasks (such as consent and randomisation procedures) and including guidance in
intervention training that directly addresses how best to deliver intervention sessions if time is limited would
go some way to minimising this issue. Nonetheless, unless additional fully trained staff are made available,
and adequate space for them to work in is made available, this challenge is unlikely to be fully resolved.
Although removing the term ‘risky drinking’ from the project title and study materials appears to have
aided improvements in patient recruitment, feedback following alcohol screening and information about
the low-risk drinking guidelines often draw on this or similar terminology. Therefore, qualitative work in
the subsequent pilot RCT sought to explore the preferred terminology in more depth.
Conclusions
The proposed research and intervention methods, once amended, were found to be acceptable to both
patient and HCP participants. Although recruitment of patient participants was initially challenging, the
changes made during the feasibility study greatly improved the percentage of eligible patients who
consented to participate in the study. The planned pilot RCT was therefore considered justifiable.
Changes made prior to pilot randomised controlled trial
With well-documented screening effects and subject reactivity in previous research133,134 and some participants
in this feasibility study reporting that completion of the screening questionnaire resulted in changes to drinking
behaviour, possible changes to the screening and eligibility process were considered. Completion of an initial
screen (AUDIT-C) followed by a more in-depth (full AUDIT) screening questionnaire to confirm eligibility at
a later date (the method used in this work) may well induce changes in drinking behaviour between the
two screens and lead to participants who are motivated, and already acting to reduce consumption, being
excluded from intervention delivery. Therefore, the subsequent pilot RCT will assess eligibility relating to
drinking behaviour based on the initial AUDIT-C screen. The full AUDIT will then be used at baseline and
at follow-up to provide a more detailed assessment of alcohol consumption.
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Chapter 4 Pilot randomised controlled trial
Introduction
The feasibility study showed that the screening and intervention methods were broadly acceptable to both
patient and HCP participants. A pilot RCT was therefore considered to be justified. Pilot RCTs involve the
rehearsal of full trial processes, including randomisation and follow-up, to provide estimations of rates of
eligibility, recruitment, retention and data completion that can be used to inform a decision about the
feasibility of proceeding to a definitive trial.
The methods of the pilot RCT are reported in the trial protocol.1
Aims
Primary objective
To assess the feasibility of a definitive RCT by estimating rates of eligibility, recruitment and retention in a
pilot RCT.
Secondary objectives
l Assess of completion rates for all data collection tool, including measures of alcohol consumption,
quality of life and joint functionality.
l Establish response variability of proposed outcome measures for a definitive trial, which will include
drinking status and quality of life.
l Estimate rates of secondary outcomes and perioperative complication rates, including bleeding
and infections.
l Explore the acceptability of intervention and research methods with HCPs and patients in qualitative
interviews.
Methods
Design
The design was a three-centre, two-arm (TAU vs. BBI), parallel-group, individually randomised pilot trial
with an embedded qualitative interview study.
Setting and subject population
The pilot RCT was conducted across three secondary care hospitals in the north of England, one of which
was the site of the feasibility study. All three sites have dedicated PACs with surgical care pathways of
6–10 weeks for patients undergoing hip and knee arthroplasty.
Eligible patients were those aged ≥ 18 years who were listed for elective primary hip or knee arthroplasty,
met the criteria for increasing risk drinking, had the capacity to provide informed written consent and were
able to write and converse in English.
Sample size
Based on recommendations for external pilot trials,135 this pilot trial aimed to obtain data from 30 patient
participants in each trial arm at 6 months post recruitment. Systematic reviews of alcohol BI trials show
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mean follow-up rates of approximately 75%,82,136 although rates of follow-up for older adult populations
may be higher.137 It was therefore decided to allow for a loss to follow-up of 25% providing an initial
recruitment target of 80 patients (40 per trial arm).
Progression criteria
The criteria for progression to a definitive trial were recruitment of 40% of patients identified as eligible
and retention of 75% of participants at 6-month follow-up.
Procedure
Initial screening for alcohol consumption was conducted by a HCP trained in the use and scoring of the
AUDIT-C. This initial screen was conducted after a patient had been listed for elective orthopaedic surgery,
either face to face in the outpatient clinic or over the telephone, with the responses immediately assessed
for eligibility. Eligibility for the study was confirmed if the patient screened positively for increased risk
drinking (AUDIT-C score of ≥ 5) or reported drinking six or more standard drinks in one session at least
weekly (identified from question 3 on the AUDIT-C). Patients who scored an AUDIT-C score of < 5 and
who consumed six or more standard drinks in a single session less frequently than weekly were thanked
for their time and received positive feedback on their low-risk drinking status. Patients were excluded
if they were scheduled to undergo sequential joint replacements (bilateral replacement of both joints
within a short time) during the study, displayed current (active) withdrawal from alcohol, or had a severe
psychiatric disorder requiring medical treatment, cognitive impairment or dementia, affecting their ability
to interact with the intervention.
All patients who screened eligible were given a verbal description of the trial and those who expressed
interest in participating were provided with a copy of the participant information sheet (see Appendix 13)
and were asked if they were willing to be contacted about the study. Those willing to be contacted provided
either telephone or e-mail contact details (dependent on patient preference), which were recorded on the
expression of interest form. Patients were then given a minimum of 24 hours to consider participation.
After this time the HCP contacted them by their preferred method to gauge ongoing interest in the trial.
When patients expressed ongoing interest, the PAC was informed of their likely participation and
arrangements were made for the completion of the consent and randomisation process as well as
potential delivery of the BBI.
Patients were met at the PAC by a member of the research team not involved in screening or intervention
delivery. The researcher checked that each patient was still interested in participating in the study,
confirmed their eligibility, including establishing their capacity to consent, and conducted the informed
consent discussion, during which the patient completed the written consent form including indication of
their willingness to have their intervention session recorded and to be contacted about participating in the
optional booster session and a qualitative interview.
Once informed consent had been obtained, the researcher accessed the electronic randomisation system,
which randomised patients to either TAU or BBI on a one-to-one basis. All participants were provided
with copies of the WOMAC and EQ-5D questionnaires to complete while they waited to be seen by
the PA HCP.
Following consent and randomisation, all participants were seen by a PA HCP. Participants allocated to
the control condition received TAU and completed the AUDIT questionnaire. Participants allocated to the
intervention condition received TAU and completed the AUDIT questionnaire before receiving BBI.
Brief behavioural intervention
The intervention and its development are described in detail in Chapter 2 and summarised here. The intervention
commenced with completion of the full AUDIT questionnaire. This was followed by the delivery of approximately
5 minutes of structured advice relating to alcohol consumption (based on completion of the AUDIT). The
HCPs used the BA tool as a visual prompt and to guide their delivery of advice about alcohol consumption.
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Following BA, the BI protocol was used to guide up to 25 minutes of brief behaviour change counselling
targeting alcohol reduction or cessation. This aspect of the intervention was designed to be tailored to the
individual patient’s needs and motivations and could include assessing motivation and confidence to
change, pros and cons of changing, goal-setting, problem-solving and identifying of sources of social
support. Patients were provided with copies of the intervention tools to take away with them, as well as a
copy of the patient leaflet.
Patients who consented to be approached for the second booster session were contacted around 1–2 weeks
before surgery to gauge their ongoing interest in the booster session and to arrange this. Where possible,
booster sessions were delivered by the HCP who delivered the initial intervention session. If this was not
possible, for example because of availability, another appropriately trained HCP delivered the session.
Booster sessions were delivered either in clinic or over the telephone according to patient preference.
As with the initial intervention session, the booster session began with completion of the full AUDIT tool.
The remainder of the 10- to 20-minute session aimed to review or revise behavioural goals, provide feedback
on progress and increase self-efficacy. For participants who had expressed interest in changing their drinking
behaviour during the initial intervention session, but had not yet set any goals, this session allowed them
to set goals and produce action plans to reach these goals and address any potentially ‘difficult’ times.
Control condition: treatment or care as usual
The comparator condition of TAU is described in detail in Chapter 2 and summarised here. Patients allocated
to the TAU condition did not receive the intervention but did complete all study baseline measures. As part
of the standard PA for hip or knee arthroplasty, patients were asked a variety of health-related questions,
had blood samples taken and had other observations, including blood pressure and echocardiograms,
completed. Patients considered by the PA HCP to be ‘heavy drinkers’ or those identified as heavy drinkers
as a result of LFTs were routinely referred for consideration by a consultant anaesthetist who assessed any
potential risk to anaesthesia or surgery itself.
All three sites included in the trial also had specialist alcohol support services available. However, referral
of patients from PA to in-hospital alcohol services was reported to be rare, with no standard process for
identifying and referring patients (see Chapter 2 for further detail). Further to this, these services were
hospital wide and not designed to provide specific support for preoperative alcohol reduction or cessation.
Follow-up
From screening to final follow-up there were six or seven key points of contact between participants and
members of the research team, depending on trial arm. The trial process is summarised in Figure 4 and the
measures and activities completed at study visit are shown in Tables 13 and 14.
All baseline measures were completed at visit 1. Follow-up assessments took place 1–3 days preoperatively
(either over the telephone or in hospital if admitted the day before surgery); 3–5 days post surgery; at or
around the 6-week postoperative outpatient appointment; and at 6 months post intervention.
Data collection
The primary outcomes of this pilot trial were the number of patients screened, the percentage of eligible
patients recruited, and the percentage retained at 6-month follow-up. In addition to these outcomes to be
utilised in designing a definitive trial, we collected, at the time points shown in Table 13:
l alcohol consumption – assessed with the full AUDIT tool9
l health-related quality of life – assessed with the EQ-5D114,115
l joint functionality – assessed with the WOMAC.113
Rates of postoperative complications and length of hospital stay were assessed with the Clavien–Dindo
tool112 and POMS.111
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Covariate data relating to health behaviours [smoking, physical activity and body mass index (BMI), which
have been shown to be associated with surgical complication rates] routinely captured during PA were also
collected at visit 1.
Qualitative methods
Patient interviews
At the point of consent to the pilot RCT, patient participants indicated whether or not they were willing
to be contacted about participating in a qualitative interview. At 6 months post intervention, Ellen Lynch
contacted participants by telephone to conduct the final follow-up. Participants who had previously provided
their consent were asked if they would be willing to take part in an interview. Those who assented were sent
a copy of the interview-specific information sheet by e-mail or post (depending on participant preference)
and Ellen Lynch made arrangements to conduct the interview at a time and place convenient to the participant.
On the day of the interview, the participant was met by Ellen Lynch, who provided them with a hard copy
of the interview-specific patient information sheet and gave them a verbal introduction to the interview
process, including ethical considerations. She also gave a verbal summary of her research experience and
Setting Timeline
(Week n)
Intervention Staff member
Surgical
outpatients
PAC clinic
Outpatient
PAC clinic
Outpatient
Inpatient
hospital
(4–7 days)
Outpatient
patient’s 
home
Surgical
outpatient
clinic
(6 weeks
post surgery)
Weeks
0–6
Weeks
6–9
Week
10
Week
11
Weeks
12–16
Weeks
17–32
Listed for elective
arthroplasty
AUDIT-C
(score of ≥ 5)
Expression of
interest
Telephone/e-mail
expression of
interest
confirmation
Written consent
Randomise
Intervention
AUDIT
(score of ≥ 8)
Intervention
session 1
Intervention
session 2
and AUDIT
Surgery and
in-hospital
recovery
Outpatients
(6 weeks
post surgery)
Visit 6 months post
intervention
(16–20 weeks post
surgery)
Research
associate
Control
AUDIT
(score of ≥ 8)
Intervention-
trained
PAC nurse
Research nurse
PAC HCA
Screening-
trained
PAC HCA
FIGURE 4 Pilot RCT process.
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her role in the project. The participant then had the opportunity to ask any questions before completing
the informed consent discussion and signing the interview-specific consent form. Once consent had been
gained, Ellen Lynch began the interview by asking the participant what led to them coming into hospital
and then utilised the questions and prompts contained within the arm-appropriate (TAU or BBI) interview
topic guide (see Appendix 15) to structure the interview.
TABLE 13 Pilot RCT schedule of events
Time point
Study period
Screening
Visit 1: 6–8
weeks pre
surgery
Visit 2:
1–2 weeks
pre surgery
(intervention
arm only)
Visit 3: 1
and 3 days
pre surgery
Visit 4: up
to 5 days
post surgery
Visit 5: 6
weeks post
surgery
Visit 6: 6
months post
intervention
Enrolment
AUDIT-C ✗
Expression of
interest
✗
Consent ✗
Randomisation ✗
Interventions
Intervention ✗
Booster ✗
TAU ✗
Assessments
AUDIT baseline ✗
EQ-5D baseline ✗
AUDIT outcome ✗ ✗ ✗ ✗
EQ-5D outcome ✗ ✗
WOMAC ✗ ✗
POMS ✗
Clavien–Dindo
score
✗
Interview ✗
TABLE 14 Pilot RCT patient recruitment and randomisation by arm
Site Number Intervention Control
1 19 11 8
2 34 17 17
3 15 7 8
Total 68 35 33
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At the end of the session, the participant was thanked for their participation in the interview and in the
trial as a whole, and had the opportunity to ask any further questions.
Interviews lasted between 35 minutes and 1 hour 45 minutes and were audio-recorded and transcribed
verbatim. Transcripts were anonymised and were then subject to framework analysis.
Health-care professional interviews
Each HCP who consented to take part in the pilot RCT and went on to be involved in delivery of the
screening or intervention was offered the opportunity to participate in a qualitative interview regarding
their experience of the trial. The research associate contacted HCPs by e-mail asking if they were willing
to participate in such an interview.
Those who assented to participate were sent an electronic copy of the HCP interview-specific information
sheet and the research associate arranged a time and place convenient to the HCP for the interview to take
place. At the beginning of each interview session, the HCP was provided with a hard copy of the interview-
specific information sheet. The research associate provided a verbal summary of her research experience, her
role in the project and the interview process including ethics considerations. The HCP then had the opportunity
to ask any questions before completing the informed consent form. Once consent had been gained, the
research associate began the interview by asking the HCP to explain their role in the project and then utilised
the questions and prompts contained within the interview topic guide to structure the interview.
At the end of the session, the HCP was thanked for their participation and had the opportunity to ask
any questions.
Interviews lasted between 20 minutes and 1 hour 30 minutes, and were audio-recorded and transcribed
verbatim. Transcripts were anonymised and then subject to framework analysis.
Analysis
Statistical analysis
The numbers of screened and eligible patients and the rates of recruitment, randomisation and retention
were reported, and any reasons for ineligibility and non-participation were summarised. The baseline
characteristics and outcomes at follow-up time points were summarised, with descriptive statistics presented
by arm or site (means, medians and ranges for continuous data and frequencies and proportions/rates for
categorical data). We investigated the data completeness of the study tools by reporting the number of
missing data by outcome and arm. This information was then used to identify the primary outcome for a
definitive trial and estimate the necessary sample size.
Qualitative analysis
Qualitative data from HCP and patient interviews were analysed using framework analysis.126 This is a
recommended approach for qualitative health research with objectives linked to quantitative investigation.138
As in the feasibility study, patient and HCP participant interviews were analysed separately.
For patient participant interview data, a subset of transcripts were repeatedly read and coded with initial
codes used to develop a framework of themes and subthemes. All transcripts were then coded within this
framework with additional emergent themes and subthemes added to the framework. Finally, themes
relevant to the aim of assessing acceptability and feasibility of study and intervention methods were
selected and are discussed here.
For HCP interviews, initial descriptive codes were generated from the transcripts before being grouped into
a framework that used the components and constructs of NPT128 as themes and subthemes but was left
open enough to allow the emergence of additional themes relating to the acceptability of the study
research, screening and intervention methods.
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Results
Screening, recruitment and retention
The flow of participants through the trial, including screening, recruitment and retention at follow-up, is
presented in the CONSORT (Consolidated Standards of Reporting Trials) flow diagram in Figure 5. In total,
1117 patients were approached; 866 completed the screening questionnaire (AUDIT-C), 198 were potentially
eligible based on the AUDIT-C screen (22.9% of those screened) and 68 (34.3% of those eligible) consented
and were randomised (Figure 6).
Approached
(n = 1117)
Not screened
(n = 251)
Screened
(n = 866)
Intervention
(n = 33)
Consented
(n = 68)
Expression of interest
(n = 128)
Eligible
(n = 198)
Did not consent
(n = 60)
No expression of interest
(n = 70)
Control
(n = 35)
Not eligible
(n = 668)
Booster session
(n = 4)
Visit 3
(n = 22)
Visit 4
(n = 31)
Visit 5
(n = 24)
Visit 6
(n = 34)
Visit 3
(n = 22)
Visit 4
(n = 29)
Visit 5
(n = 26)
Visit 6
(n = 31)
• Intervention delivered,
   n = 32
• Intervention not
   delivered, n = 1
Follow-up
Allocation
FIGURE 5 Pilot RCT CONSORT flow diagram.
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Although recruitment of eligible participants fell short of the progression criterion (40%) and the target
of 80 patients recruited was not met, retention at final study visit was much higher than estimated, with
65 patients completing the final follow-up. Thus, the subsequent target of follow-up data obtained from
60 patients was exceeded.
Tables 15 and 16 show the reasons patients were found to be ineligible or declined to participate in the trial.
Table 17 presents a summary of screening and recruitment data from the feasibility study and pilot RCT to
allow direct comparison. Although the percentage of eligible patients expressing interest in the study was 31%
lower in the pilot RCT than in the feasibility study, the percentage of eligible patients recruited increased by
20%. The most frequent reasons for ineligibility remained consistent and related to alcohol consumption
behaviour, with 88% of ineligible participants scoring < 5 on the AUDIT-C questionnaire and a further 6%
reporting that they did not drink alcohol at all. The most frequently cited reasons for non-participation among
eligible patients were lack of interest in the study and not having enough time available to participate;
17 eligible patients had no clearly recorded reason for non-participation.
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FIGURE 6 Pilot RCT recruitment graph.
TABLE 15 Reasons that participants did not meet eligibility criteria
Reason Frequency (%)
AUDIT-C score of < 5 668 (88.1)
Did not drink at all 46 (6.1)
Surgery too soon 24 (3.2)
Psychiatric disorder 6 (0.8)
Possible alcohol dependence 5 (0.7)
Pre-assessment already complete 4 (0.5)
Patient requested rescreen – not eligible 3 (0.4)
Sequential surgeries 1 (0.1)
Did not speak English 1 (0.1)
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Participant characteristics at baseline
Table 18 summarises the baseline characteristics of the trial participants. The age of the 68 patients recruited
ranged from 40 to 85 years (median 67 years); the patients were predominantly male (80.9%), all but one
identified as white British, and 66% attended pre-assessment in preparation for knee arthroplasty surgery.
Participant health behaviour at baseline
Table 19 shows the distribution of measures of health behaviours at baseline by trial arm. Participants’
weekly alcohol consumption as reported in units at pre-assessment ranged from 1 to 90 units per week,
with a median of 18 units. Some participants reduced alcohol consumption between screening and
baseline. Although only five participants identified as current smokers, almost 60% were ex-smokers.
Forty per cent of patients reported no physical activity and the median BMI identifies the majority of the
patient group as falling into the ‘obese’ category.
The distributions were comparable across trial arms.
Patient follow-up
As seen in the schedule of events (see Table 13), follow-up was based around four or five study visits
(depending on trial arm). Visit 2 was an optional booster session and therefore available only to those in
the intervention condition. All participants were asked to provide data at all other study visits, although the
occurrence and timing of visits 3, 4 and 5 were dependent on participants undergoing surgery (eight of
the 68 participants recruited did not have surgery during the study period). Rates of completion varied by
visit, with the highest rates of completion at visits 1 and 6 and participation in the optional booster session
being especially low (4/35).
TABLE 16 Reasons eligible participants declined to participate in the trial
Reason Frequency (%)
Not interested 44 (42.7)
Unclear 17 (16.5)
Not enough time 12 (15.6)
Unable to contact 9 (8.7)
No staff available 8 (7.8)
Cut down on own 4 (3.9)
Left clinic 3 (2.9)
Did not attend 1 (1.0)
TABLE 17 Comparisons of screening and recruitment rates for feasibility and pilot studies
Recruitment stage
n (%) % of eligible
Feasibility Pilot Feasibility Pilot Difference
Approached 658 (100) 1117 (100) – – –
Screened 620 (94) 866 (78) – – –
Eligible 105 (16) 198 (18) 100 100 –
Expressed interest 101 (15) 128 (11) 96 65 –31
Consented 15 (2) 68 (6) 14 34 + 20
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TABLE 18 Demographic characteristics at baseline by trial arm
Demographic characteristics
Arm
Total (N= 68)BBI (N= 33) TAU (N= 35)
Age (years)
Mean 63.8 68.4 66.2
Minimum 40 46 40
Median 64 69 67
Maximum 75 85 85
Missing – – –
Gender, n (%)
Number (N = 33) (N = 35) (N = 68)
Male 27 (81.8) 28 (80.0) 55 (80.9)
Female 6 (18.2) 7 (20.0) 13 (19.1)
Missing – – –
Ethnicity, n (%)
Number (N = 33) (N = 35) (N = 68)
White British 33 (100) 34 (97.1) 67 (98.5)
Other 0 1 (2.9) 1 (1.5)
Operation type, n (%)
Number (N = 33) (N = 35) (N = 68)
Hip 13 (39.4) 10 (28.6) 23 (33.8)
Knee 20 (60.6) 25 (71.4) 45 (66.2)
Missing – – –
TABLE 19 Participant health at baseline by trial arm
Health factor
Arm
TotalBBI TAU
Units of alcohol per week
Number (N = 32) (N = 34) (N = 66)
Mean 24.6 18.5 21.4
Minimum 1 2 1
Median 20 16 18
Maximum 90 60 90
Missing 1 1 2
Number of days physically active per week
Number (N = 18) (N = 18) (N = 36)
Mean 5.0 4.6 4.8
Minimum 1 1 1
Median 6 5 5
Maximum 7 7 7
Missing 15 17 32
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Time interval between baseline and surgery
It was expected that surgery would take place between 6 and 10 weeks after the baseline visit. Table 20
and Figure 7 show the distribution of the time intervals between baseline and surgery observed during the
pilot trial.
Eight patients did not undergo surgery before the end of the trial. Two (one in each arm) were removed
from the surgical waiting list and six (three in each arm) were awaiting surgery at the close of follow-up.
A small number also had the 6-month post-intervention follow-up very shortly after surgery.
TABLE 19 Participant health at baseline by trial arm (continued )
Health factor
Arm
TotalBBI TAU
BMI (kg/m2)
Number (N = 33) (N = 34) (N = 67)
Mean 31.7 31.6 31.7
Minimum 24.6 21.9 21.9
Median 32.2 32.1 32.1
Maximum 44.6 43.6 44.6
Missing 0 1 1
Any physical activity, n
Number (N = 31) (N = 34) (N = 65)
Yes 20 19 39
No 11 15 26
Missing 2 1 3
Smoking history, n (%)
Number (N = 33) (N = 34) (N = 67)
Current 2 (6.1) 3 (8.9) 5 (7.5)
Ex 16 (48.5) 23 (67.7) 39 (58.2)
Never 15 (45.5) 8 (23.5) 23 (34.3)
Missing 0 1 1
TABLE 20 Distribution of time interval between baseline and surgery
Time interval (number of weeks)
Arm
Total (n= 65)BBI (n= 32) TAU (n= 33)
Minimum 0.7 0.3 0.3
Mediana 6.6 5.6 5.7
Maximuma > 70.6 > 46 > 70.6
a For the five participants who were still waiting for surgery at trial close, a proxy measure of time from baseline to trial
end has been used. Specifically two participants in the TAU arm waited 28.3 and 46 weeks, and three participants in the
BBI arm waited 25.1, 46 and 70.6 weeks.
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Completion rates for baseline and outcome measures
If patient participants attended a study visit, completion of each questionnaire was high, especially for
AUDIT and EQ-5D. The WOMAC questionnaire was less well completed, with five partially complete at visit 1,
four partially complete and 18 not completed at visit 4; this instrument required contact with the patient
within a short period following surgery. By contrast, measures of complication rates and length of hospital
stay could be completed from patient notes by an appropriately trained HCP and did not require patient
input (Table 21).
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FIGURE 7 Number of weeks between baseline and surgery.
TABLE 21 Rates of completion for outcome measures at baseline and follow-up visits by trial arm
Study visit Measure Completion
Arm
TotalBBI TAU
1 AUDIT Complete 32 35 67
Partiallya complete 1 – 1
Missingb – – –
EQ-5D Complete 33 35 68
Partially complete – – –
Missing – – –
EQ-5D score Complete 32 35 67
Missing 1 – 1
WOMAC Complete 30 32 62
Partially complete 3 2 5
Missing – 1 1
2 (optional booster 1 week pre surgery) AUDIT Complete 4 0 4
Partially complete – – –
Missing 5 – 5
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Summary statistics for clinical measures across study visits
Tables 22–25 summarise the clinical outcomes by trial arm. Because varying numbers of participants
provided data at each study visit, it is difficult to comment on the pattern over time, but typical AUDIT
scores decreased in both arms until visit 6. The AUDIT scores were also summarised as whether or not they
were in the ‘risky drinking’ category (AUDIT score of ≥ 8). At baseline, 55% of those in the BBI arm were
risky drinkers, compared with 49% in the TAU arm. At visit 6, 45% of those in the BBI arm were risky
drinkers, compared with 38% in the TAU arm. Typical EQ-5D visual analogue scale scores increased slightly
over time in both arms. Typical WOMAC scores were little changed in either arm.
TABLE 21 Rates of completion for outcome measures at baseline and follow-up visits by trial arm (continued )
Study visit Measure Completion
Arm
TotalBBI TAU
3 (1–3 days pre surgery) AUDIT Complete 22 22 44
Partially complete – – –
Missing 2 6 4
4 (in hospital 3–5 days post operative) POMS Complete 29 31 60
Missing 4 – –
Clavien–Dindo Complete 29 31 60
Missing 4 – –
WOMAC Complete 20 24 48
Partially complete 2 2 4
Missing 7 5 12
5 (6 weeks post operative) AUDIT Complete 26 24 50
Partially complete – – –
Missing 1 5 6
EQ-5D Complete 24 24 48
Partially complete – – –
Missing 3 5 8
EQ-5D score Complete 24 24 48
Missing 3 5 8
6 (6 months post intervention) AUDIT Complete 31 34 65
Partially complete – – –
Missing – – –
EQ-5D Complete 31 34 65
Partially complete – – –
Missing – – –
EQ-5D score Complete 31 34 65
Missing – – –
Interview Consented 7 7 14
a ‘Partially complete’ refers to those that have missing items but are still usable with the application of particular rules for
dealing with missing data for the particular questionnaire.
b Missing refers to questionnaires that either are completely missing or have more than the acceptable number of missing
items, and so cannot be used.
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Complication rates for orthopaedic surgery were relatively low, at approximately 4–5%.17,22 In this sample,
four patients developed at least one postoperative complication. Of these, one patient developed two
different complications. Although the numbers are very small, this equates to approximately 6% of the
overall sample, and almost 7% of those who completed visit 4. This is in line with evidence from larger trials
that complication rates are higher among AUDIT-C-positive patients.
TABLE 22 The AUDIT scores by arm and study visit
Study visit
Arm
TotalBBI TAU
(N = 32) (N = 35) (N = 67)
1
Mean 9.7 7.7 8.6
Minimum 3 3 3
Median 9 8 8
Maximum 24 18 24
Missing 1 – 1
(N = 4) (N = 0) (N = 4)
2
Mean 6.8 – 6.8
Minimum 3 – 3
Median 4 – 4
Maximum 16 – 16
Missing 5 – 5
(N = 22) (N = 22) (N = 44)
3
Mean 6.3 4.6 5.4
Minimum 0 0 0
Median 5.5 4 5
Maximum 19 15 19
Missing 2 6 8
(N = 26) (N = 24) (N = 50)
5
Mean 5.5 3.6 4.6
Minimum 0 0 0
Median 5 3 4
Maximum 16 10 16
Missing 1 5 6
(N = 31) (N = 34) (N = 65)
6
Mean 7.6 6.6 7.1
Minimum 0 0 0
Median 7 7 7
Maximum 17 12 17
Missing – – –
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TABLE 23 The EQ-5D visual analogue scale scores by trial arm and study visit
Study visit
Arm
TotalBBI TAU
(N = 32) (N = 35) (N = 67)
1
Mean 63.0 60.9 61.9
Minimum 20 10 10
Median 65 70 65
Maximum 95 95 95
Missing 1 – 1
(N = 24) (N = 24) (N = 48)
5
Mean 67.1 76.1 71.6
Minimum 35 35 35
Median 70 80 75
Maximum 90 95 95
Missing 3 4 7
(N = 31) (N = 34) (N = 65)
6
Mean 73.2 71.3 72.3
Minimum 30 25 25
Median 80 80 80
Maximum 95 100 100
Missing – – –
TABLE 24 The WOMAC scores by trial arm and study visit
Study visit
Arm
TotalBBI TAU
(N = 30) (N = 32) (N = 62)
1
Mean 55.1 54.3 54.7
Minimum 31 4 4
Median 52.5 51 52
Maximum 86 90 90
Missing 3 3 6
(N = 20) (N = 24) (N = 44)
4
Mean 54.2 50.3 52.1
Minimum 23 6 6
Median 55 52 53
Maximum 79 89 89
Missing 10 7 17
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In addition to collecting details of postoperative complications, the Clavien–Dindo measure collects data
relating to length of hospital stay and length of intensive care unit stay. The national average length of
hospital stay is 4.3 days following primary knee arthroplasty and 4.4 days following primary hip arthroplasty.
However, length of stay varies from site to site, with hospitals that employ enhanced recovery procedures
reporting shorter postoperative hospital stays. This variation is reflected in our data. None of the participants
for whom visit 4 was completed was admitted to intensive care following surgery; however, a number of
participants had extended hospital stays, with the maximum length of stay being 18 days.
Sample size estimates for a definitive study
After a discussion of the pilot trial results, it was decided that the effectiveness of a preoperative alcohol
intervention in a definitive study should have a primary outcome based on alcohol consumption behaviour,
and that measures of complications would be a secondary outcome. The primary outcome would be based on
AUDIT. This offers the opportunity to use either a continuous (AUDIT score) or a binary (risk group) measure.
TABLE 25 Postoperative complication rates and length of stay by trial arm
Visit 4 outcome measure
Arm, n (%)
Total, n (%)BBI TAU
POMS: morbidity category
None 26 (89.7) 31 (100.0) 57 (95.0)
Pulmonary 1 (3.5) – 1 (1.7)
Infectious 2 (6.9) – 2 (3.3)
Renal – – –
Gastrointestinal – – –
Cardiac – – –
Neurological – – –
Wound – – –
Haematological – – –
Pain – – _
Missing 2 2 4
Any complications (Clavien–Dindo)
No 27 (93.1) 29 (93.6) 56 (93.3)
Yes 2 (6.9) 2 (6.5) 4 (100.0)
Missing 4 – 4
Clavien–Dindo grade
1 1 (33.3) 2 (100.0) 3 (60.0)
2 1 (33.3) – 1 (20.0)
3a 1 (33.3) – 1 (20.0)
3b – – –
4a – – –
4b – – –
5 – – –
Length of stay (days)
Mean 3.4 3.4 3.4
Minimum 2 1 1
Median 3 3 3
Maximum 13 18 18
PILOT RANDOMISED CONTROLLED TRIAL
NIHR Journals Library www.journalslibrary.nihr.ac.uk
76
A number of considerations led us to select a binary measure of AUDIT score of ≥ 8 or < 8 at 6 months after
the intervention. First, the intervals between each point on the AUDIT are not necessarily equivalent. Thus, a
reduction of, for example, 2 points for someone originally scoring 20 points does not represent the same level
of change or associated benefit as a reduction of 2 points for someone originally scoring 10 points. Second,
there is evidence that reduction in risk levels assessed by AUDIT is associated with improvements in physical
and mental health and quality of life, as well as reductions in alcohol-related consequences.139,140 This is
mirrored in the literature about PA, which shows that those drinking at least two standard drinks per day (i.e.
the cut-off point for lower-risk drinking) and high but not low to moderate drinkers are at increased risk of
experiencing surgical complications.58–60 Meanwhile, no current evidence explicitly identifies what would be a
clinically meaningful reduction in either alcohol consumption or AUDIT score in the preoperative setting. Third,
employing a dichotomous variable for a sample size calculation will project larger numbers and thus would
provide a sample size that would be more than adequate for conducting analysis on a continuous outcome
should this be adopted in a future trial. Finally, it was also felt that the binary risk measure would be better
understood by those less familiar with alcohol screening tools and the interpretation of screening scores.
Studies of other brief alcohol interventions have used an effect size of 13% as the basis of the sample size
calculation, when the outcome was whether or not the patient managed to reduce from an AUDIT score of
≥ 8 to that of < 8 over the follow-up period. A study of the PRE-OP BIRDS intervention could not use exactly
the same outcome as some of the patients had reduced their alcohol consumption between screening and
baseline, meaning that although they were eligible based on the initial AUDIT-C screen, they reported lower-risk
drinking at baseline. We have nevertheless used 13% as the effect size, but also shown the sensitivity of the
estimates by calculating for an effect size of 10% and 15%. The proportion of patients in the pilot trial with
an AUDIT score of ≥ 8 at 6 months was 42%. Because the sample size is largest when the percentages are
close to 50%, the differences to be detected have been calculated for 40–50%, 40–53% and 40–55%.
Standard sample size calculations to compare proportions will give the number of responses needed at
follow-up, using a type 1 error rate of 5% and a power of 90%.
It is also necessary to take into account other estimates from the pilot trial to work out how many patients
would need to be screened, approached and recruited to the trial:
l percentage of those screened who are eligible = 23%
l percentage of those eligible who are recruited = 34%
l percentage of responses to primary outcome at follow-up – this was 96% in the pilot study, but a
conservative figure of 80% was used for the calculation.
Table 26 shows the total number of patients necessary for a definitive trial. To have 90% power to detect
a difference between risky drinking rates of 40% and 53%, it would be necessary to screen 9843 patients,
of whom 2264 would meet the eligibility criteria and 770 would be recruited (385 randomised to each
arm), to obtain the primary outcome for a total of 616 patients at 6 months. Depending on the number
of surgeries undertaken at the sites selected for a definitive trial, it would be possible to achieve such a
sample size with 8–10 sites recruiting for between 12 and 18 months.
TABLE 26 Total number of patients needed in definitive trial when outcome is % AUDIT score of ≥ 8 at 6 months
Trial stage
Difference to be detected
10% 13% 15%
Number of responses to primary outcome 1038 616 462
Number of recruited patients 1298 770 578
Number of eligible patients 3818 2264 1700
Number of patients screened 16,600 9843 7391
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Safety reporting
No serious adverse events were identified during the pilot trial.
Qualitative results
Patient interview results
Fourteen pilot trial patient participants consented to and participated in qualitative interviews about their
experience of being involved in the trial. Demographic details of these participants are provided in Table 27.
Seven themes relating to the acceptability of research, screening and intervention processes were identified
from the data and these are presented here.
Acceptability of trial design
Interviews considered the acceptability of the trial as a whole, as well as some specific aspects of the pilot
RCT design (time to consider involvement, randomisation and follow-up). Many participants stated that
they took part simply because they had been asked to. However, participation in research was also viewed
as a way of contributing to something that could help others in the future and was a method of ‘giving
back’ to the NHS both for previous treatment and for the fact that they would be receiving a hip/knee
arthroplasty:
I have had two previous involvements with the NHS, both emergencies, one 10 years ago and the
other about 20 years ago. On both of those occasions I couldn’t speak too highly of the treatment
I got. Here you are again and you realise what it’s all about. It’s up to you to do what you can to
play your part and contribute, I think.
Male, knee, 78 years
TABLE 27 Participant characteristics (of those who attended the interview) at baseline by arm
Participant characteristic
Arm
Total (N= 14)BBI (N= 7) TAU (N= 7)
Age (years)
Mean 67.7 71.3 69.5
Minimum 60 63 60
Median 67 69 69
Maximum 75 84 84
Missing – – –
Gender, n (%)
Number (N = 7) (N = 7) (N = 14)
Male 7 (100) 6 (85.7) 13 (92.9)
Female 0 (0) 1 (14.3) 1 (7.1)
Missing – – –
Ethnicity, n (%)
Number (N = 7) (N = 7) (N = 14)
White British 7 (100) 7 (100) 14 (100)
Other – – –
Operation type, n (%)
Number (N = 7) (N = 7) (N = 14)
Hip 2 (28.6) 1 (14.3) 3 (21.4)
Knee 5 (71.4) 6 (85.7) 11 (78.6)
Missing – – –
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The potential individual benefit of receiving additional information from a HCP and the possibility of
reducing the risk of complications arising from surgery or improving recovery time was discussed by only
one of the interviewees as a motivation for taking part:
I thought, ‘Well, yes’. With initially them saying, ‘Well, it could be beneficial for the operation and
after the operation–’ I’ve never had an operation like this before. I think, ‘Well, if it’s going to help,
then I’ll have a look at that’.
Male, knee, 64 years
Having the necessary free time to participate in the research also appeared to play a role in the decision.
However, one participant explained that it was important that patients were not required to take part,
and others indicated that there was still a limit to how much time they would be willing to give up in order
to participate, which highlights the need to minimise the potential burden of research on participants:
That’s fine, you know, you don’t mind. It’s when it’s every week, people are, ‘Can we come in?’
and I think if that happened, I would just say, ‘Sorry, I’ve had enough’ . . .
Male, knee, 70 years
Although participants stated that they were ‘quite happy’ with the trial, that they understood the questions
they were asked and that the study was ‘fine’ and even ‘enjoyable’ and one of the 14 interviewees
expressed a desire to know more about how the analyses would be completed and what was expected of
them in terms of behaviour change:
It was always a bit vague about what the nature of the trial was. Obviously, I know the aim and what
it’s about, but I didn’t know what you were trying to get out of me. I didn’t know what you were
trying to get from me, so it was always a bit vague, I thought . . .
Male, knee, 61 years
The majority of participants identified their participation in the trial as ‘completely independent’ from and
‘separate’ to their treatment but were clear that the trial activities and visits fitted around their existing
appointments, with no indication that their participation had any negative impact on the care that they
received during the perioperative period:
It’s like today, it’s fitted in absolutely brilliantly today in the hospital. You’re there. It’s not as though
you’ve got to put things aside for it. No, it’s fine.
Male, knee, 64 years
When asked about particular aspects of the research design that could have influenced participation,
interviewees showed little need for a specified amount of time to consider their participation (24 hours),
with the majority stating that they had made the decision to participate when they were first approached
or contacted:
Well I was happy anyway because when she asked me I said, ‘I’ll do it anyway’. I was happy just to go
ahead with it anyway.
Male, knee, 71 years
Similarly, the randomisation process was found to be acceptable to participants and did not influence
their decision to take part. Some participants expanded on this to explain that although there may be
some benefit to being allocated to the intervention condition, they did not necessarily feel that they
needed that additional information and support; being assigned to the control arm had its own benefits
in that it took up less time and that randomisation was an important part of the research method and a
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requirement if evidence to inform practice was to be gained. However, one participant did feel that being
allocated to the intervention arm may have helped them to further decrease their alcohol consumption:
I didn’t object to that because I knew it was a 50/50 thing. If I’m honest, well what did I think? I mean
part of me thought, ‘Well that’s me off the hook. They’re not going to probe too deeply’. But on the
other hand, I wouldn’t have objected to it. I thought, ‘Well that might have helped me drink even
less’. I just accepted it really because that’s the basis on which I went into it.
Male, knee, 85 years
One participant also explained that although the prospect of randomisation did not influence their decision
to take part, they did feel that it would be important in the future, should interventions be found to be
beneficial, that all patients receive information about alcohol use and surgery:
Personally, I can see why it has to be randomised at the moment, but also I think, longer term, once
the research has been pulled together, my view would be it would be great for people to receive it.
Male, knee, 78 years
Trial follow-up methods were also described as acceptable by participants. Specifically, follow-ups were
not considered to occur too frequently or to take up too much time, and neither were they described as
too intrusive. Participants identified that they never felt pressured to complete the follow-ups and that they
felt they could easily request a callback at another time if they were busy:
I didn’t think it was too intrusive and it didn’t take too long. The questions were pretty straightforward
and I gave honest answers. I haven’t found it a difficult process.
Male, knee, 85 years
A number of interviewees explained that the follow-ups were fine because they had agreed to them or
had been made aware of them when they consented to the trial. One participant went further, identifying
that because follow-ups were described in the trial information they would be expected and it was
therefore important that they took place:
I think I would have been a little bit frustrated if I hadn’t received the ‘phone call. So going back,
earlier on, you were talking about the process. If somebody said, ‘Right, I’m going to ring you
in 4 weeks,’ and it’s gone 4 weeks and 2 days, I’m thinking, ‘Why haven’t you phoned me?’
So I would have been on to them just to say, ‘Hang on, you were supposed to ring me’.
Male, knee, 63 years
Acceptability of alcohol screening
In addition to exploring the acceptability of the trial design, the interviews considered the acceptability of
the screening and intervention procedures to build on evidence collected in the feasibility study, which
found the processes generally acceptable. As in the feasibility study, very few of the participants had
identified a link between alcohol use and surgery prior to taking part in the study and thus had not
considered that they would be asked about alcohol use as part of the PA:
It never even entered my mind that alcohol would affect the outcome of the operation, the recovery
period . . .
Male, knee, 67 years
However, one of the participants identified that a hospital stay could be problematic for ‘heavy’ drinkers:
If anybody was going in who I knew to be a heavy drinker, I would tell them to come and see me
and we’ll cut it down. Because it doesn’t go hand in hand . . . You’re only in hospital for a couple of
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nights. If you’re a heavy drinker, a couple of night can be a long, long time. I think anybody who was
a heavy drinker would get asked a lot more questions.
Male, knee, 70 years
Despite this, four of the interviewees expected to be asked about alcohol at PA either because they
considered alcohol consumption to be relevant to health generally or because alcohol use was frequently
asked about in health-care settings:
Yes, I suppose so, when I look back, because when you go into hospital, you’re always asked about your
current health situation, how you are at the minute and how healthy you are. I suppose alcohol would
come into that, so, on reflection, possibly, yes, I think it would be part of the standard questionnaire.
Male, knee, 61 years
One participant also identified that he had not expected to be asked about alcohol because he did not
consider his consumption to be problematic. However, this participant identified that he was accepting of
being asked about alcohol consumption because he recognised that those drinking to excess may present
problems for the HCPs:
I don’t consider myself a drinker really, so it didn’t even cross my mind. It’s something that I would
never, ever have thought of . . . Doesn’t bother me in the least. They’ve got a right to know because
they need to know. If the prospective patient has a problem and makes it cause them a problem. By that
I’m talking about somebody who maybe uses a lot of alcohol could cause a problem in the ward . . .
Male, knee, 70 years
Indeed, all of the participants described alcohol screening as acceptable, explaining that they were not
‘bothered by it’, were ‘quite comfortable’ and ‘didn’t object to it’. However, the importance of explaining
the relevance of questioning patients about their alcohol consumption in this setting, or at least explaining
that it is a standard question, was raised by one interviewee who felt that he had been asked about his
alcohol use specifically because he was overweight and expressed a desire to understand why HCPs felt
the need to ask about alcohol consumption if the individual was otherwise well:
It’s not really an imposition, it seems to be the way slimmer people view older people or people that are
overweight, that means they’ve got to be smokers, drinkers or eaters. Nobody’s ever the perfect person.
Male, knee, 71 years
Much of the acceptability of alcohol screening appeared to derive from the fact that participants were
generally open to discussing their alcohol consumption and had ‘nothing to hide’. As such, they did
not have a preference about whether it was a doctor, a nurse or a researcher who asked about their
drinking behaviour:
It doesn’t really make any difference. No, I’m quite open to whoever it is.
Male, knee, 63 years
Despite the reported acceptability of alcohol screening, the issue of alcohol as a potentially ‘sensitive
subject’ for others was raised by a subset of participants, who explained that some people would not be
comfortable answering questions about their alcohol use and as a result would not provide honest answers
and would not agree to take part in this type of research. However, this assumption is at least partially
contradicted by two of the interviewees who self-identified as drinking more than they should. Although
one explained that screening could be awkward, the other was pleased that the issue was being raised:
. . . it’s still awkward talking about something which you know is wrong. You’re trying to tell
somebody that what you’re doing is not good for yourself. It’s always a bit awkward.
Male, knee, 61 years
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I was actually pleased that they were concerned, you know, drinking could be a bit of a problem so I
was quite happy that they did . . .
Male, knee, 70 years
Acceptability and effect of the intervention
Interviewees who received the intervention identified it as acceptable and ‘great’ and that it contained
the right amount of information, and one went so far as to say ‘I love advice’. Further to this, for one
participant the motivational, non-judgemental approach adopted by staff was key as it allowed him to
come to his own decision about whether or not he wanted to change their drinking behaviour once he
had received the intervention:
I wanted to help, but I didn’t want to be preached to when I’d already made these decisions
myself . . .
Male, knee, 61 years
In contrast to the fact that very few of the participants were aware of any association between alcohol use
and surgery, a number of interviewees explained that the intervention did not include any information that
they were not already aware of:
I felt like I, pretty much, knew, anyway, about the drinking. I’m getting on a bit now, and I’ve seen
a lot of it. I didn’t feel like I was learning a great lot. You tend to know what’s right and wrong,
anyway, don’t you?
Male, hip, 67 years
Findings regarding the potential effects of the intervention varied, with some participants identifying that
they had made significant, long-lasting changes to their drinking behaviour, some saying that they had
‘cut down’ and others saying that they had not changed their drinking at all. This variation was anticipated
and summarised by one participant:
I think that some people would just say, ‘I’m going to do what I’m doing. I’m going to have the
surgery, then I’m going to do what I’m doing’. I think there are other people who would say,
‘Yes, I can see the benefits, fair is fair’.
Male, hip, 67 years
Reasons for changing were similarly varied and included the calorific content of alcohol, the influence of
alcohol on weight, interactions with medication, not ‘feeling’ like drinking in the postoperative period,
the intervention confirming existing knowledge and wanting to improve recovery following surgery:
I think it was actually the research which was saying if you cut down on alcohol, you’ll recover better.
Something like that.
Male, hip, 67 years
There was some indication that the messages of the intervention specifically about when alcohol
consumption should be reduced may need further clarification, as four of the participants explained that
they had reduced their drinking postoperatively in order to benefit their recovery:
I was still drinking up until I went into hospital, then following the operation I didn’t drink for
4 weeks, simply because I’d been told that alcohol could be a factor in how well you recovered.
Male, knee, 67 years
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Findings regarding the potential benefit of a booster sessions were similarly mixed, with some participants
explaining that additional contact would have been beneficial and others explaining that it would not
make any difference because they were confident that they could make the changes they wanted without
any further input:
I don’t think it would have made much difference to me, personally, simply because I would have
said to myself I’d signed up to it or agreed to it pre-op. So I knew it was going to happen, and so I,
personally, wouldn’t have needed much, perhaps, assistance or reminding of it. I don’t think I needed
to do that . . .
Male, knee, 63 years
The preoperative setting, optimisation, obligation and opportunity
The PAC was considered to be an acceptable setting for the delivery of alcohol screening and intervention
and for some it was simply considered to be part of the PA package:
Just as staff at the hospital talk about, for example, ‘These are the tablets you’ll need to take. These
are the things you need to bring in on the day,’ ‘This is what you need to think about alcohol.’ So I
can see it being part of just general, normal routine stuff that is part of that package . . .
Male, knee, 63 years
However, for those participants who did not draw an association between alcohol consumption and
surgery, offering an explanation of this prior to screening could influence acceptability of the alcohol
screening and intervention:
I was quite surprised because like I say, I didn’t have a clue that it would have an effect on the
recovery at all until it was explained.
Male, knee, 67 years
Upcoming surgery was identified to act as a motivator for changing alcohol consumption in a number of
ways. One participant explained that they had planned to reduce their drinking prior to surgery even
before they had received the intervention because they wanted to be ‘be fit and right’ for surgery. Others
explained that they reduced their drinking to enhance their recovery:
. . . it was mainly for the recovery of my knee; I wanted the best outcome possible for my knee.
So, that sort of spurred me on just to try and keep off it.
Male, knee, 67 years
Some participants felt that getting surgery presented them with a certain amount of obligation to do their
bit to ensure that the operation went well:
There’s a lot of time and money going into your hip, or whatever, and you need to play the game.
Male, hip, 67 years
Building on this sense of obligation and the desire to undergo surgery that could lead to improvements in
health and quality of life, a number of participants identified that they would cut down or stop drinking if
this was a requirement for them to have their surgery:
It’s like I said, they told me I couldn’t take warfarin, and it’d be exactly the same as saying, ‘Before you
come in, you mustn’t have alcohol for 10 days, but we will test you when you come in’. If you’re in
pain, you’re going to stop.
Male, knee, 73 years
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The physical effects of surgery itself and specifically of the early postoperative phase could lead to changes
in drinking behaviour because participants were not mobile enough to go out, they were taking medication
or they did not feel like drinking:
It didn’t occur to me, I wasn’t really interested I suppose. I was groggy half the time anyway. I slept a
lot, with all this dope inside me.
Male, hip, 67 years
Alcohol health communication
With the feasibility study identifying that terminology concerning ‘risky drinking’ had a negative impact on
recruitment and that the term ‘standard drink’ was not widely understood by participants, these interviews
probed the understanding and acceptability of the key terminology used in health communication about
alcohol use. Four participants raised the topic of the low-risk drinking guidelines, which they broadly
rejected as ‘unrealistic’, inconsistent with their normative perceptions of alcohol consumption and
‘impossible’ to stick to:
Maybe it’s just the circles I mix in, I don’t know. Maybe people do, by and large, but it doesn’t make
sense to me, the units. I think they’re so low, I’m sure you’d be able to drink more than that safely.
Male, hip, 67 years
Two participants also questioned the motivation and perspective of those behind the low-risk drinking
guidelines, stating that these were decided by the ‘anti-drink lobby’ and those that ‘actually have the
money’.
A number of participants were able to provide accurate descriptions of a standard drink as being equivalent
to a ‘unit’ and equate a ‘standard drink’ to servings such as half a pint, a small glass of wine or a single
measure of spirits. However, four of the interviewees provided inaccurate descriptions of servings that
would equate to a standard drink:
Is a measure where you say ‘standard drink’? My standard drink is a pint.
Male, knee, 71 years
Participants identified being more familiar with the term ‘unit’ than the term ‘standard drink’, explaining
that ‘unit’ was used in alcohol labelling as well as in health promotion. Indeed, this increased familiarity
is demonstrated by the fact that when participants were asked about their understanding of the term
‘standard drink’, transcripts show that a number immediately interpreted this as referring to ‘units’:
Interviewer: I wondered what you understood that term to mean, so what a standard drink is?
Participant: I’ve kind of given up trying to understand what a unit and . . . Personally, I don’t think
they’re realistic.
Male, hip, 67 years
This increased familiarity appeared to equate to a more accurate understanding of the term ‘unit’, with
more than half of participants providing accurate descriptions of servings that equate to 1 unit. However,
familiarity was not considered to be universal and could potentially be lower among those who were
drinking heavily:
Not everybody is aware of units and not a lot of people that drink a lot care about units.
Male, hip, 67 years
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Despite the familiarity with the term ‘unit’, participants were clear that they were most comfortable talking
about alcohol in terms of servings such as pints, half pints and glasses, and that talking in this form
allowed them to ‘give you quicker answers’. One participant expanded on this, explaining that although
they were familiar with ‘unit’, it required additional work on their part:
I’ve got to translate. It’s using Fahrenheit and celsius or kilos and pounds. You only think in one way.
You’ve got to actually work out the other way.
Male, knee, 61 years
When asked what the terms ‘risky drinking’, ‘hazardous drinking’ and ‘harmful drinking’ meant to them,
interviewees provided a range of descriptions relating to volume of alcohol consumed, frequency of
drinking, drinking in the morning or before driving, drinking the ‘wrong type’ of drinks, short-term
negative outcomes of drinking, including being involved in accidents and suffering memory loss, and
longer-term health outcomes:
Well I mean it means there must be degrees, there is quite low level of risky drinking. I mean you
can fall over and injure yourself. I mean any excess drinking can have long-term harm, cancer, heart
attack and all this sort of thing but also social effects, domestic effects, driving, just because it frees
you from inhibitions. You can act in ways which it would be better that you didn’t but it’s a matter
of degree.
Male, knee, 78 years
Some participants considered the terms to be synonymous and reported no preference about which terms
were used in health communication:
I’d know exactly what they were talking about when I saw either, and they would both mean exactly
the same.
Male, knee, 61 years
However, others identified distinctions between harmful and hazardous drinking specifically, with hazardous
considered to refer to short-term negative outcomes and harmful to longer-term health implications:
I would think hazardous drinking was risk of having an accident or getting in a situation, harmful I
would put down to medical. I would just draw that difference for the two terms.
Male, hip, 67 years
Finally, the potential for ‘risky’ drinking to be interpreted in a positive manner and be something to aspire to
was raised by one participant, who explained that this term may be appealing to young people specifically:
No, I don’t think it is. Especially for, like, the younger generation, because them, to take a risk is far
better than being dull. So, when you say ‘risky’, they think, ‘I’ll have a go at that’.
Male, knee, 73 years
By contrast, the term ‘harmful’ drinking was identified as potentially more effective for use in health
communications as it would not have positive implications:
In a way, ‘harmful’, I think, is the word that hits things home with me, because you can harm yourself
in a number of ways, some of which are self-inflicted, some of which you can’t do anything about.
The idea of if you say to somebody, ‘This is harmful to you’: that seems to simplify things . . .
Male, knee, 63 years
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Although some participants identified that they were drinking ‘too much’, drank in excess of the guidelines,
or were ‘heavy’ drinkers, when participants were asked directly whether they would use the terms ‘risky’,
‘hazardous’ or ‘harmful’ to describe their own drinking, they stated they would not. However, one
participant explained that the researcher might use that term to describe his drinking:
I don’t know what you would class as risky drinking, quantity-wise. It’s probably what I’m drinking.
Male, knee, 61 years
Others also explained that, retrospectively, they would describe their previous drinking, specifically their
drinking when they were younger, in these terms, although they would not have done so at the time:
In the past. Well yes, that’s an honest answer. I mean not all that much but it has happened, I’ve got
to say that.
Male, knee, 78 years
Talking to older patients
Two key factors can be used to broadly characterise the participant population in this trial: they were all
‘patients’ attending for orthopaedic surgery and they were generally in later life. Interviewees were asked if
specific considerations should be made when working with older adults and with patients.
Participants raised a number of reasons that older adults may choose to drink alcohol or may increase their
alcohol consumption. These reasons predominantly related to changes in circumstances. Retirement was
seen to provide an increased opportunity to drink and may lead to people getting ‘carried away’. Similarly,
there was an increased chance of boredom, which would act as a motivator to drink. One participant also
explained that older adults were less risk-averse and, another pointed to the relatively lucrative financial
situation of some retirees, which might facilitate increased drinking:
I think a lot of people our age just think, ‘That’s it, I’ve retired, I’m going to enjoy it’. You can get
carried away, can’t you? . . . And people tend to have a few bob in their pocket, it seems.
Male, hip, 67 years
The issue of death was seen to have the potential to influence drinking behaviour in a number of ways.
Loneliness following the death of partners or friends could motivate increased drinking. Meanwhile, the
increased salience of death could either lead to a ‘why not’ approach to drinking or motivate individuals to
do more to ensure their health:
Loneliness. When you get to the age I’m at and a little bit further on, that’s when people die. People
do get lonely and it’s very, very easy to turn to drink if you’re lonely.
Male, knee, 70 years
. . . if you are a heavy drinker you just think well so what, I’m going to die anyway. I might as well go
really happy.
Male, knee, 85 years
Consideration of whether or not older adults were an appropriate target for alcohol interventions revealed
split opinions. Some interviewees felt that older adults were more likely to be open and honest about their
drinking, whereas others explained that older adults would not want to be asked about their alcohol
consumption and would not want to be ‘educated’ about alcohol use:
I’m very careful about the words ‘educate people’ because I’m not convinced that some people like to
be educated in this sort of age bracket.
Male, knee, 63 years
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Some participants explained that because there was the potential for alcohol use to increase in later life it
was appropriate to work with older adults to increase their awareness of alcohol issues and support them
in monitoring or changing their behaviour:
It’s easy for people to say, ‘Oh, we’ll go and have a beer or whatever and sit in the garden’. Then one
thing leads to another, doesn’t it? So I think maybe people our age could be aware of that.
Male, hip, 67 years
In contrast to this, a number of participants felt that alcohol interventions targeting older adults were
unlikely to make any difference because the target population would not pay attention or would not be
able to change their drinking behaviour:
I think people are set in their ways aren’t they? When they get to over 50, they’re either drinkers or
they’re not. Then I think changing someone’s habits at my age is really asking a lot.
Male, knee, 67 years
Others pointed to the fact that there was no need to target this population because they did not have the
opportunity to drink to excess and their drinking behaviour would already have decreased. One participant
went so far as to state that excessive drinkers simply did not live long enough to reach the point of later life:
Big drinkers are not older because well it kills them doesn’t it?
Male, knee, 85 years
All participants were directly asked if any specific considerations should be made when working with
patients; however, the majority felt that there was nothing additional that should be considered. Five
participants did provide specific responses. Once again, opinion was split about whether or not alcohol
would be a potentially sensitive subject; two interviewees felt that discussing drinking behaviour would not
be a problem and that patients would be honest, whereas two others felt that patients, especially those
drinking to excess, were unlikely to tell the truth:
I suppose the more you drink, the less likely you are to tell the truth about what you drink.
Male, knee, 73 years
This difference in opinion was summarised by one patient, who identified that responses were likely to vary
from one patient to another depending on the amount of alcohol consumed and that it was important to be
aware that some patients would feel less comfortable discussing alcohol use and to take this into account
in the way that the subject was approached:
If there’s an issue, they probably won’t tell the truth. If they’re more than happy to say, ‘Oh, I have
one glass of wine a week,’ they’d be proud of it and they’d shout it from the rooftops, but I think it’s
something that you’ve just got to bear in mind that not everybody wants to talk about.
Male, knee, 61 years
One participant once again identified that he felt that people were unlikely to act on the advice or
information provided:
I don’t know what you could say, really. I’m not sure how many people would actually take a great
deal of notice, you know.
Male, hip, 67 years
In contrast to this view and the view of other interviewees who felt that little could be done to change the
drinking behaviour of older adults, five participants identified that more should be done to address alcohol
consumption in general, with a number of diverse approaches suggested. One participant felt that more
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should be done to remove high-volume, low-price alcoholic beverages from sale; another felt that drinking
to excess should be taxed in some way; another recommended improvements to alcohol labelling to make
alcohol content more visible and easier to interpret; and two considered that increasing ‘hard-line’ health
communication messages and fear appeals, especially those involving personalised feedback, was more
likely to lead to change:
I don’t think that the hospital makes people aware of it, of the damage it could do. Maybe if that
could be made a bit more forcefully.
Male, knee, 70 years
Gender differences
With a much greater number of men than women consenting to participate in both the feasibility study
and the pilot RCT, participants were asked if they could provide any insight into gender differences that
might influence participation. Participants raised the issue of potential gender differences in orthopaedic
surgery and in alcohol consumption that would make women less likely to meet the inclusion criteria.
However, these opinions were not consistent across interviewees, with some explaining that women drank
as much as or as often as men and that from their experience a greater number of women than men were
undergoing surgery:
Oh God, this day and age, I don’t know. I go out and just see more women out than bloody men.
Male, knee, 64 years
Two participants also explained that women were generally less likely to want to share information
about their personal lives. These views suggest that women may decline screening, refuse participation
or under-report their alcohol consumption when screened:
I don’t think women like being asked invasive questions about themselves. I’m trying to picture my
wife being asked the questions and I think you’d be getting a lot of. ‘Erm, but, erm’. Maybe she
wouldn’t quite give you the exact amount.
Male, knee, 70 years
Other participants felt that men would be more open about their alcohol consumption than women, with
one suggesting that this might be motivated by seeing friends and family members going through health
scares and treatment:
Maybe they’ve come to their senses and think too much drink is doing too much damage. There are a
lot of people, like I’ve got a couple of friends who are having problems and going through tests on
their liver and stuff like that. Maybe it’s something to do with that, too much drink, and they realised.
Female, hip, 67 years
One participant also felt that male participants may have been motivated to take part by their female
partners:
I don’t know. Probably their wives have told them to do it.
Male, knee, 70 years
Health-care professional interview results
Eleven HCPs were recruited during the pilot RCT: four each from sites 1 and 2 and three from site 3.
Of these, eight went on to deliver at least one intervention session, one conducted screening only and
two had no further involvement. Five HCPs (two from site 1, one from site 2 and two from site 3)
consented to and participated in interviews about their experience of being involved in the trial. All five
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were female: three conducted both screening and intervention, one conducted the screening only and one
conducted the intervention only. Owing to the small number of HCPs involved in the trial and the visibility
of their involvement, quotations are identified by site only.
Coherence
Differentiation and individual specification
The HCPs interviewed were asked about both their day-to-day roles and their study-specific roles. The
descriptions provided clearly demonstrated that participants had an understanding of their own tasks and
responsibilities within the pilot RCT as well as how these differed from their usual preassessment role:
We do the AUDIT, the alcohol questions and then we go through the materials so reasons to cut
down, why it’s important for surgery and then looking at ways to cut it down . . .
Site 3
I was doing pre-assessments for patients that were going through surgery, minor surgery. Taking
heights, weights, blood pressure, bloods, stuff like that.
Site 1
Similarly, when asked how appointments differed for patients involved in the study, HCPs were able to
identify key differences between the trial intervention and standard PA processes. They highlighted a focus
on taking additional time to complete the AUDIT questionnaire and discuss alcohol consumption as the
key aspect of the trial for those involved specifically in intervention delivery. They also mentioned that
completion of screening and co-ordination were trial tasks for others:
So it’s about we take some extra time to go through the questionnaire and to talk more about
alcohol. Sometimes I am doing the pre-assessment as well so I will mention it at the beginning
of the assessment and say we will come back to that at the end and I think they have some more
questionnaires and forms to fill out for the study . . .
Site 3
There was also some recognition that as the trial participants were taking part in something additional on
a voluntary basis it was important to ensure that the experience was as positive as possible for them:
. . . people that are coming in for a booked BIRDS appointment, I never let them wait. So, if their
appointment time is 2 o’clock, they won’t be in this room any later than 2 o’clock, even if the research
team are not here, just give them a cuppa, ask them if they want a cuppa, and let them feel relaxed
really. Whereas the other appointments, some people are waiting there a very long time . . .
Site 3
Communal specification
Interview transcripts revealed that the study processes, and specifically screening and intervention, were
considered to fit well with existing PA specifically because questions about alcohol use and other health
behaviours are already a standard part of PA. Trial processes could be seen to build and expand on these
aspects of TAU:
. . . we do already ask about alcohol but we don’t really do much with that information. Other than
maybe refer the notes to anaesthetist review if they are drinking a lot or maybe do like liver function
tests and see how that comes out. So it does fit and it gives a bit something extra that we can do . . .
Site 1
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From the patient perspective, the delivery of screening and intervention was also considered to fit
well because it was scheduled around times when patients were already attending the hospital for
appointments:
So I think it is quite good, the fact of having it in pre-assessment when they come, because they’ve
got to come for their appointment anyway.
Site 3
Because the pilot RCT tasks were additional to TAU, it was considered necessary to have additional time
allocated for these sessions in order to allow for implementation:
Although it fitted in well, time is a big thing in this clinic. I think they found it was a bit more
time-consuming for them and they were getting held back a little bit. It went OK, just time wise.
Some patients like to talk more than others.
Site 1
Further to this, even when adequate time was available to deliver the intervention, there were instances
when issues emerged that had to be prioritised over intervention delivery to ensure patient safety:
I think one patient wanted to talk more about something else like they were using some other drugs
as well so that was what we talked about that a lot more really but otherwise it was fine with all the
others it really was fine.
Site 3
Internalisation
Interviewees identified a number of potential benefits of the trial and intervention at personal, system and
societal level. Personal benefits included positive outcomes for professional development, with potential
cost-saving benefits for the NHS and wider benefits of addressing alcohol consumption:
I think it will have a positive impact on the NHS. People are taking it in and cutting down on their
drinking, it’s going to benefit them and us . . .
Site 1
Well, it was to move myself up and get more experience within the NHS. I know the research is a
good thing to have on a CV [curriculum vitae].
Site 3
There was a clear indication that many of the potential benefits of screening and intervention were
communicated during the trial training suggesting limited understanding of the association between
alcohol and surgery:
. . . in the training it said about alcohol making it more likely for the patients to have complications
and possibly get infections and things like that and taking longer to recover so if they can cut down
then obviously that would help.
Site 3
Cognitive participation
Initiation
Only one of the five participants interviewed directly referred to managerial support of the implementation of the
trial process, explaining that one of the consultant anaesthetists was ‘keen for us to be involved’ and wanted
them to ‘get to the target’. This was identified as beneficial. In addition, two HCPs described instances when they
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discussed difficulties balancing trial work with clinical work and received support to prioritise their trial roles as
well as in communicating this prioritisation with the wider clinical team:
I did tell my manager, ‘I need you to tell everybody what my priority is and it’s the study,’ and there
was an e-mail sent at one point saying that my job role was the study . . .
Site 3
Despite this support, one of the interviewees identified that it ‘didn’t really make a difference’ to her
workload or to others expectations of her in the subsequent weeks.
Enrolment
The HCAs who were responsible for conducting the majority of the screening also took ownership of the
study and worked to push it forwards at each of the three sites:
I think I sort of took ownership of it and just went out there and did it.
Site 2
Although this was recognised by other interviewees, one of whom stated that the HCAs’ support ‘helped a
lot’ with the co-ordination of study visits, balancing clinical and research work was not always easy and
often the research work did not seem to be recognised by other HCPs in the PACs:
I think everybody here thinks you’re doing the same as them. They try and get you involved in what
they’re doing but you don’t really have the time.
Site 3
Legitimation
Two of the interviewees clearly expressed the view that nursing staff, and specifically PA nursing staff,
were best placed to deliver screening and intervention processes with patients. To some extent this was
because of the content of the PAs that they were conducting:
Yes. I think when you’re doing a pre-assessment with somebody it is quite in-depth questions, so you
have to feel like you’ve got that bond with the patient for them to be able to tell you things honestly,
anyway. So I think if you were to give them a bit of brief advice or brief intervention included in your
pre-assessment, then it would be best off a prep nurse.
Site 3
However, one HCP also identified that having nursing staff conduct the interventions would be preferable
to doctors doing it as guidance from doctors would be less motivationally focused:
Obviously, a normal person doing it. Not a doctor saying, ‘Well, this is what you should be doing, and
this, and this, and this’.
Site 2
Similarly, patients were thought more likely to provide truthful, accurate responses to screening questions
when screening was conducted by nursing staff rather than by doctors:
I think the problem with doctors [is] that they will say, ‘Oh, how many units have you had?’ And
obviously they will be like, ‘Oh, I just have 3 units a week,’ or something like that, which you know is
totally a lie.
Site 3
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Activation
There was limited discussion of how visible the trial was within the PACs. Although there was some
indication in interviews that staff were aware of one another’s roles, with one of the HCPs describing
the supporting role of the screening HCA, there were also instances, as discussed in Enrolment,
when screening was not recognised as a priority:
It’s been hard because you would want to get some of your BIRDS stuff done, but you couldn’t
because you were being used as a health-care assistant . . .
Site 3
However, the process of randomisation in combination with screening reactivity led to limited involvement
of one HCP, despite the fact that she had undertaken training and was scheduled to conduct visit 1 with a
number of participants:
I think it has just been by chance but whenever I am going to do the intervention they get allocated
to the no intervention or like they are only just on the guidelines or already reduced so there isn’t that
much to do . . .
Site 1
Collective action
Interactional workability
Interviewees discussed how they interacted with other staff members in the PACs, how they worked with
the screening and intervention tools and how patients interacted with these tools.
Regarding interactions with other staff members, it was considered important to maintain positive
relationships with PA staff not involved in the trial and to minimise any impact on the day-to-day running
of the clinic:
I’ve always just said to them, ‘If you need the patient I’m here all day anyway. You just take them first
of all, and I will see them afterwards’ . . . obviously you’ve got to have a good rapport with them,
which obviously now we do . . .
Site 2
Both the AUDIT-C and the full AUDIT questionnaires was considered easy to use and fairly self-explanatory,
and the infographic detailing standard drinks was seen as beneficial for both the HCPs and the patients:
Yes. The alcohol units are quite good. A lot of patients did like that as well.
Site 2
However, some questions on the full AUDIT questionnaire were considered more likely to generate adverse
reactions specifically because they were related to potential dependence. This could in turn hinder the
interaction between the HCP and the patient participant:
. . . there was a particular question that had a couple of raised eyebrows. It was, ‘How often in the last
year have you needed an alcoholic drink to get you going in the morning?’ A couple of patients were
all right until you got to that question and then they would kind of retract themselves back a bit as if
to say, ‘Are you calling me an alcoholic?’
Site 1
The BI tools were also considered easy to use and were described as having ‘everything that you need’,
with one HCP explaining ‘I don’t think they need to change’. However, familiarity with these tools and
PILOT RANDOMISED CONTROLLED TRIAL
NIHR Journals Library www.journalslibrary.nihr.ac.uk
92
practice using them was considered important both for the effective delivery of the intervention and for
assessing their benefit:
. . . there is a lot of information like they have all the things you would need I suppose I just I can’t
really say more than that I don’t know what it’s like really to go through it all with a patient . . .
Site 1
Skill set workability
In terms of delivering the screening and intervention, HCPs considered themselves to be experienced in
asking about alcohol use and, therefore, well placed to conduct the screening:
. . . it’s just about how you say it and you know we ask about alcohol all the time so I’m used to it and
I don’t it’s not about judging them it’s about making sure they are safe for their surgery so that can
help too.
Site 1
However, training was considered necessary to develop the additional knowledge and skills required to
deliver the intervention, with practice needed to ensure effective delivery:
I don’t think that you could do it without having the training. I don’t think that you could just go and
just reel off what was on there, because obviously there are different crib sheets that you go off.
Site 2
Additionally, one of the interviewees identified that those who were interested in and enjoyed delivering
the interventions were best placed to deliver them:
I think there were a few of us doing it at the beginning but I am the only one really now doing the
interventions. I enjoyed doing it so I suppose it just makes sense because some of the others they were
quite nervous about It . . .
Site 3
Contextual integration
Consideration of the interview transcripts identified a number of issues relating to the allocation of
resources, specifically in terms of staff and time allocation. As discussed in Chapter 3, Communal
specification, the allocation of adequate time to deliver the intervention was important. However, there
was a potential downside to this. Even with the work of HCAs to co-ordinate the pilot RCT, there were
times when staff time was allocated to deliver sessions but the session was delayed, the participant was
allocated to the TAU condition or the patient did not turn up:
It is a bit frustrating because you set the time aside and you know you’ve done the training and then
you set the time aside and it’s a lot of standing around and waiting while they do the like the consent
then at the end of it they don’t go in the intervention so you just do the preassessment . . .
Site 1
When staff had both clinical and research responsibilities, this could also lead to issues with HCAs having
to remind other staff to complete the AUDIT screening questionnaires and return them in a timely manner
to ensure that expressions of interest could be completed for eligible patients:
A lot of the nurses do forget to give us them and I had a lot of patients that were missed, because if
I was working in the investigation suite the AUDITs would be popped on this desk and then I would
come in and they had scored over five, but they had left the department . . .
Site 3
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Reflexive monitoring
Systematisation
There was that the effectiveness of screening and intervention was formally assessed. One interviewee,
however, did express a desire to see the final results of the pilot trial, although she did not demonstrate
a clear understanding of the fact that a pilot trial would not be powered to detect between-group differences:
. . . it would be good to see the results because some of them they do seem positive but it would be
really nice to know if it helped and if it did make a difference.
Site 3
Communal appraisal
Discussion of communal engagement in assessing of the effectiveness of research, screening and
intervention processes was also limited. Although there was some evidence of HCPs discussing the
trial and assessing issues around implementation, there was no suggestion that such conversations
had considered the potential benefits or effectiveness of the work:
. . . other people I know had a patient booked in but then they didn’t turn up or cancelled at the last
minute and that is annoying . . .
Site 1
Individual appraisal
In contrast to the limited evidence of systematisation and communal appraisal, there were numerous
examples of how individuals had collected anecdotal evidence of effectiveness. Some of these related
specifically to completion of the screening questionnaires, which was seen to increase patients’ awareness
of their alcohol consumption:
The patients that I’ve talked to have said, ‘Actually, I didn’t realise how much I was drinking’ . . .
Site 2
Others thought that the intervention would lead to more changes in drinking behaviour than screening alone:
. . . they want the surgery and they want to get better more quickly and then like the questions they
realise that maybe they are drinking more than they thought so we can then we look at cutting it
down and they are quite positive so I think that some of them they will change for the surgery.
Site 3
In addition, the fact that the trial involved multiple contact points across the full course of the surgical pathway
not only offered HCPs the opportunity to get an idea about whether or not the intervention was having a
positive impact on patients’ alcohol consumption but was also seen as beneficial to the patient experience:
I think it was just the fact as well of having that extra bit of contact that actually made it enjoyable.
Within the trust more. The patient experience was a bit better.
Site 2
The HCPs also identified a number of benefits to themselves as individuals from being involved in the trial.
In addition to the anticipated benefits for their own professional development, being involved was described
as ‘interesting’ and ‘enjoyable’ and for some had led to a change in their own drinking behaviour:
I know my drinking habit has changed since doing it completely. And it still has changed now. We will just
have alcohol if we go out. Which is very rarely, obviously, with a young child. But we don’t have alcohol in
the house anymore . . . The whole family has reduced alcohol intake, which I think has been a good thing.
Site 2
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Reconfiguration
The HCPs described tailoring the delivery of the screening questionnaire to help ensure positive interactions
with patients when completing them. For some, this involved ‘forewarning’ patients that some of the
questions might or might not apply to them:
People do adapt a little bit to their own style, but you still have to ask them questions and get
them answers.
Site 2
However, HCPs also made some suggestions about how the trial could be improved, with a
recommendation to use the term ‘units’ instead of ‘standard drinks’:
. . . as a pre-assessment nurse you go by units, whereas the auditing is by standard drinks and people
will get a bit confused about a unit or a standard drink.
Site 3
Conclusions
The pilot trial identified that a definitive trial is feasible. We aimed to recruit 80 patient participants to
allow the collection of outcome data from a total of 60 patient participants at 6 months post recruitment.
Sixty-eight patient participants were recruited (86% of target) but data were collected from 65 participants
(96% of target) at 6 months post recruitment. There were very small numbers of missing data at baseline
and at 6 months post recruitment in both trial arms. Therefore, the very high retention rate and high levels
of data completion mitigated the fact that the initial recruitment target was not met.
To detect a between-group difference of 13% in the number of participants identified as lower-risk drinkers
at 6 months post recruitment follow-up (AUDIT score of 0–7), just less than 10,000 patients would need to
be screened to recruit 770 patients to the trial. With approximately 160,000 patients undergoing hip or
knee arthroplasty in the UK annually24 and the majority of sites employing some form of assessment of
preoperative alcohol consumption,116 this level of screening and recruitment is considered to be achievable.
Further to this, qualitative findings identified the proposed screening, intervention and research processes as
broadly acceptable to both HCPs and patient participants. The randomisation process was shown to have
little influence on patient participants, although, as we did not interview decliners, it is possible that they
hold different views. Similarly, the burden of participation was also acceptable, with patient participants
identifying themselves as having the necessary free time to participate.
The amendment of the inclusion criteria so that patients were not required to report regular high-intensity
consumption (consumption of six or more standard drinks on a single occasion at least weekly) and to
judge eligibility on the initial AUDIT-C screen rather than the completion of full AUDIT at baseline led to
the identification of 23% of patients screened as being eligible. This also ensured that reductions in
alcohol consumption following screening and invitation to participate did not lead to the exclusion of
patients who were potentially eligible at initial screening.
Just over one-third of eligible patients were recruited to the pilot trial. With higher rates of recruitment
seen in RCTs that conduct screening, consent and intervention on a single occasion,141 further streamlining
of the trial processes may enhance recruitment rates.
A total of 68 patient participants were randomised to the BBI or TAU. Of the 33 patient participants allocated to
the BBI arm, 32 (97%) received the intervention as intended and all received a copy of the patient information
leaflet. However, delivery rates of the optional booster intervention session was very low, with only four out
of 33 participants (12%) allocated to the intervention receiving this session. With such low rates of delivery
and limited indications of any additional benefit or potential benefit of this session in qualitative data from
patient participants, it is considered neither feasible nor necessary to employ a booster session in a definitive trial.
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Very few problems were identified with the proposed follow-up measures, although length of hospital stay
could limit collection of self-reported patient data at the in-hospital (visit 4) follow-up. Rates of completion
of the AUDIT tool, the proposed primary outcome measure, were consistently high. Although qualitative
interview data from HCP participants identified that some of the wording and terminology in the AUDIT
tool could lead to adverse reactions among patient participants, something that they acted to mitigate by
tailoring delivery, this was not something that emerged from interviews with patient participants.
The proportion of missing data was higher at interim study visits, although this never fell below 65% for
required follow-up points (i.e. excluding the optional booster session). Rates of completion were lowest for
visit 3, which was designed to be conducted over the telephone 1–3 days before surgery. Scheduling this
visit to occur on the day of surgery, when patients present at the hospital, may improve rates of completion,
but the acceptability of this should be further explored.
Alcohol use at baseline, as assessed by AUDIT and self-reported units of alcohol consumed per week,
was observed to be lower in the BBI arm than in the control arm. Although no inferential statistics were
conducted to assess the significance of this difference, a definitive trial may need to assess and control
for such differences.
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Chapter 5 Discussion
This chapter draws together and discusses the findings from the three key phases of the project(feasibility, pilot RCT and characterising TAU). Findings are discussed in order of trial processes
(screening and recruitment, intervention compliance, retention and follow-up) followed by additional
findings related to the implementation of trial processes and variation in perioperative pathways and TAU.
Key findings and their implications for future research are summarised in Table 28.
TABLE 28 Summary of findings and implications
Issue Findings Implications for future research
Identifying potential
participants
Screening for AUDIT-C score of ≥ 5 or
consumption of six or more standard
drinks weekly increased the number of
eligible patients. Initial screening and
study invitation can lead to reductions
in alcohol consumption prior to
intervention. Waiting time between
listing for surgery and attendance at the
PAC (≥ 3 months) could create a lag
between screening and recruitment
Use revised screening criteria. Inclusion
should be based on initial screening to
avoid excluding patients who are highly
motivated to change. Consider postal
invitation and telephone screening
Consenting eligible
participants
Removal of the term ‘risky drinking’ from
the study title and a reduction in the
period of time before expression of
interest was followed up increased the
proportion of patients consenting. In the
pilot RCT, 34% of eligible participants
were consented to the trial. The most
common reasons for declining
participation were lack of interest and
not having enough time
Future trials must avoid any pejorative
terminology in recruitment materials and
streamline trial visits. Improve appeal of
initial approach by including information
on the potential benefits of the trial
Meeting recruitment
target
Recruitment fell short of target, with
68 patient participants recruited against
a target of 80 (85%)
Recruitment of preoperative patients to
alcohol intervention trials is challenging
Compliance with
intervention
In total, 32 out of 33 patient participants
allocated to the intervention arm received
the intervention and all 33 received a
copy of the patient information leaflet.
Only 4 out of 33 received the optional
booster intervention
Delivery of BI in the PAC is feasible. Future
trials need not include a booster session
Fidelity of delivery Fidelity of delivery improved between
the feasibility study and the pilot RCT.
Motivational BCTs were well delivered
but volitional ones less so
Additional training may be required for
HCPs to effectively deliver volitionally
focused BCTs. Alternatively, the adoption
of an advice-focused intervention could be
adopted to ensure consistent delivery
Characterising TAU TAU relating to alcohol screening,
availability of advice and availability of
referral was found to vary between
individuals and between sites
TAU at trial sites should be considered
during selection. Standardisation of TAU
across sites may also be necessary
Retention Retention at 6 months post recruitment
was very high (96%)
Retention unlikely to be a concern for
future trials
Outcome assessments There were few missing data on AUDIT
and EQ-5D. WOMAC was less well
completed
AUDIT and EQ-5D are acceptable outcome
measures. Consider when WOMAC is
completed and how patient participants
are instructed to complete it
Safety issues No serious adverse events were reported No safety issues for future trials
continued
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Screening and recruitment
Findings from the feasibility study and comparison of screening and recruitment rates from the feasibility
and pilot RCT clearly demonstrate the importance of working with end-users (both HCPs and patients) to
refine study processes and materials to ensure and enhance acceptability before attempting to recruit to
a definitive RCT. Specifically, amendments made during and following the feasibility study led to a 20%
increase in the percentage of eligible patients recruited. As a result, four times as many patient participants
were recruited from screening only twice as many patients.
Initial results of screening in the feasibility trial identified that a large proportion of patients who screened
AUDIT-C positive (score of ≤ 5), indicating increased risk from drinking, were judged ineligible because
they did not report consumption of six or more standard drinks on a single occasion at least weekly.
Amending the screening criteria to include both regular and high-intensity drinking (AUDIT-C score of
≤ 5 or consumption of six or more standard drinks on a single occasion at least weekly) increased eligibility
rates from 16% to 20%. In the pilot RCT, the rate of eligibility based on alcohol screening with the
AUDIT-C was approximately 34% when the criteria were set as AUDIT-C score of ≤ 5 or consumption of
six or more standard drinks on a single occasion at least weekly. Taking into consideration the fact that
one site employed pre-screens to avoid screening those already documented as abstainers, this is reflective
of overall population rates of exceeding the lower-risk guidelines.10 Although this means that a large
number of patients (approximately five) have to be screened to identify one eligible patient, it is these
patients who are most at risk of developing alcohol-related complications. Further to this, assessment of
alcohol consumption is already part of the standard preoperative care pathway, and the use of validated
tools is becoming more common, especially with the advent of the CQUIN programme.
Although the number of patients who declined participation is much smaller than the number of those
found to be ineligible, the recruitment of eligible patients (34%) fell short of the predefined progression
criteria. Taking into account the high retention rate, which indicates that progression to full trial would
be feasible, it is important to consider if and how further improvements can be made to recruitment.
With over 40% of those declining doing so because they were not interested in the trial, future trials
should ensure that the initial approach to patients is appealing and clearly sets out the possible benefits
of involvement to health and postoperative recovery.
The percentage of eligible patients who did not express an interest in being involved in the trial was higher
in the pilot RCT than in the feasibility study (35% vs. 4%). This is interpreted as either resulting from the
addition of the randomisation process or resulting from the increased number of study visits in the pilot RCT.
This points to a need to ensure that study visits are kept to a minimum. This issue is further highlighted by
the fact that 15% of participants who declined participation did so on the basis that they did not have enough
time to take part or to attend the intervention session. In addition, the findings of qualitative interviews with
patient participants identified that even among those who considered themselves to have a large amount
of free time there was a limit to the frequency of contact that would be acceptable. Minimising the time
burden placed on patients by ensuring that the number of study visits are kept to a minimum, that the
TABLE 28 Summary of findings and implications (continued )
Issue Findings Implications for future research
Sample size calculation Sample size calculation feasible Indicated that 385 participants per arm to
be recruited for definitive trial
Communication of
alcohol health messages
There was limited understanding of
associations between alcohol and surgical
risk, as well as of the term ‘standard
drink’ and to a lesser extent ‘unit’
HCPs need adequate training to conduct
screening and intervention. Training and
interventions should adopt the term ‘unit’
and better explanations of alcohol use
DISCUSSION
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intervention itself and any required research processes are as succinct as possible and that study visits are
arranged around existing hospital appointments or over the telephone will be key for a successful full trial.
Possible streamlining of study visits is discussed in more depth in Follow-up and retention.
Participants in qualitative interviews were specifically asked about the acceptability and importance of the
number of study visits. Although time is required for all participants to consider entry into any study, many
patients indicated that offering a minimum of 24 hours following screening was not necessary. This
information lends itself to the possibility of conducting same-day screening, consent and randomisation.
Indeed, this pragmatic approach would be more consistent with how screening and intervention would
occur if the intervention were implemented as part of standard care. It would also minimise the number
of ineligible patients who had already been through PA or for whom the date of surgery would not have
allowed adequate time for behaviour change (the third most frequent reason for non-eligibility). However,
it would also require consistent availability of staff for consent and intervention delivery and, therefore,
may not be practical in the research trial.
A final point to consider concerning patient eligibility and recruitment is that there was no clear reason
recorded for 16.5% of the patients who declined to participate. This points to the need to ensure accurate
recording of the outcomes of all patient contact while protecting patients’ right to decline or withdraw
from participation without giving a reason.
Intervention compliance and fidelity of delivery
Findings from the pilot RCT show a high level of compliance to allocation, with 96% of patient participants
allocated to the intervention receiving the BA and BI elements and all receiving a copy of the patient
information leaflet. However, the specific content of the intervention sessions, as documented by assessments
of fidelity of delivery, showed more variability.
The AUDIT questionnaire was found to be acceptable to both patients and HCPs in the feasibility study and
pilot RCT. However, some of the questions designed to assess harm experienced as a result of drinking
behaviour were identified by HCPs as potentially more likely to provoke adverse reactions. This reflects early
feasibility findings that the term ‘risky drinking’ was not acceptable to potential participants. BIs emphasise
a non-judgemental, positive, motivational approach that can be seen to be inconsistent with some of the
terminology routinely included in alcohol screening and alcohol-related health communication. Therefore,
qualitative interviews conducted as part of both the feasibility study and the pilot RCT were used to further
explore the issue of appropriate terminology. Findings from the pilot RCT show that although interviewees
demonstrated a large amount of variation in how they interpreted the terms risky, harmful and hazardous
drinking, none considered these terms to be applicable to their own current drinking behaviour. Indeed,
the majority of participants identified their drinking as acceptable or moderate even if it was in excess of
the low-risk drinking guidelines. Even the two participants who self-identified as ‘heavy’ drinkers did not
relate to these terms. Similarly, findings from the feasibility study point to the use of ‘defensive othering’
as a technique to distinguish own drinking from the ‘problematic’ drinking of others. In combination, these
findings point to a need to avoid the use of any language that categorises participants’ drinking behaviour
in a negative manner (e.g. ‘risky drinking’), even when providing feedback on screening.
Fidelity of intervention delivery was low in the feasibility study but improved in the pilot RCT. This change is
likely to have resulted from a combination of two factors: first, the work to optimise the training package
between the feasibility and pilot RCT and, second, the greater number of patients recruited to the pilot trial.
The resulting increase in frequency of intervention delivery offered HCPs the opportunity to gain additional
experience of delivering the intervention and enhanced their familiarity with the intervention tools, two
factors that the HCP qualitative interview data identified as contributing to the effective delivery of
interventions. Nonetheless, in both phases of the study, although motivationally focused BCTs, especially
those related to communicating the health, social and emotional consequences of alcohol consumption,
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were consistently delivered, volitionally focused BCTs such as problem-solving and pros and cons were less
consistently delivered. This suggests that further refinement of the training package, and possibly a longer
period of time dedicated to training, may be required to enable PA HCPs to deliver these BCTs.
Although HCPs identified alcohol consumption as a priority for health care, awareness of the link between
alcohol consumption and surgery was low among both patient and HCP participants. The training was
identified as increasing HCPs’ knowledge in this area and thus increasing the perceived benefit of delivering
alcohol screening and BI in this setting. Similarly, findings from patient interviews identified that messages
around alcohol and surgical risk are most relevant to screening and intervention in the preoperative setting,
with issues regarding weight loss and medication management also considered relevant. Therefore, further
amendments to the intervention to increase the focus on the perioperative setting may be beneficial.
There was very low uptake of the optional booster intervention session planned to be delivered approximately
1 week before surgery. Findings from qualitative interviews regarding the potential benefit of this session
were mixed, with no clear indication that it was considered necessary or beneficial. This is in line with
previous trials that have found no additional benefit from offering more extended interventions and lower
rates of compliance when interventions require multiple sessions.75
Follow-up and retention
Follow-up data from the pilot RCT demonstrate that this population is highly amenable to follow-up, with
a very high retention rate (96%) at 6 months post recruitment. This means that provision for a 25% loss to
follow-up rate in the setting of recruitment targets was not necessary to allow adequate data at outcome.
This compares favourably with a previous trial of alcohol interventions in the preoperative setting95 and trials
from primary84 and emergency84 care, which report lower but still acceptable retention rates at 6-month
follow-up (72–88%). With variation in retention rates for other alcohol intervention trials, and lower
completion of interim follow-ups in this pilot trial, a retention rate of 80% was employed for the sample
size calculation necessary for a definitive trial. This will produce more conservative recruitment targets.
The proportion of missing data was higher at interim study visits, although it never fell below 65% for required
follow-up points (i.e. excluding the optional booster session). Rates of completion were lowest for visit 3,
designed to be conducted over the telephone 1–3 days before surgery. Completion of this measure face to
face when patients present at the hospital prior to surgery could improve rates of completion. However, the
acceptability of this to patient participants has not yet been considered and thus would need to be explored
prior to implementation.
The average length of hospital stay in our study of 3–4 days is in line with national data available from
Scotland.142 Given this information, and the fact that eight patient participants did not undergo surgery
during the study, the low completion rate for visit 4 (planned to take place 3–5 days postoperatively) is
unsurprising. Any future trial should aim to conduct post-surgical follow-up on or before 3 days post
surgery in order to maximise opportunities for measure completion. Further to this, completion of the
WOMAC questionnaire at visit 4 was additionally complicated by the nature of the questionnaire.
Triangulation with qualitative data shows that some items in the WOMAC require respondents to have
completed certain activities (e.g. climbing the stairs) before being able to accurately assess their ability to
complete these activities. Providing guidance on how to manage situations when accurate assessments
cannot be made may be helpful in this regard. However, it would be more appropriate to address these
issues (variation in length of stay, minimising of participant burden and lower completion rates of the
WOMAC questionnaire) by ensuring that visit 4 is focused primarily on postoperative complications that
could be mainly accessed from patient notes, thereby reducing patient contact.
If these changes were made, along with the completion of screening, recruitment and intervention on a
single occasion, it could reduce the current seven-visit trial design to four visits.
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Surgical care pathway variation
Although many hospitals have a standard care pathway of 6–10 weeks from PA, variation in pathways,
even in this pilot study, was notable. Some eligible patients when identified had < 7 days before their
operation, whereas eight of the 68 patients recruited to the pilot RCT had not undergone surgery before
the end of the study. This variation would be difficult to control without having an adverse impact on
patient care. Nevertheless, some considerations may be relevant to minimise the impact of such variation.
First, identifying and intervening with patients as early as possible in the preoperative care pathway
remains a priority for preoperative intervention trials. Second, tailoring interventions to individual
preoperative pathways will be important in facilitating both shorter- and longer-term behaviour change.
Finally, it may be appropriate to consider including a trial follow-up visit to occur a specified length of time
after surgery.
Both the focus groups and the survey responses demonstrate a large amount of variation in day-to-day
practices between individuals and between sites, as well as over time. This variation was seen across
processes for alcohol screening, the identification of patients whose drinking represented a potential
surgical risk, the management of patients following assessment of alcohol consumption and the availability
of alcohol specialist services. Despite previous research demonstrating that applying validated screening
tools in PA improves the identification of both dependent and increased risk drinkers,67 findings from this
work indicate that such tools remain infrequently adopted in PA, although the CQUIN initiative may
change this. This is in line with a previous survey of PA leads.10
Although many respondents identified the availability of support and potentially interventions for
dependent drinkers, including anaesthetic review and referral to alcohol specialist nurses, limited options
were available to address increased risk drinking either specifically in relation to surgery or more generally.
However, the availability of generalised interventions may increase for sites participating in the CQUIN
initiative as the second phase of this focuses on delivery of appropriate interventions. Further to this, some
HCPs indicated that they provide simple advice to reduce drinking or avoid alcohol consumption prior to
surgery or that such a recommendation was included in the information leaflets provided to patients.
Overall, this variation points to a need for high-quality evidence to inform policy and practice around
alcohol consumption and surgery. However, this very same variation means that the selection of trial sites
for a future definitive trial will need to involve consideration of the method of alcohol screening, level of
information and available alcohol specialist support. Work to standardise the TAU condition would also be
beneficial to ensure consistency in its delivery.
Implementation of trial processes
Qualitative interviews with HCP participants identified a number of factors that could act as barriers to or
facilitators of the implementation of trial processes.
It was clear that initial knowledge of associations between alcohol consumption and surgical outcomes was
limited and that knowledge of the potential benefits of the research predominantly derived from the training
provided. Without this understanding, it is unlikely that HCPs would volunteer to participate in the trial. Having
the required time to complete trial activities, including screening, intervention, co-ordination and follow-up,
was important as PACs were considered to be busy and individual appointments included a relatively
extensive assessment. Having adequate staff time allocated for intervention delivery was considered vital
to the effective delivery of intervention sessions but could present a problem if patients failed to attend or
declined to participate on the day. Furthermore, HCPs based in PACs often struggled to balance research
tasks against PA roles. In addition to having the necessary training to deliver screening and intervention,
gaining ‘real-life’ experience of delivery and becoming familiar with the tools were highlighted as important
to effective delivery and to maintaining a sense of professionalism. This was not considered to be possible
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through training or role-play activities but required experience with actual patients and within the day-to-day
clinic. The application of NPT allowed further identification of issues specifically related to the implementation
of trial activities. These included limited higher-level management support for trial activities, infrequent
intervention delivery and limited visibility of the research within the PAC.
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Chapter 6 Conclusions and recommendations
Conclusions
This work finds that preoperative alcohol screening using the AUDIT-C and full AUDIT is acceptable to
patients and HCPs. Similarly, delivering BBI in the PAC is possible and the intervention methods adopted
were acceptable to patients and HCPs. The evidence supports the feasibility of a definitive trial to assess
the effectiveness of these methods in bringing about reductions in preoperative alcohol consumption and
secondary outcomes of surgical complications if recommendations to enhance recruitment are adopted.
Recommendations
The primary recommendation from this project is that a definitive RCT is feasible. The very high levels of
retention in the pilot RCT and data completion at baseline and follow-up mitigate the fact that recruitment
fell slightly short of the initial target. With the background literature identifying a wealth of evidence on
the associations between preoperative alcohol consumption and surgical outcomes, but a sparsity of
evidence regarding the effectiveness of behavioural interventions in reducing preoperative alcohol
consumption, such a definitive trial is also considered to be appropriate.
A number of secondary recommendations for the design and conduct of a definitive trial can also be
made. These are arranged in priority order.
1. Evidence from both the feasibility study and the pilot RCT shows that avoiding potentially pejorative
terminology in any recruitment materials and the adoption of a non-judgemental approach throughout
are vital for recruitment to be successful. Specifically, a future trial should:
– avoid any categorisation of drinking as ‘risky’, ‘harmful’ or ‘hazardous’
– communicate that all patients are being invited to complete screening.
2. Qualitative evidence shows limited understanding of, and low familiarity with, the term ‘standard drink’;
it is therefore recommended that:
– the term ‘units’ be adopted in all trial materials
– HCPs be trained and prepared to ensure that they are confident in converting patient descriptions of
alcohol consumed in terms of pints or glasses into units in order to enhance the accuracy
of screening
– interventions include a description of units to enhance interpretation of the lower-risk drinking
guidelines and increase the accurate monitoring of alcohol.
3. Although qualitative evidence from trial participants identified that the burden of participation was
acceptable, the rate of eligible participants (34%) consented may be further improved by streamlining
the trial visits. Specifically:
– with the very low delivery of the optional booster session, this visit should be excluded from any
future trials
– with low completion rates of visit 3 (1–3 days pre surgery), this visit could be scheduled to take
place when patients arrive at the hospital on the day of surgery.
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– with variable length of stay and some difficulties completing the WOMAC questionnaire at visit 4
(in-hospital follow-up 3–5 days post surgery), a future trial should consider either conducting this
visit 1–3 days post surgery or amending it to focus only on postoperative complications that can be
collected from patient notes
– as in this pilot RCT, all study visits should be arranged to either take place around existing hospital
appointments or be conducted over the telephone or at the patients’ home in order to minimise
burden and remove any requirement for additional travel to the hospital site.
4. With 40% of eligible patients who declined participation in the trial stating that they did so because
they were ‘not interested’, future trials should ensure that the initial approach and introduction to the
study is appealing and clearly sets out potential health benefits of participation.
5. With HCP interviews identifying difficulties in balancing research roles with clinical demands in busy
PACs, it is recommended that future trials:
– arrange for all follow-ups to be conducted by research-specific staff while PA staff maintain the role
of intervention delivery
– work with PA leads throughout the trial to raise the profile of the research in the clinic, track
progress against targets and identify any issues.
6. With evidence from the focus groups and HCP survey showing that PA frequently involves the
assessment of alcohol consumption and may include a brief recommendation to reduce drinking prior
to surgery alongside qualitative evidence that some participants in both the feasibility study and pilot
trial report reducing their alcohol consumption following initial screening and invitation to participate,
future trials should:
– assess eligibility in terms of alcohol consumption based on initial screening
– carefully consider and characterise the comparator condition.
CONCLUSIONS AND RECOMMENDATIONS
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Appendix 1 Behaviour change techniques present
in intervention materials
TABLE 29 Behaviour change techniques present in BA and BI tools
Intervention tool BCT
BA 5.1 Information on health consequences
5.1 Information on health consequences
2.2 Feedback on behaviour
2.7 Feedback on outcomes of behaviour
6.2 Social comparison
5.1 Information on health consequences
5.3 Information on social and environmental consequences
5.6 Information on emotional consequences
8.2 Behaviour substitution
12.1 Restructuring the physical environment
12.2 Restructuring the social environment
12.3 Avoidance/reducing exposure to cues for behaviour
1.1 Goal-setting behaviour
BI 9.2 Pros and cons
9.2 Pros and cons
1.1 Goal-setting behaviour
1.2 Problem solving
3.1 Social support unspecified
TABLE 30 Behaviour change techniques present in patient information leaflet
Intervention tool BCT
Patient information leaflet 5.1 Information on health consequences
5.3 Information on social and environmental consequences
9.2 Pros and cons
2.3 Self-monitoring of behaviour
1.2 Problem-solving
8.2 Behaviour substitution
12.3 Avoidance/reducing exposure to cues for behaviour
12.1 Restructuring the physical environment
12.2 Restructuring the social environment
1.2 Problem-solving
3.1 Social support unspecified
2.3 Self-monitoring of behaviour
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Appendix 2 Capability, Opportunity
and Motivation to perform a particular
Behaviour questionnaire
COM-B Self-Evaluation Questionnaire
(COM-B-Qv1)
When it comes to you personally providing a brief intervention that targets alcohol reduction
or cessation to patients during pre-assessment, what do you think is needed for you to do it? 
Please circle any of the items on the list that you think apply to you. You can circle as many
or as few as you think appropriate. Some of the items may look strange, but that is just
because we need to cover all areas – some which may not apply to you. 
For each item you circle could you also say why you think it might be important for you in
the free text box provided beneath.
I would have to....
Capability 
1. Know more about why it 
was important 
e.g. have a better understanding of the benefits of
providing a brief intervention targeting alcohol reduction
and cessation prior to surgery to my patients.
2. Know more about how to
do it
e.g. have a better understanding of how to effectively
deliver a brief intervention targeting alcohol reduction 
and cessation to my patients. 
3. Have better physical 
skills 
e.g. acquire/develop new skills to effectively deliver a 
brief intervention targeting alcohol reduction and 
cessation to my patients. 
4. Have better mental skills e.g. learn how to reduce the likelihood that patients go
off on tangents during discussions about alcohol
reduction or cessation
5.  Overcome physical
limitations
e.g. proceed to deliver a brief intervention targeting
alcohol reduction and cessation effectively to patients
when feeling tired.
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6.  Overcome mental 
obstacles
e.g. overcome the urge to avoid delivering the 
intervention to a patient who has previously been
resistant to changing their alcohol consumption.
7.  Have more physical
stamina 
e.g. develop greater capacity to maintain physical effort, 
particularly following delivery of an intervention to a 
challenging patient.
8.  Have more mental 
stamina 
e.g. increase mental capacity to discuss alcohol reduction 
and cessation with patients, particularly following 
delivery of an intervention to a challenging patient.
I would have to....
Opportunity
9. Have more time to do it e.g. dedicate time to provide an intervention to patients
targeting alcohol reduction or cessation. 
10. Have the necessary
materials
e.g. have materials available to me to help target alcohol
consumption or cessation in my patients 
11. Have colleagues around
me doing the same thing
e.g. be part of a group of colleagues who are also
providing the intervention to patients.
12. Have triggers to prompt
me
e.g. have reminders at strategic times to prompt me to
use specific parts of the intervention.
13. Have support from others e.g. have colleagues/supervisors supporting me to
provide the intervention.
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I would have to....
Motivation 
14. Feel that I want to do it 
enough
e.g. feel a sense of pleasure or satisfaction from
using/providing the intervention to patients to target 
alcohol reduction or cessation. 
15. Feel that I need to do it
enough
e.g. care more about the negative consequences of not 
providing the intervention to target alcohol reduction or
cessation. 
16. Believe that it would be a 
good thing
e.g. have a strong sense that I should provide the 
intervention.
17. Develop better plans for 
doing it
e.g. have  clearer and well-developed plans for providing
the intervention.
18. Develop a habit of doing 
it
e.g. getting into a pattern of providing the intervention 
without having to think too much about it.
19. Something else (please 
specify): 
Thank you for taking the time to respond to this questionnaire. 
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Appendix 3 Capability, Opportunity and
Motivation to perform a particular Behaviour
questionnaire responses
TABLE 31 The COM–B questionnaire responses from HCPs
Category Item Summary of free-text responses
Number of
responses
Capability Know more about why it was
important
Have better understanding of postoperative
risks to explain to patients why they should
do it. Facts and figures to back up
To have a better understanding of risks
related to surgery in order to allow an
explanation of why it would benefit the
patient(s) and encourage them to try to cut
down/quit
Important to understand why the
intervention is targeting alcohol reduction
9
Know more about how to do it No previous experience in this area so
increased knowledge and training are
required
A structured pathway for patients to be
able to follow to reduce alcohol intake
would help
Need a guide including precise facts and
information to provide to patients
Can be a difficult subject to approach
especially if the patient feels that their
alcohol intake is not high/problematic
1
Have practical skills to adequately
deliver each part of the intervention
Guidance on what should be covered 6
Have skills to navigate the intervention
in the way that is required
Training required to enable delivery of
deliver a positive/effective intervention
without it being too time-consuming
8
Have the ability to keep going despite
physical barriers
5
Have the ability to keep going despite
lacking in determination/motivation
Can be difficult to encourage patients
when they lack interest or are resistant to
change or accepting help
Could be a challenging role especially for
patients who have had habits for a
number of years
6
Have more physical stamina I think we have to do this anyway on lots
of things and is part of working in NHS
1
Have more mental stamina 2
continued
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TABLE 31 The COM–B questionnaire responses from HCPs (continued )
Category Item Summary of free-text responses
Number of
responses
Opportunity Have more time to do it Time is short and may neglect other
issues if spending time on the
intervention
Need longer appointment times if to
deliver more interventions
8
Have the necessary materials Protocols and guidelines as to who you
want targeted and key things to cover
Visual aids often good at helping patients
understand the importance of reducing
alcohol/smoking from my experience
7
Have colleagues around me doing the
same thing
Everyone working towards the same goal
and outcome
Working as a team advice from
colleagues how they managed certain
situations/support
Working as team – can bounce ideas off
each other/help motivate
6
Have reminders in place to deliver the
intervention
Very basic forms would be good due to
time limits
These patients will hopefully be identified
on set lists
4
Have support from others 3
Motivation Feel that I want to do it 2
Feel that I should do it 2
Believe that it would be a good thing 5
Develop better plans for doing it Time allocated
Need to be clear, concise, easy to follow
I believe in it if it’s done properly with
time planning ahead
Need a structured plan to feel confident
in talking to patients about it
9
Develop a habit of doing it Would need some continuity,
not ‘one-off’ sessions
Set time/follow on from a questionnaire
in PAC, which would automatically
trigger if needed intervention
6
Something else (please specify) Increase PAC time
Needs to work where patients do not
feel judged – patients should not be
dictated to
2
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Appendix 4 Affordability, Practicability,
Effectiveness, Acceptability, Safety and
Equity questionnaire
Pre-ops Bird Training Program Design 
Dear x,
Thank you very much for agreeing to assist us with the development of the Pre-ops Bird Training
Program. The training program is targeted at practice nurses who will be delivering a screening and
short intervention for risky drinking to pre-operative patients.
To support nurses with the delivery of the intervention we have designed an outline for a 2, 5 hour
training program that aims to provide nurses with the necessary knowledge and skills to effectively 
deliver the intervention. Given your experience in pre-operative care we would like to involve you in
the design of this training to make it as appealing and relevant as possible for the nurses.
The following questionnaire provides an outline of the preliminary components of the training. 
Could we please ask you to look at each individual component and rate each in terms of: 
• Effectiveness (Will the component help nurses gain necessary knowledge and skills to
effectively deliver the intervention?)
• Acceptability (Is the intervention component appropriate for the nurses?)
• Side-effects (Are there any potential negative side-effects of the component? E.g. nurses 
might feel uneasy or distressed to do an exercise) 
Please respond to each item with Yes or No in the third column. If you feel like a specific component 
doesn’t fit any of the criteria (effectiveness, acceptability, or side-effects) could you provide a short
description of your rationale?
Intervention
function
Individual training
components 
Does the intervention function 
meet the following criteria 
(effectiveness, acceptability,
side-effects, equity)?
Why no? 
Education Providing information/ 
education regarding risks 
associated with risky 
drinking behaviour 
Effectiveness: 
Acceptability:
Side-effects: 
Education Providing information about 
what constitutes 
normal/abnormal drinking
behaviour 
Effectiveness: 
Acceptability:
Side-effects: 
Persuasion Scientific evidence will be 
used to strengthen the
credibility of the 
intervention package
Effectiveness: 
Acceptability:
Side-effects: 
Incentivisation Nurses will be quizzed about
their knowledge regarding 
the intervention package 
and a prize will be given 
Effectiveness: 
Acceptability:
Side-effects: 
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Education, 
Training
Instructions on how to
complete the intervention
package with the patient
Effectiveness: 
Acceptability:
Side-effects: 
Modelling Short video demonstrations 
of the delivery of the 
individual intervention
package
Effectiveness: 
Acceptability:
Side-effects: 
Training Nurses will be prompted to
practice delivering the brief 
intervention to each other 
Effectiveness: 
Acceptability:
Side-effects: 
Training Intervention deliverers will 
provide feedback to the 
nurses on how they
delivered the intervention
Effectiveness: 
Acceptability:
Side-effects: 
Enablement Nurses will be prompted to
come up with a plan on how 
to deal with difficult/
challenging situations 
Effectiveness: 
Acceptability:
Side-effects: 
Enablement Nurses will be encouraged 
to form ‘supportive couples’
or groups in which they can 
discuss their experiences
and address any concerns
Effectiveness: 
Acceptability:
Side-effects: 
Thank you very much for completing this questionnaire. We will have a look at your responses and
integrate your feedback in the final version of the Pre-ops Bird Training program. 
Kind Regards,
Your Pre-ops Bird Research Team
APPENDIX 4
NIHR Journals Library www.journalslibrary.nihr.ac.uk
126
Appendix 5 Training feedback form
Preoperative Behavioural Intervention for Risky Drinkers before elective orthopaedic 
Surgery (Pre-Op BIRDS)
Training Intervention Evaluation
Name (optional):
We are keen to find out whether you found the training intervention we delivered both 
informative and practically useful (i.e. whether you felt it equipped you with the knowledge 
and skills required to deliver a brief behavioural intervention to your patients). You will be
presented with a series of statements for which you will be asked to circle a response that 
most closely matches how you feel about the session. If you have any additional comments to
make about the session generally, or those delivering it (Ellen Lynch, Leah Avery, and 
Sebastian Potthoff), then those will be gratefully received in the free text box at the end of
this form. 
The objectives of the session were clearly stated and appropriate
Strongly agree Agree Disagree Strongly Disagree N/A 
The session was well structured and relevant 
Strongly agree Agree Disagree Strongly Disagree N/A 
The content of the session was appropriately related to the overall outcomes 
Strongly agree Agree Disagree Strongly Disagree N/A 
The session was appropriately timed and delivered at an satisfactory pace
Strongly agree Agree Disagree Strongly Disagree N/A 
The session was delivered with interest and enthusiasm
Strongly agree Agree Disagree Strongly Disagree N/A 
I was invited to ask questions and participate in discussions
Strongly agree Agree Disagree Strongly Disagree N/A 
Appropriate practical examples were used to illustrate theoretical points
Strongly agree Agree Disagree Strongly Disagree N/A 
The content was made relevant to my practice 
Strongly agree Agree Disagree Strongly Disagree N/A 
The training accommodation was suitable 
Strongly agree Agree Disagree Strongly Disagree N/A 
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Audio-visual aids (e.g., PowerPoint) intervention materials and handouts were used 
effectively to deliver/support the session
Strongly agree Agree Disagree Strongly Disagree N/A 
The individuals delivering the session were approachable and non-judgemental
Strongly agree Agree Disagree Strongly Disagree N/A 
Having attended the above session, I feel I left with a good knowledge of the topic delivered 
Strongly agree Agree Disagree Strongly Disagree N/A 
The knowledge gained from the session will assist me further in my clinical practice 
Strongly agree Agree Disagree Strongly Disagree N/A 
The skills gained from the session will assist me further in my clinical practice 
Strongly agree Agree Disagree Strongly Disagree N/A 
Overall I enjoyed the session
Strongly agree Agree Disagree Strongly Disagree N/A 
If you have any additional comments you would like to make, please write them in the 
space below: 
Signed: 
Date:
Thank you for completing this evaluation questionnaire. 
APPENDIX 5
NIHR Journals Library www.journalslibrary.nihr.ac.uk
128
Appendix 6 Focus group participant
information sheet
Feasibility Study: Pre-Operative Behavioural Intervention
to Promote Responsible Drinking before elective
orthopaedic Surgery 
(PRE-OP BIRDS) 
Participant Information Sheet
Health Care Professionals Focus Groups
We would like to invite you to take part in a focus group discussion as part of the PRE-OP
BIRDS research study. Before you decide you need to understand why the research is being 
done and what taking part would mean for you. Please take time to read the following 
information carefully, and feel free to talk to others about the study, if you wish. Take some 
time to consider it carefully before you decide. 
Please ask us if there is anything that is not clear.
What is the purpose of the study?
Alcohol consumption is known to be associated with increased complications after surgery, 
which prevent early recovery and prolong rehabilitation times. It is therefore important that we
are able to detect increased alcohol intake by patients much better than we currently do.  
This study aims to test a revised screening and behavioural intervention which will be used 
with patients being referred for surgery. The behavioural intervention will help you to provide 
simple advice and guidance to patients on how reducing alcohol consumption prior to surgery
could improve recovery time and reduce the amount of time spent in hospital after an 
operation.
In order to fully understand if the new intervention is successful we will need to test it against 
the standard treatment provided to these patients. These focus groups will therefore be used 
to gather information regarding what is standard practice in local NHS Trusts. The information
provided will be used to inform a larger pilot trial that will run straight after this feasibility study 
and will compare the new intervention against standard practice, as identified during the focus 
groups. 
Why have I been invited to take part in PRE-OP BIRDS? 
You have been invited to participate as you currently work within or alongside a Preoperative
Assessment Clinic and are involved in the development, organisation or delivery of the elective 
surgical patient pathway.
Do I have to take part? 
You do not have to take part, and it is up to you to decide. If you do agree to take part, you 
can withdraw without giving a reason. 
Once the Focus Group has started you are also free to leave at any point but data collected
up to that point will be retained for use in the study.
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What will I have to do? 
After you have signed the study consent form you will take part in a focus group that will last 
approximately one hour. The focus group will involve approximately 6-8 staff members per 
group and will involve a mix of healthcare professionals involved in the orthopaedic surgery
patient pathway. This will take place at a time and location convenient for you. The aim of the 
focus group is to explore current views of preoperative alcohol screening and behavioural 
intervention in older orthopaedic patients. We also aim to clarify and understand what defines 
usual practice in preoperative assessment clinics particularly with regard to screening patients
for high-risk alcohol consumption. 
The focus groups will be audio recorded and transcribed verbatim. This data will then be 
analysed by a researcher and will assist the research team in defining the comparator or
treatment as usual group for the pilot trial. 
What are the possible benefits of taking part? 
Taking part in the focus group will not benefit you directly but the information we gather from
these focus groups will help inform a larger pilot trial and may help patients and Health Care
Professionals in the future. 
Will my taking part in this study be kept confidential? 
All study information, including personal details, will be kept confidential and will not be made
public. The study data may be looked at by people who are monitoring or auditing the study,
a Research Ethics Committee (REC) or other regulatory authorities, or the hospital Trusts
involved in the study, to make sure that the study is being run correctly. By signing the consent 
form, you are giving your permission for this to happen. 
Everyone involved in this study has a duty of confidentiality to the participants and this will be
maintained throughout the session. If however, during the course of the focus group any 
abusive and/or unprofessional behaviours and/or actions are disclosed by staff this will need
to be reported to the study Chief Investigator. It will also be reported to their line manager and,
if applicable, through the appropriate NHS safeguarding process. 
Who is organising and funding the research?
This study is being funded by the NIHR Health Technology Assessment programme. This
body is funded by the UK government to carry out research for the benefit of the NHS and its 
patients. It is being organised and carried out by a team of researchers based in Newcastle
upon Tyne. 
Who has reviewed the study? 
This study has been reviewed and given favourable opinion by Newcastle & North Tyneside
2 Research Ethics Committee.
What will happen to the results of this study? 
Data from this study will be used to improve the behavioural intervention and the next phase
of the research. Data from your focus group may be used, anonymously, in the study report
and publications from the research.
Further information and contact details 
These are the key contacts for this study. If you have any further questions or would like any 
further information about the study or the rights of participants, please feel free to contact
them. 
[insert local details here]
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Appendix 7 Focus group consent form
Paent Idenficaon Number for this trial:
CONSENT FORM
Health Care Professionals Focus Group 
Title of Project: Preoperat ive Behavioural Intervent ion to promote Responsible Drinking
before elect ive orthopaedic Surgery (PRE-OP BIRDS) – Feasibility Study 
Chief Investigator: Dr Chris Snowden 
Please init ial all boxes 
1. I conf irm that I have read and understand the informat ion sheet dated [                  ] 
version [       ] for the above study.  I have had the opportunity to consider the 
information, ask quest ions and have had these answered sat isfactorily. 
2. I understand that my part icipat ion is voluntary and that I am free to withdraw at any 
t ime without giving any reason, without my legal rights being affected.
3. I understand that data collected during the study, may be looked at by individuals from 
Newcastle University, from regulatory authorit ies or from the NHS Trust, where it is
relevant to my taking part in this research.  I give permission for these individuals to
have access to my data. 
4. I give my permission for the focus group to be audio recorded and for these recordings
to be saved by the research team
5. I agree to take part in the above study. 
Name of Part icipant Date Signature                 
Name of Person Date Signature 
taking consent.
When completed - 1 copy for part icipant and 1 original copy for Invest igator Site File
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Appendix 8 Focus group discussion guide
Before commencing Interview: 
Ensure have completed consent forms, discussed recording interview and anonymisat ion 
of data. 
Check staff members are happy to start focus group and inform you will turn audio 
recorder on. 
Introducons:
I’m sure some of you know each other already but it would be really benef icial for me if you
could introduce yourselves, give your job t itle and a brief descript ion of your role in
preoperat ive assessment. 
Usual Care Quesons: 
1. Could you talk me through the preoperat ive care pathway for individuals undergoing
primary hip or knee arthroplasty?
Prompts:
Is that right from the f irst contact with the pat ient?
Is there anything that any of you do with or for pat ients that hasn’t been
covered?
2. Do you do any kind of preoperat ive alcohol screening, if so can you tell me about it? 
Prompts:
when/how?
How do pat ients respond to being asked about alcohol?
What about other health behaviours?
Are there any specif ic issues or concerns about conduct ing such screening 
with older orthopaedic pat ients? 
3. What happens as a result of screening, for example if a pat ient screens posit ive?
Prompts: 
Do they get given any informat ion?
What about if they screen negat ive?
Percept ions of Current Status Quest ions:
1. How do you feel about the current approach to preoperat ive alcohol screening?
Prompts:
Is screening important? If so why?
Should we be doing more? 
Is this the right t ime to be asking about alcohol use?
Are there any specif ic issues or concerns about conduct ing such screening 
with older orthopaedic pat ients? 
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2. What are your thoughts about conducng behavioural intervenons as part of
preoperave assessment? 
Prompts:
Is that specific to alcohol intervenons or any intervenon? 
From your experience would you expect any differences when dealing with 
older orthopaedic paents compared to other paent groups? 
3. Have any of you been involved in any behavioural intervenons during preoperave 
care? 
Prompts:
If so what for/how did you find that? 
Closing Quesons 
1. Is there anything else that we should consider when looking at alcohol screening and 
behavioural intervenons with older orthopaedic populaons?
2. Does anyone have anything that they would like to add or anything that you think
we should have talked about today?
To close the session: 
Turn off recorder.
Thank the staff members for giving up their me to take part and for providing useful
insight.
Remind that data will be used to inform future trial and may be used in publicaons but will 
be transcribed and anonymised so they are unidenfiable
Ask if they have any quesons
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Appendix 9 Treatment-as-usual survey
Age:  
 
Gender  
Male  
Female  
Other (please specify)  
Please indicate your current job role in the preoperave care pathway  
Please note: this survey is specifically aimed at individuals currently employed in preoperave 
assessment. If you are not currently employed in preoperave assessment please ck this box and 
end the survey here.  
Healthcare Assistant    
Prefer not to say  
Senior Healthcare Assistant   
Other (please specify)  
Band 4 Nurse  
Band 5 Nurse  
Band 6 Nurse  
Band 7 Nurse  
Team Leader  
Manager  
Sister  
Senior Sister  
Matron  
Anaesthest  
Consultant Anaesthest  
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How long have you: 
   Years  Months  
Held your current 
post?      
Worked in
pre-assessment?     
In your department, approximately how long does a preoperative assessment appointment last 
for paents undergoing primary knee arthroplasty?  
 
In your department, approximately how long does a preoperative assessment appointment last 
for paents undergoing primary hip arthroplasty?  
 
As part of preoperative assessment for hip and knee arthroplasty are paents asked about their 
alcohol consumption?  
Yes as part of formal pre-operave assessment procedure  
Yes paents are asked but this is not part of formal preoperave assessment procedure  
No  
Don’t Know  
Prefer not to say  
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How (in what form) are paents asked about their alcohol use? (please respond yes, no or don’t 
know to each opon)  
   Yes  No  Don’t know  Prefer not to say  
A simple yes or no 
indicaon of 
alcohol 
consumpon  
        
Paents are asked 
‘how much do you 
drink' 
        
Paents are asked 
‘how oen do you 
drink’ 
        
Paents are asked 
how many 
units/standard 
drinks they 
consume per week  
        
Paents are asked 
'how many 
units/standard 
drinks they 
consume per day  
        
Compleon of a 
screening tool or 
quesonnaire 
(please give details 
below)  
        
Please provide details of screening tools used or specify any other method of questioning not 
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As part of preoperative assessment for hip and knee arthroplasty are paents provided with any 
information about alcohol use? 
Yes, this is part of formal pre-operave assessment procedure  
Yes paents are given information but this is not part of formal preoperave assessment 
procedure  
No  
Don’t know  
Prefer not to say  
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What form does this information take? (please indicate yes, no or don’t know for each opon)  
   Yes  No  Don’t know  Prefer not to say  
Informaon 
leaflet/booklet 
about alcohol in 
general  
        
Informaon 
leaflet/booklet 
about alcohol use  
relaon to surgery  
        
Face to face
informaon 
about alcohol in 
general  
       
Face to face
about alcohol use  
relaon to surgery  
        
Websites to access 
information online 
in their own me  
        
Contact numbers 
for telephone 
information/support 
lines to use in their 
own me  
        
Paent is told to 
contact their GP 
surgery for 
information  
        
Other (please specify) 
 
in
informaon 
in
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Which paents are given this information about alcohol use? (please indicate yes, no or don’t 
know for each opon)  
   Yes  No  Don’t know  Prefer not to say  
All paents (regardless  
of whether they drink 
alcohol) receive advice  
        
All paents who report 
drinking alcohol receive 
advice  
        
All paents who request 
information          
Paents who consume 
over a specified number 
of units/standard drinks 
receive information 
(please provide details 
below)  
        
Paents who state, when 
asked, that they would 
like to cut down their 
alcohol consumpon 
receive information  
        
Paents idenfied 
through liver funcon 
tests receive informaon 
(please give details 
below of who interprets 
liver funcon tests and 
follows up if abnormal)  
         
Paents idenfied 
through other blood test 
receive information 
(please give details 
below of who 
interprets blood tests and 
follows up if abnormal)  
 
        
Other (please give details 
below)           
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Please give details here 
 
Are you able to refer paents for addional advice or support related to alcohol consumption? 
Yes, this is part of standard pracce  
Yes, but this is not part of standard pracce 
 
No  
Don’t know  
Prefer not to say  
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To whom can paents be referred? (please indicate yes, no or don’t know for each opon) 
   Yes  No  Don’t know  Prefer not to say  
Referral to 
consultant 
anaesthest  
        
Referral to GP          
Referral to in-
hospital alcohol 
liaison nurse or 
nurse specialist  
        
Referral to in-
hospital addicon 
psychiatrist  
        
Referral to 
Alcoholics 
Anonymous (AA) 
groups  
        
Referral to 
other external 
organisaon 
(please give details 
below)  
        
Other (please give 
details below)          
Please give any details here: 
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Which paents are idenfied for referral? (please indicate yes, no or don’t know for each opon) 
   Yes  No  Don’t know  Prefer not to say  
All paents are 
referred regardless of 
whether they report 
alcohol consumpon  
or not  
        
All paents who report 
drinking alcohol receive 
referral  
        
Paents who consume 
over a specified number 
of units/standard drinks 
receive referral(please 
give details below)  
        
Paents who state, when 
asked, that they would 
like to cut down their 
alcohol consumpon 
receive referral  
        
Paents idenfied 
through liver funcon 
tests receive referral  
        
Paents idenfied 
through other blood test 
receive referral  
        
paents who ask to be 
referred receive referral          
Paents who show signs 
of alcohol dependence 
receive referral  
       
Paents who are already 
idenfied as alcohol 
dependent receive 
referral  
        
Please give details 
 
DOI: 10.3310/hta24120 HEALTH TECHNOLOGY ASSESSMENT 2020 VOL. 24 NO. 12
© Queen’s Printer and Controller of HMSO 2020. This work was produced by Snowden et al. under the terms of a commissioning contract issued by the Secretary of State for
Health and Social Care. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional
journals provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should
be addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science
Park, Southampton SO16 7NS, UK.
143
As part of routine pre-operative assessment does your department currently provide intervenons 
(term described above) for any of the following health behaviours?  (please indicate yes, no or don’t
know for each opon) 
   Yes  No  Don't know  Prefer not to say  
Alcohol use          
Smoking          
Physical acvity          
Diet/nutrion         
Other (please give 
details below)          
Please give details here 
 
As part of routine pre-operative assessment do you personally currently provide intervenons 
(term described above) for any of the following health behaviours?  (please indicate yes, no or don’t
know for each opon)  
   Yes  No  Don’t  Prefer not to say  
Alcohol 
consumpon          
Smoking          
Physical acvity          
Diet/nutrion          
Other (please give 
details below)         
Please give details 
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As part of routine pre-operative assessment have you personally ever provided intervenons 
(term described above) for any of the following health behaviours?  (please indicate yes, no or
 don't know for each opon) 
   Yes  No  Don’t Know  Prefer not to say  
Alcohol 
consumpon          
Smoking          
Physical acvity          
Diet/nutrion          
Other (please give 
details below)           
Please give details here 
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Appendix 10 Feasibility study health-care
professional interview participant information sheet
Feasibility Study: Preoperative Behavioural Intervention to
promote Responsible Drinking before elective orthopaedic
Surgery
(PRE-OP BIRDS) 
Participant Information Sheet 
Health Care Professional Interviews 
We would like to invite you to take part in an interview as part of the PRE-OP BIRDS study. 
Before you decide you need to understand why the research is being done and what taking
part would mean for you. Please take time to read the following information carefully, and feel
free to talk to others about the study if you wish. Take some time to consider it carefully before
you decide.
Please ask us if there is anything that is not clear. 
What is the purpose of the study?
Alcohol consumption is known to be associated with increased complications after surgery,
which prevent early recovery and prolong rehabilitation times. It is therefore important that we
are able to detect increased alcohol intake by patients much better than we currently do.
This feasibility study aims to test a revised screening and behavioural intervention which will
be used with patients being referred for surgery. The behavioural intervention will help nurses
to provide simple advice and guidance to patients on how reducing alcohol consumption prior 
to their surgery, which could in turn improve their recovery time and reduce the amount of time
they have to spend in hospital after their operation. 
As part of this study we have trained pre-operative assessment clinic staff, to deliver the 
AUDIT C and AUDIT screening tools and have also trained some of them to deliver the 
intervention. We are now inviting all those trained to take part in interviews to find out how 
acceptable this screening procedure and the new intervention is and how easily these 
procedures can be embedded as standard practice during pre-operative assessment clinics. 
Why have I been invited to take part in PRE-OP BIRDS? 
You have been invited to participate as you have received training on the use of the AUDIT C 
and AUDIT screening tools and/or the intervention and have been using them in the 
preoperative assessment clinic. 
Do I have to take part? 
You do not have to take part, and it is up to you to decide. You can withdraw from the study 
at any time, without giving a reason. 
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What will happen to me if I take part? 
Members of staff from both groups (those trained in screening only and those trained in both
screening and behavioural intervention) will be asked to take part in a one-to-one interview 
with the researcher. This will last approximately one hour and will take place at a time and
location convenient for you. The interview will explore your views on the feasibility of the new
screening and behavioural intervention, any factors that may affect the delivery of the 
intervention and the acceptability of the intervention.
With your permission, interviews will be audio recorded and transcribed verbatim. This data 
will then be analysed and will assist the research team in designing a larger pilot trial.
What are the possible benefits of taking part? 
Taking part in an interview will not benefit you directly but the information we gather from this
feasibility study will help inform a larger pilot trial and may help patients in the future. 
Will my taking part in this study be kept confidential? 
All study information, including personal details, will be kept confidential and will not be made
public. The study data and patient medical records may be looked at by people who are 
monitoring or auditing the study, Research Ethics Committee (REC) or other regulatory
authorities, or the hospital Trusts involved in the study, to make sure that the study is being 
run correctly. By signing the consent form, you are giving your permission for this to happen. 
Everyone involved in this study has a duty of confidentiality to the participants and this will be
maintained throughout the session. If however, during the course of the interview any abusive 
and/or unprofessional behaviours and/or actions are disclosed by staff this will need to be 
reported to the study Chief Investigator. It will also be reported to their line manager and, if
applicable, through the appropriate NHS safeguarding process. 
Who is organising and funding the research? 
This study is being funded by the NIHR Health Technology Assessment programme. It is being 
organised and carried out by a team of researchers based in Newcastle upon Tyne. 
Who has reviewed the study?
This study has been reviewed and given favourable opinion by Newcastle & North Tyneside
2 Research Ethics Committee. 
What will happen to the results of this study?
Data from this study will be used to improve the behavioural intervention and the next phase
of the research. Data from your interview may be used, anonymously, in the study report and 
publications from the research. 
Further information and contact details 
These are the key contacts on this study. If you have any further questions or would like any
further information about the study or the rights of participants, please feel free to contact 
them. 
[insert local details here]
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Appendix 11 Feasibility study health-care
professional interview topic guide
HCP Interviews Discussion Guide 
Before commencing Interview: 
Ensure have completed consent form, discussed recording interview and anonymisat ion of
data. 
Check staff member is happy to start interview and inform you will turn audio recorder on. 
Check we have access to Age and Gender 
Introduct ion: 
1. To start with could you tell me about your experience of the study to date? 
Prompts:
What was your role? 
What motivated you to take part?
Where you happy to be involved?
2. How have you found using the AUDIT to screen patients for alcohol use?
Prompts:
have you used it before? 
was it easy to score?
were you comfortable asking all the questions? 
3. And what about the intervention? 
Prompts:
Have you used these material before? 
Have you used another intervention (other materials before) – if so what? 
How did you feel about talking to your patient about alcohol?
How did the patient react?
Feasibility Quesons:
1. How did you find the screening fit in with usual preoperative assessment procedures?
Prompts:
What worked well? 
What didn’t work well?
Suggestions for improvements?
2. Do you think it is practical to conduct screening during preoperative assessment? 
Prompts:
Why is that?
Can you expand on that? 
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3. How did you find the intervenon fit in with usual preoperave assessment procedures?
Prompts:
What worked well?
What didn’t work well?
Was there enough me to deliver the intervenon? 
Can you expand on that? 
4. Do you think it is praccal to deliver an intervenon during preoperave assessment?
Intervenon Materials:
1. We’ve got the study materials here, could you tell me what you thought of them? 
Prompts:
Do you have any suggestions about how we could improve the materials?
Where there any aspects that you thought were parcularly good or bad? 
2. Where you able to link these materials to the theories covered in the training you received?
Prompts:
Could you give me some examples of the key components of the intervenon and 
where they appear in the materials?
3. How did paents react to the study materials?
Prompts:
Were they well received?
Were there any negave comments or reactions? 
Procedure Quesons 
1. How did you find the overall procedure? 
Prompts:
So things like gaining consent, screening paents, conducng the intervenon and 
the booster?
Can you think of any way the procedure could be improved?
Fidelity Quesons:
1. Did you find it easy enough to sck to the intervenon? 
2. Were there any factors that influenced how you delivered the intervenon? 
Prompts:
Can you think of any that would?
Acceptability: 
1. How did you feel talking about alcohol with paents during preoperave assessment?
Prompts:
Did you feel you had the necessary skills and understanding to do this? 
2. How did paents react to talking about their alcohol use in this seng? 
Prompts:
Do you think that’s specific to older orthopaedic paents?
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Closing Quesons:
1. Is there anything that you think we should have talked about that we haven’t?
2. Is there anything that you would like to add? 
To Close the Interview: 
Turn off recorder.
Thank the staff member for giving up their me to take part and for providing useful insight.
Remind that data will be used to inform future trial and may be used in publicaons but will 
be transcribed and anonymised so they are unidenfiable
Ask if they have any quesons 
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Appendix 12 Feasibility study patient interview
information sheet
Feasibility Study: Preoperative Behavioural Intervention to 
promote Responsible Drinking before elective orthopaedic 
Surgery 
(PRE-OP BIRDS) 
Participant Information Sheet
Patient Interviews
We would like to invite you to take part in an interview as part of the PRE-OP BIRDS research 
study. Before you decide you need to understand why the research is being done and what
taking part would mean for you. 
Please take time to read the following information carefully, and feel free to talk to others about 
the study, if you wish. Take some time to consider it carefully before you decide. 
Please ask us if there is anything that is not clear.
Why have I been invited to take part in an interview?
You have been invited to take part in an interview because you have recently attended an 
appointment with a pre-operative assessment nurse using the behavioural intervention. As
such, we are interested in hearing your thoughts on this experience and how useful the newly 
developed intervention was for you. 
What is the purpose of the study?
Alcohol consumption is known to be associated with increased complications after surgery, 
which prevent early recovery and prolong rehabilitation times. It is therefore important that we
are able to detect increased alcohol intake by patients more accurately than we currently do.  
This study aims to test a revised screening and behavioural intervention, which will be used 
with patients being referred for surgery. The behavioural intervention will help healthcare
professionals provide simple advice and guidance to patients on how reducing alcohol
consumption prior to surgery could improve recovery time and reduce the amount of time
spent in hospital after an operation. 
As well as asking patients to take part in two sessions using this behavioural intervention, we
are also asking if they would be willing to take part in an interview once the sessions have
been completed. This is to gather the thoughts and feelings of those that will actually be using
the advice to see how they felt about it. 
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Do I have to take part? 
You do not have to take part, and it is up to you to decide. You can withdraw from the study 
at any time, without giving a reason, and this will not affect the care that you receive.
What will happen if I take part? 
After you have signed the consent form you will take part in an interview with a member of the 
research team. The interview will take place after you have received your operation and have
been discharged from hospital. It will last approximately one hour and will take place at a time
and place convenient for you. The interview will explore your thoughts regarding the 
intervention and how acceptable you found it. 
The interview will be audio recorded. This is to make sure that the researchers have access
to the information that you provide. This helps them make any changes needed to the 
intervention and improve how it works in the future. By recording the interview, they can
concentrate on what you are saying, rather than being distracted by taking notes.
Expenses and payment
You will not receive payment or reimbursement of expenses for taking part in this study.
However the interview can be conducted when you attend your 6 week post-operative follow
up appointment or in your home, at a time convenient to you. This ensures that you won’t incur 
any additional costs as a result of taking part in this study.
What are the possible benefits of taking part? 
By taking part in an interview you are providing valuable information that will help us to further 
develop the screening and behavioural intervention used as part of this study. We cannot 
promise the study will help you directly but the information we get from this study may help
other patients in the future.  
Will my taking part in this study be kept confidential? 
All study information, including personal details, will be kept confidential and will not be made
public. The study data and your original medical records may be looked at by people who are 
monitoring or auditing the study, a Research Ethics Committee (REC) or other regulatory 
authorities, or the hospital Trusts involved in the study, to make sure that the study is being 
run correctly. By signing the consent form, you are giving your permission for this to happen. 
Everyone involved in this study has a duty of confidentiality to the participants and this will be
maintained.
What will happen if I don’t want to carry on with the interview?
You have the right to withdraw at any time for any reason, and without giving a reason. But 
we might ask you to allow us to record why you have decided to withdraw. We will also keep
the data we have collected from you up to the point of withdrawal if you agree for us to do so. 
What if there is a problem?
If you have a concern about any aspect of this study you should ask to speak to the researcher 
who will do their best to answer your questions: [insert staff details here]
In the event that something does go wrong and you are harmed during the research and this
is due to someone’s negligence, then you may have grounds for a legal action for 
compensation against The Newcastle upon Tyne Hospitals NHS Foundation Trust but you 
may have to pay your legal costs. NHS indemnity does not offer no-fault compensation (for
harm that is not anyone’s fault). 
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If you are still unhappy and wish to complain formally, you can do so through the hospital’s 
procedure Patients Complaints Service (PALS) [insert details here]
Who is organising and funding the research?
This study is being funded by the NIHR Health Technology Assessment programme. This
body is funded by the UK government to carry out research for the benefit of the NHS and its 
patients. It is being organised and carried out by a team of researchers based in Newcastle
upon Tyne. 
Who has reviewed the study? 
To protect your interests, all research in the NHS is looked at by an independent group of
people called a Research Ethics Committee. This study has been reviewed and given 
favourable opinion by Newcastle & North Tyneside 2 Research Ethics Committee. 
How have patients and the public been involved in this study?
Members of Voice North have been involved in the design of this study. Voice North is a 
voluntary organisation that includes members of the public. Members actively volunteer to
assist researchers with the design of research studies to improve the quality of the research
and make sure it fits with what is important for both patients and the public. You can find out 
more about Voice North at: http://www.ncl.ac.uk/ageing/partners/voicenorth/#about
What will happen to the results of this study? 
Data from this study will be used to improve the behavioural intervention and the next phase 
of the research. Data from your interview may be used (anonymously) in the study report and 
in other publications from the research.
Further information and contact details 
These are the key contacts for this study. If you have any further questions or would like any 
further information about the study or the rights of participants, please feel free to contact
them. 
[insert local details here]
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Appendix 13 Feasibility study patient interview
discussion guide
Before commencing Interview: 
Ensure have completed consent form, discussed recording interview and anonymisation of
data. 
Check participant is happy to start interview and inform you will turn audio recorder on. 
Check we have access to Age, Gender, Audit Score
Introduction Questions:
1. Could you tell me what led to you coming into hospital for surgery in the first place?
2.  Before coming in to hospital did you expect to be asked about alcohol use? Why?
3. Would you link alcohol use and surgery in anyway?
Experience of the study
1.  So, moving on, can you tell me about your experience of being involved in the 
study? 
Prompts:
Could you tell me what motivated you to take part? 
Who did you speak to about the study?
How did you feel about being involved? 
2.  Next I’d like to know about the process of the study so could you start by taking me
through step by step what the study involved? 
Prompts:
What parts of the process could be improved?
Did you feel comfortable with all parts of the process?
Where there any parts that were unclear?
Acceptability Questions:
1. How did you feel being asked about alcohol use by a nurse?
Prompts:
Were you comfortable talking about your drinking? 
2. We used the pre-operave assessment as an opportunity to talk about your alcohol 
use: how did you feel about that? 
3. This is the tool or questionnaire (present AUDIT) that we used to assess your alcohol 
use which you have completed a few times now, can you tell me what you thought 
of it? 
Prompts:
Were the questions acceptable? 
Did you understand them all? 
How easy was it to complete? 
4. Focusing on the advice you received: how did you feel about that?
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Feasibility Quesons: 
1. How did you find the quesons and discussion about alcohol fit in with your care? 
Prompts:
Do you think it influenced the rest of your care? 
If so was this in a good or bad way?
2. I’m not sure if you know this already but this was a feasibility trial which means we
work with a small number of staff and paents to assess if these methods are
praccal and the findings then inform a larger study. With that in mind there are a 
few things which didn’t happen in this study but would in a larger trial that I’d like to
ask you about. Firstly in a full trial we would want to contact parcipants 6 months
aer the intervenon session to ask them some more quesons. How would you 
have felt about doing that? 
Prompts:
Specifically we’d ask you the AUDIT (show AUDIT) quesons again, to look at
alcohol use and these quesons about your health (show EQ-5D). Would you
have been happy to complete those? 
Also in this study everyone who wanted to take part received informaon about 
alcohol use but in a full trial only half the parcipants would be randomly selected to
receive informaon the other half would just get standard treatment. How would 
you have felt about that? 
Prompts:
Would it have influenced your decision to take part? 
Intervenon materials: 
1. We have the study materials here in front of us, the ones you were given by the 
nurse, and I wondered what you thought of them? 
Prompts:
Is there any way we could improve the materials?
Did you find some of these more useful than others?
Was it too much informaon, not enough informaon or about right?
2. You’ll noce the term standard drinks is used quite a bit in the materials. Did you
understand this? 
Prompts:
Somemes people use the term ‘unit’ or ‘units’ rather than ‘standard drink’
would you prefer that?
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3. If I could get you to look at the Brief Advice sheet – we had quite a few lists of
benefits from reducing alcohol intake and risks associated with higher alcohol intake
did you think we had the most important or most relevant points at the top of each
list?
Prompts:
Did you think there was anything missing from these lists? 
4. Is there anything we should know about talking to people your age about alcohol
use?
5. What about talking to paents about alcohol use?
Closing Quesons 
1. Is there anything that you think we should have talked about that we haven’t?
2. Is there anything you would like to add before we finish? 
 To Close the Interview: 
Turn off the recorder. 
Thank the parcipant for giving up their me to take part and for providing useful insight.
Remind that data will be used to inform future trial and may be used in publicaons but will 
be transcribed and anonymised so they are unidenfiable
Ask if they have any quesons 
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Appendix 14 Pilot randomised controlled trial
patient participant information sheet
Pre-Operative Behavioural Intervention to Reduce Drinking
before elective orthopaedic Surgery (PRE-OP BIRDS): A 
Pilot Randomised Controlled Trial 
Participant Information Sheet
We would like to invite you to take part in a research trial. Before you decide you need to
understand why the research is being done and what taking part would mean for you. 
Please take time to read the following information carefully, and feel free to talk to others about 
the trial if you wish. Take some time to consider it carefully before you decide. 
Please ask us if there is anything that is not clear.
Why have I been invited to take part in PRE-OP BIRDS? 
You have been invited to take part because you have recently been placed on the waiting list 
for elective hip or knee replacement surgery. As part of your pre-operative care you will be
asked to complete a questionnaire called AUDIT C. This questionnaire is routinely used before
a patient has surgery in order to find out how much alcohol the patient consumes on a regular 
basis. Once completed this questionnaire will be reviewed by the PRE-OP BIRDS study team
to see if you are eligible to take part in this trial. 
What is the purpose of the trial?
Alcohol consumption is known to be associated with increased complications after surgery, 
which can prevent early recovery. 
This trial aims to test a method which aims to reduce alcohol intake in patients known as a 
‘behavioural intervention’. This will be used with patients being referred for surgery. The 
behavioural intervention will be used by healthcare professionals to provide simple advice and 
guidance to patients on how they can reduce their alcohol consumption should they want to
and what benefits this could bring. 
Do I have to take part? 
It is up to you to decide whether you want to take part or not. You can withdraw from the trial 
at any time, without giving a reason, and this will not affect the care that you receive.
What will happen if I take part? 
Taking part in the trial will not influence if or when you receive your surgery. If the AUDIT C 
shows that you are eligible and you decide to take part you will be asked to complete and sign
a consent form. After which you will be asked to complete the AUDIT questionnaire, which is
a slightly longer version of the AUDIT C questionnaire that you previously completed. You will 
then be randomly allocated to one of two groups:
Behavioural intervention plus treatment as usual 
Or
Treatment as usual only
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You will have a 50-50 chance of being allocated to one of the groups. Your group will be
randomly picked by a computer. Neither you nor the trial team will have a say on which group 
you are put in, but you will be told straight away which group you have been allocated to. You 
will then attend your pre-assessment appointment, receiving your usual care. 
What will I have to do? 
As part of this trial there are some visits that you will be required to attend/take part in. In this
trial all visits to the hospital have been scheduled to take place either when you are already at 
hospital (for example during routine appointments or whilst you are an in-patient around the 
time of your surgery) or at your home/by telephone. This is to ensure you do not have to make
additional trips to hospital. 
Once you have been randomised you will be informed straight away which group you have
been allocated to either (a) behavioural intervention or (b) usual care. 
(a) Behavioural intervention 
If you are allocated to receive the behavioural intervention, the trial team will go through the 
intervention with you as part of your pre-assessment appointment. As part of the behavioural 
intervention you will be provided with brief advice on alcohol intake and support to reduce your
alcohol consumption before surgery should you want to. The team will also ask you some
questions about your alcohol use and feelings of wellbeing. The behavioural intervention 
session will last approximately 30 minutes which means your pre-assessment appointment 
will last approximately 30 minutes longer than usual. Approximately one to two weeks before
your surgery the research team will contact you (by telephone) to ask you a few more
questions and to offer you a second intervention session. This session will last approximately 
10 to 20 minutes and can be delivered by telephone if it is easier for you. During this second
session you will be asked to complete the AUDIT tool and receive the behavioural intervention 
which will involve some feedback and support. The aim of this session is to provide a refresher
of the advice and guidance you received during the first session and to provide you with an
opportunity to receive feedback and ask any questions. This second session is optional and 
you will be asked when signing the consent form to indicate if you are willing to take part in a 
second session and this will be confirmed with you again when you are contacted by the team
one to two weeks before surgery. 
We would like to make an audio recording of the behavioural intervention sessions in order to
help with the training of staff delivering the intervention. For example, researchers will listen 
to the recording and make a note of whether the nurse delivering the session is covering 
everything they need to. The recordings will also ensure that the behavioural intervention is
being delivered correctly and delivered in the same way each time. The recorded data will be
anonymised and then analysed by a researcher to assist the research team in improving the 
intervention content for future use. The attached consent form will ask you to indicate whether 
or not you are willing to have your intervention sessions recorded. The recording will only be
listened to by members of the research team.
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(b) Usual Care 
If you are allocated to receive treatment as usual you will not receive the intervention sessions 
and your consultations will not be audio recorded, but you will be asked some questions about 
your alcohol use and quality of life at the trial visits. These will only take a few minutes to
complete. 
Regardless of which group you are randomised to, you will be followed up for 6 months after 
randomisation. A schedule of the trial visits are listed in the diagram below along with what
information will be collected:
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When you come in for your surgery you will be asked if you would like to take part in the 
National Joint Registry. This is national registry which collects information on all hip, knee,
ankle, elbow and shoulder replacement operations and you will be provided with a separate 
information sheet which will contain much more detailed information about the National Joint 
Registry and what it does. The WOMAC questionnaire mentioned in the table above is
collected as part of the National Joint Registry and therefore if you agree to take part in the 
registry we will be able to use the WOMAC questionnaires completed as part of that (with your
permission) and you will not have to complete them again as part of this trial. If however you 
decide not to take part in the registry we will need to go through these questionnaires with you 
as part of the PRE-OP BIRDS trial. 
You will also be offered the opportunity to take part in an interview after you have completed
the trial. The interview will last around 60 minutes and will ask you how useful you found this
trial. Again this is entirely optional and you do not have to take part in an interview if you don’t 
want to. If you are interested in taking part we will provide you with an additional information
sheet that provides more information on what the interview will involve. 
Expenses and payment
As part of this trial you should not have to attend hospital for any additional visits outside of
your routine appointments. However, in the unlikely event that you do have to attend an 
additional visit at hospital in order to complete a trial visit, reasonable travel expenses will be 
reimbursed. 
What are the possible benefits of taking part? 
By taking part in this trial and following advice provided it is possible that you may recover 
more quickly following your operation and you may not have to spend as much in time in
hospital afterwards. We cannot promise that the trial will help you directly but the information
we gain from this trial will inform future research and may help other patients in the future.  
What are the possible disadvantages of taking part? 
There are no direct risks involved in taking part in this study and the standard of care you 
receive will not be affected whether you decide to take part or not. If you do agree to take part
in the study you will be required to give up a small amount of your time to complete the study 
visits, however we will ensure that you do not have to attend hospital for additional visits
outside of routine appointments wherever possible. 
You may be asked some potentially sensitive questions regarding your use of alcohol. These 
questions are asked routinely, as part of standard clinical practice, in the pre-assessment clinic
prior to any surgery. 
Will my taking part in this trial be kept confidential? 
All trial information, including personal details, will be kept confidential and will not be made
public. With your permission, we will let your family doctor (GP) know that you are taking part. 
The trial data and your original medical records may be looked at by people who are monitoring 
or auditing the trial, a Research Ethics Committee (REC) or other regulatory authorities, or the 
hospital Trusts involved in the trial, to make sure that the trial is being run correctly. It is
possible that the trial team might share anonymous information collected with other
researchers in the future. Sharing trial information with other researchers is very important as
it helps us to make sure that we are running a trial in the best possible way and it means that
we can make the most of the information collected during a trial. Any information that is shared 
DOI: 10.3310/hta24120 HEALTH TECHNOLOGY ASSESSMENT 2020 VOL. 24 NO. 12
© Queen’s Printer and Controller of HMSO 2020. This work was produced by Snowden et al. under the terms of a commissioning contract issued by the Secretary of State for
Health and Social Care. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional
journals provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should
be addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science
Park, Southampton SO16 7NS, UK.
165
will contain none of your personal details and will be fully anonymised. By signing the consent 
form, you are giving your permission for this to happen. Everyone involved in this trial has a 
duty of confidentiality to the participants and this will always be maintained. The Newcastle
Clinical Trials Unit would like to receive a copy of your consent form for safety purposes. This
will be confidentially destroyed once it has been reviewed.
What will happen if I don’t want to carry on with the study? 
You have the right to withdraw from the trial at any time for any reason, and without giving a 
reason. But we might ask you to allow us to record why you have decided to withdraw. We will
also keep the data we have collected on you up to the point of withdrawal. 
What if there is a problem?
If you have a concern about any aspect of this trial you should ask to speak to the researcher 
who will do their best to answer your questions: [insert staff details here] 
In the event that something does go wrong and you are harmed during the research and this
is due to someone’s negligence, then you may have grounds for a legal action for 
compensation against The Newcastle upon Tyne Hospitals NHS Foundation Trust but you 
may have to pay your legal costs. NHS indemnity does not offer no-fault compensation (for
harm that is not anyone’s fault). 
If you are still unhappy and wish to complain formally, you can do so through the hospital’s 
procedure Patients Complaints Service (PALS) [insert details here]
Involvement of the General Practitioner/family doctor (GP)
With your permission, we will let your family doctor (GP) know that you are taking part. 
Participation in the trial will also be noted in your hospital records so that anyone who treats
you will know you are taking part in the trial.
Who is organising and funding the research?
This trial is being funded by the NIHR Health Technology Assessment (HTA) programme. This
body is funded by the UK government to carry out research for the benefit of the NHS and its 
patients. It is being organised by a team of researchers based in Newcastle upon Tyne. 
Who has reviewed the trial?
To protect your interests, all research in the NHS is looked at by an independent group of
people called a Research Ethics Committee. This trial has been reviewed and given 
favourable opinion by [insert name of REC]. 
How have patients and the public been involved in this trial?
Members of Voice North have been involved in the design of this trial. Voice North is a 
voluntary organisation that includes members of the public. Members actively volunteer to
assist researchers with the design of research studies to improve the quality of the research
and make sure it fits with what is important for both patients and the public. You can find out 
more about Voice North at: http://www.ncl.ac.uk/ageing/partners/voicenorth/#about
Patients have also been involved in a feasibility study as part of this project to help inform the 
design of the screening and intervention materials as well as the development of this pilot trial.
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What will happen to the results of this study? 
Data from this trial will be used to inform future research. Data may be used, anonymously, in
the trial report and publications from the research.
Further information and contact details 
These are the key contacts on this trial. If you have any further questions or would like any 
further information about the trial or the rights of participants, please feel free to contact them. 
[insert local details here] 
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Appendix 15 Pilot randomised controlled trial
patient participant interview topic guides
Pre-op BIRDS pilot RCT Patient Interview Topic Guide – Control Condition
Ensure have completed consent form, discussed recording interview and anonymization of data.
Check participant is happy to start the interview and inform you will turn the audio recorder on. 
Check we have access to age, gender and AUDIT scores. 
Introducon Questions 
1. Could you tell me what led to you coming in to hospital for surgery in the first place?
2. Before you came into hospital did you expect to be asked about alcohol use?
Prompts:
Why?
3. Before you became involved in the research would you have linked alcohol to surgery in any 
way? 
4. Would you mind telling me about your alcohol consumption before you took part in the 
trial? 
Change Questions 
5. And did you feel that your alcohol use changed at all over the course of the research? 
Prompts:
Would you say that’s because of the surgery itself or being involved in the research? 
6. Were there specific aspects of the trial that motivated you to change your drinking? 
7. Do you remember if you set yourself any specific goals in terms of the change you wanted to
achieve? 
Experience of the Trial 
1. Could you tell me what motivated you to take part in the trial? 
2. I’d like to know about the process of the trial, could you start by talking me through step by
step what the study involved?
Prompts:
Who did you speak to about the trial? 
Did you feel comfortable with all parts of the process?
Where there any parts that were unclear? 
What parts of the process could be improved? 
3. At the beginning of the trial you may remember that you were contacted about the trial and
then given time to think about your involvement before coming back to be consented into
the trial. Was it important to you to have this time to consider whether or not you wanted to
take part?
4. I’m not sure if you remember but at the beginning of the trial you were told you had a 50/50 
chance of receiving the information about alcohol use or treatment as usual. How did you 
feel about that?
Prompts:
Did it have any influence on your decision to take part?
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5. How did you feel about being asked some quesons while you were in hospital recovering 
from your surgery? 
6. How did you feel about being followed up at six weeks post-surgery and six aer joining the 
trial? 
Acceptability Quesons 
8. How did you feel being asked about alcohol use by a nurse?
Prompts:
Are you generally comfortable talking about your alcohol use? 
Are you more/less comfortable talking to a nurse?
Feasibility Quesons 
1. How did you find the quesons and discussion about alcohol fit in with your care? 
Prompts:
Do you think it influenced the rest of your care?
If so was this in a good way or a bad way?
2. How did you find compleng the different study quesonnaires fit in with your care?
Prompts:
Do you think it influenced the rest of your care?
If so was this in a good way or a bad way?
3. You’ll noce the term standard drink is used quite a bit in the materials. Did you understand 
that term? 
Prompts:
Somemes people use the term units or units instead of standard drink. Would you 
have preferred that?
1. We used the term risky drinking in the intervenon materials, could you tell me what you 
thought of this term? 
Prompts:
What did you think was meant by the term risky drinking?
Somemes the terms hazardous or harmful drinking are also used. Would you have
preferred this?
How would you feel if those terms were used to describe your drinking behaviour?
4. Is there anything you think we should know about talking to people your age about alcohol 
use?
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Closing Quesons 
1. Is there anything that you think we should have talked about today that we haven’t?
2. Is there anything you would like to add before we finish?
To Close the Interview 
Turn off the recorder. 
Thank the parcipant for giving up their me to take part and for providing useful insight.
Remind that data will be used to inform future research and may be used in publicaons but will be
transcribed and anonymised so that they won’t be idenfiable. 
Ask if they have any quesons.
5. What about talking to paents about alcohol use?
6. We have noced that a lot more men than women have agreed to take part in the trial. Can 
you think of any reasons why that might be the case? 
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Pre-op BIRDS pilot RCT Patient Interview Topic Guide – Intervenon Condion
Ensure have completed consent form, discussed recording interview and anonymizaon of data.
Check parcipant is happy to start the interview and inform you will turn the audio recorder on. 
Check we have access to age, gender and AUDIT scores. 
Introducon Quesons 
Could you tell me what led to you coming in to hospital for surgery in the first place?
Before you came into hospital did you expect to be asked about alcohol use?
Prompts:
Why?
Before you became involved in the research would you have linked alcohol to surgery in any way?
Would you mind telling me about your alcohol consumpon before you took part in the trial? 
Change Quesons 
And did you feel that your alcohol use changed at all over the course of the research? 
Prompts:
Would you say that’s because of the surgery itself or the informaon you received?
Were there specific aspects of the informaon and advice that movated you to change your
drinking? 
Do you remember if you set any specific goals in terms of the change you wanted to achieve?
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Experience of the Trial 
Could you tell me what movated you to take part in the trial? 
I’d like to know about the process of the trial, could you start by talking me through step by step 
what the study involved?
Prompts:
Who did you speak to about the trial? 
Did you feel comfortable with all parts of the process?
Where there any parts that were unclear? 
What parts of the process could be improved? 
At the beginning of the trial you may remember that you were contacted about the trial and then 
given me to think about your involvement before coming back to be consented into the trial. Was it
important to you to have this me to consider whether or not you wanted to take part? 
I’m not sure if you remember but at the beginning of the trial you were told you had a 50/50 chance 
of receiving the informaon about alcohol use or treatment as usual. How did you feel about that?
Prompts:
Did it have any influence on your decision to take part?
Were you offered an oponal second session of advice about 1-2 weeks before surgery? 
 Prompts:
Did you take part in this session? 
Why?
Did you choose to have the session delivered over the phone or face to face?
Was the session useful? 
How did you feel about being asked some quesons while you were in hospital recovering from your
surgery? 
How did you feel about being followed up at six weeks post-surgery and six aer joining the trial? 
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Acceptability Quesons 
How did you feel being asked about alcohol use by a nurse?
Prompts:
Are you generally comfortable talking about your alcohol use? 
Are you more/less comfortable talking to a nurse?
We used the pre-operave assessment as an opportunity to talk to you about your alcohol use. How 
did you feel about that?
Thinking about the information and advice that you received from the nurse. How did you feel about 
that?
Prompts:
Was it about the right amount of informaon? 
Did you understand it all?
Feasibility Quesons 
How did you find the quesons and discussion about alcohol fit in with your care? 
Prompts:
Do you think it influenced the rest of your care?
If so was this in a good way or a bad way?
How did you find compleng the different study quesonnaires fit in with your care?
Prompts:
Do you think it influenced the rest of your care?
If so was this in a good way or a bad way?
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Intervenon Materials 
You’ll noce the term standard drink is used quite a bit in the materials. Did you understand that 
term? 
Prompts:
Somemes people use the term units or units instead of standard drink. Would you have preferred 
that?
We used the term risky drinking in the intervenon materials, could you tell me what you thought of
this term? 
Prompts:
What did you think was meant by the term risky drinking?
Somemes the terms hazardous or harmful drinking are also used. Would you have preferred this? 
How would you feel if those terms were used to describe your drinking behaviour?
Is there anything you think we should know about talking to people your age about alcohol use? 
What about talking to paents about alcohol use?
We have noced that a lot more men than women have agreed to take part in the trial. Can you 
think of any reasons why that might be the case? 
Closing Quesons 
Is there anything that you think we should have talked about today that we haven’t?
Is there anything you would like to add before we finish?
To Close the Interview 
Turn off the recorder. 
Thank the parcipant for giving up their me to take part and for providing useful insight.
Remind that data will be used to inform future research and may be used in publicaons but will be
transcribed and anonymised so that they won’t be idenfiable. 
Ask if they have any quesons.
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